Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3008152	ab-ahco3	mmol/l (mmol/l)	18889	99656	0.00%
3008152	ab-shco3	mmol/l (mmol/l)	11088	51255	0.00%
3008152	ab-aktuaalibikarbonaatti	mmol/l (mmol/l)	4290	14350	0.00%
3008152	ab-ahco3	— (—)	2306	9723	100.00%	Distribution not available
3008152	ab-hco3	mmol/l (mmol/l)	1913	4774	0.00%
3008152	ab-hco3	mmol/L (mmol/l)	539	1211	0.00%
3008152	ab-ahco3	mmol/L (mmol/l)	486	1066	0.00%
3008152	ab-ahco3	MMOL/L (mmol/l)	421	1434	0.00%
3008152	ab-shco3	— (—)	193	252	100.00%	Distribution not available
3008152	ab-hco3	— (—)	153	206	100.00%	Distribution not available
3008152	abhco3pika	mmol/l (mmol/l)	20	20	0.00%
3008152	ab-chco3	mmol/l (mmol/l)	10	10	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Non-allergic asthma (mode), excluding more controls

1135

3317

3.69

323.31

7.9

5.2

24.84

24.12

mmol/l

8.10

1097

3162

Poisoning by drugs, medicaments and biological substances

1435

4892

3.19

323.31

8.3

6.9

24.58

24.39

mmol/l

0.99

1388

4669

Dorsalgia

4997

14412

1.90

323.31

6.8

7.0

24.56

24.37

mmol/l

2.71

4818

13766

Codes for special purposes

3184

15474

2.16

323.01

7.8

6.6

24.46

24.44

mmol/l

0.12

3086

14799

Provisional assignment of new diseases of uncertain etiology

3179

15464

2.16

321.89

7.8

6.6

24.46

24.44

mmol/l

0.11

3082

14791

Pulmonary heart disease, diseases of pulmonary circulation

2271

9842

2.52

319.52

8.5

6.6

24.81

24.50

mmol/l

3.26

2190

9425

ILD medications

5794

17902

1.80

318.26

7.5

6.6

24.59

24.41

mmol/l

2.68

5556

17122

Cerebrovascular diseases

4415

16568

1.95

315.31

8.7

6.7

24.59

24.55

mmol/l

0.31

4243

15897

Other diseases of the respiratory system

1642

6184

2.98

314.29

13.3

6.2

26.82

24.26

mmol/l

81.05

1590

5916

Other respiratory disorders and diseases

1642

6184

2.98

314.29

13.3

6.2

26.82

24.26

mmol/l

81.05

1590

5916

Sciatica+with lumbago

2916

12254

2.22

314.10

7.2

7.1

24.64

24.44

mmol/l

2.35

2822

11706

Type 2 diabetes, definitions combined

4876

15604

1.89

313.41

7.9

6.4

24.41

24.69

mmol/l

4.55

4705

14921

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4006

18582

1.98

312.54

7.6

6.8

24.92

24.48

mmol/l

10.63

3846

17823

Headache

3302

12559

2.12

311.32

7.1

6.3

24.56

24.47

mmol/l

0.68

3185

11997

Type 2 diabetes, strict (exclude DM1)

4892

15710

1.88

311.02

7.9

6.4

24.41

24.69

mmol/l

4.71

4721

15023

Mental and behavioural disorders due to psychoactive substance use

3444

16034

2.07

310.67

9.2

6.9

24.45

24.44

mmol/l

0.07

3348

15323

Other dorsopathies, not elsewhere classified

5027

14418

1.87

309.16

7.0

24.60

24.37

mmol/l

3.75

4824

13772

Opioids

4724

13205

1.91

308.10

7.4

6.6

24.55

24.37

mmol/l

2.37

4544

12596

Condition for Implicit Sepsis (Organ dysfunction codes)

6007

15684

2.86

307.65

10.0

5.6

24.46

24.58

mmol/l

1.23

5786

15000

Bacterial Sepsis

4206

11328

3.45

307.65

11.6

5.7

24.48

24.55

mmol/l

0.41

4042

10853

Care involving use of rehabilitation procedures

4293

16349

2.53

307.65

8.3

6.5

24.69

24.49

mmol/l

2.49

4043

15706

Metabolic disorders

5642

15750

2.27

307.65

8.5

6.4

24.39

24.63

mmol/l

4.08

5430

15037

General symptoms and signs

5759

13974

2.16

307.65

7.8

6.4

24.47

24.46

mmol/l

0.04

5534

13342

Pneumonias (Asthma/COPD co-morbidities)

6919

17098

2.84

307.65

9.5

5.8

24.90

24.32

mmol/l

24.13

6631

16363

Dyspnoea

6855

18174

2.96

307.65

7.6

6.6

24.74

24.42

mmol/l

8.90

6668

17333

Myocardial infarction

3194

8706

2.78

307.65

8.6

6.3

24.22

24.71

mmol/l

9.23

3071

8345

Angina pectoris

3936

9554

2.99

307.65

8.3

6.3

24.56

24.73

mmol/l

1.83

3775

9152

Renal failure

3341

13673

2.24

307.65

11.3

6.3

23.05

24.76

mmol/l

73.72

3210

13114

Asthma-related infections

3993

16289

2.56

307.65

8.3

6.5

25.06

24.38

mmol/l

21.88

3843

15592

Heart failure,strict

4179

9850

3.30

307.65

9.9

6.1

24.72

24.48

mmol/l

2.55

4058

9423

Cardiac arrhythmias

3048

5786

3.58

307.65

7.6

5.2

24.45

24.69

mmol/l

2.47

2915

5492

Anaemias

1203

815

10.25

307.65

10.0

3.9

24.11

24.26

mmol/l

0.45

1157

773

Other CVD (FINNGEN)

762

1050

6.22

307.65

8.8

5.4

24.43

24.71

mmol/l

0.87

738

992

Presence of cardiac and vascular implants and grafts

3332

10710

2.50

307.65

9.8

6.3

24.36

24.59

mmol/l

2.75

3188

10278

Hard cardiovascular diseases

5559

11593

3.07

307.65

8.5

6.2

24.56

24.72

mmol/l

2.22

5344

11085

COPD/asthma/ILD related infections

5177

12978

2.08

307.65

8.2

5.8

24.74

24.29

mmol/l

11.99

4954

12403

STROKE

3386

7425

3.31

307.65

9.3

5.5

24.56

24.82

mmol/l

3.22

3250

7108

Other bacterial diseases

6464

17523

2.62

307.65

9.3

6.1

24.51

24.57

mmol/l

0.57

6196

16777

Abnormalities of breathing

5824

11975

2.97

307.65

7.3

6.7

24.67

24.34

mmol/l

7.32

5640

11405

General examination and investigation of persons without complaint and reported diagnosis

3481

8535

2.22

307.65

9.0

6.2

24.67

24.42

mmol/l

2.96

3402

8102

Hypertensive diseases

4074

9783

2.47

307.65

7.7

6.5

24.46

24.58

mmol/l

1.06

3927

9312

Influenza and pneumonia

7097

16549

2.83

307.65

9.2

5.8

24.87

24.31

mmol/l

23.36

6796

15844

Hypothyroidism and >3 levothyroxin purchases

860

842

5.98

307.65

8.3

4.0

24.30

24.26

mmol/l

0.10

822

795

Renal tubulo-interstitial diseases

5486

18299

2.33

307.65

9.5

6.2

23.86

24.72

mmol/l

37.57

5284

17527

Erysipelas

3565

14346

2.28

307.65

8.6

6.1

24.77

24.59

mmol/l

1.84

3454

13758

Chronic lower respiratory diseases

6540

18409

1.95

307.65

7.5

6.6

24.90

24.30

mmol/l

27.11

6285

17613

Other chronic obstructive pulmonary disease

2913

11057

2.32

307.65

9.0

6.7

25.64

24.31

mmol/l

48.79

2817

10593

Other medical care

3532

12606

2.55

307.65

8.1

6.5

24.73

24.50

mmol/l

2.52

3397

12117

Septicaemia

3602

11389

3.22

307.65

11.4

6.2

24.26

24.52

mmol/l

2.76

3467

10923

First line medication for Crohn's disease

5865

16759

1.96

307.65

7.7

6.5

24.58

24.39

mmol/l

2.90

5619

16034

Bacterial infection, other or unspecified

3546

13361

2.40

307.65

9.0

6.1

24.41

24.58

mmol/l

1.41

3368

12811

Cardiovascular diseases (excluding rheumatic etc)

2966

4541

3.94

307.65

7.7

5.3

24.37

24.32

mmol/l

0.30

2851

4292

Heart failure and bmi 25plus

2598

7180

2.66

307.65

10.1

6.3

24.86

24.53

mmol/l

3.05

2510

6841

Type 2 diabetes

5205

15893

1.98

307.65

8.1

6.4

24.32

24.68

mmol/l

7.61

5020

15198

Ischaemic heart disease, wide definition

5001

12948

2.56

307.65

8.2

6.6

24.47

24.76

mmol/l

5.51

4829

12414

Asthma (only as main-diagnosis), excluding more controls

3865

7509

3.02

307.65

7.5

5.4

24.88

24.17

mmol/l

22.34

3717

7163

Ischemic heart diseases

5522

12167

2.92

307.65

8.2

6.4

24.54

24.72

mmol/l

2.67

5321

11637

Other bacterial diseases, including avohilmo

6543

17093

2.54

307.65

9.1

6.0

24.58

24.53

mmol/l

0.42

6275

16351

Asthma, excluding more controls

4266

7509

3.10

307.65

7.6

5.4

24.88

24.17

mmol/l

23.27

4102

7163

Cerebrovascular diseases (FINNGEN)

2053

2687

5.93

307.65

10.3

5.4

24.63

24.71

mmol/l

0.35

1976

2545

Explicit Sepsis, including avohilmo

3755

11296

3.36

307.65

11.5

5.6

24.26

24.53

mmol/l

3.21

3618

10810

Bleeding

5269

17780

2.20

307.65

9.5

6.3

24.47

24.58

mmol/l

1.19

5081

17019

Viral Sepsis

1827

5424

3.85

307.65

11.2

5.5

24.64

24.53

mmol/l

0.48

1751

5184

Implicit viral Sepsis, including avohilmo

2332

8123

3.17

307.65

10.6

5.5

24.59

24.51

mmol/l

0.37

2241

7769

Asthma, hospital admissions 3, pneumonia

2905

10613

3.02

307.65

9.1

6.3

25.25

24.38

mmol/l

24.41

2801

10141

Other septicaemia, including avohilmo

3317

10707

3.26

307.65

11.7

6.1

24.23

24.52

mmol/l

3.21

3197

10270

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4023

17564

2.41

307.65

9.8

6.3

24.62

24.51

mmol/l

1.07

3861

16829

Excluding asthma or asthma-COPD overlap

3767

8720

2.25

307.65

7.7

5.6

24.67

24.12

mmol/l

12.40

3593

8339

Spondylopathies

4322

13283

2.01

307.65

6.9

7.0

24.81

24.44

mmol/l

8.24

4157

12692

Non-rheumatic valve diseases

3122

8149

2.97

307.65

9.5

6.1

24.44

24.61

mmol/l

1.68

3013

7770

Other neurological diseases

4434

17787

2.04

307.65

7.6

6.8

24.54

mmol/l

0.05

4261

17056

Bacterial pneumoniae

3521

9413

3.69

307.65

10.3

5.9

24.99

24.26

mmol/l

17.38

3342

9027

Lower back pain or/and sciatica

5799

20595

1.82

307.65

7.0

6.9

24.65

24.47

mmol/l

3.29

5602

19681

Depression medications

992

877

5.93

307.65

7.3

4.0

24.50

24.30

mmol/l

0.64

953

827

2616

11360

2.43

307.65

8.3

6.6

25.07

24.37

mmol/l

17.23

2527

10863

Other diseases of pleura

3251

12777

2.40

307.65

10.6

6.4

25.78

24.29

mmol/l

66.96

3143

12231

Diabetes mellitus

5385

16235

1.99

307.65

8.2

6.3

24.25

24.67

mmol/l

9.87

5192

15520

Heart failure, not strict

5783

12978

3.32

307.65

9.6

6.1

24.68

24.52

mmol/l

1.73

5588

12427

Asthma, hospital admission 2, infections

3993

16289

2.56

307.65

8.3

6.5

25.06

24.38

mmol/l

21.88

3843

15592

Valvular heart disease excluding rheumatic fever

3139

8179

2.98

307.65

9.7

6.1

24.44

24.61

mmol/l

1.69

3030

7799

Non-ischemic cardiomyopathy

2005

5877

2.95

307.65

8.8

5.9

25.33

24.55

mmol/l

10.32

1937

5604

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

5255

17740

1.95

307.65

9.2

6.1

24.34

24.56

mmol/l

3.63

5044

16989

Asthma

4490

8649

2.84

307.65

7.6

5.6

24.88

24.12

mmol/l

27.44

4315

8272

All pneumoniae

6963

17060

2.85

307.65

9.4

5.9

24.91

24.31

mmol/l

25.71

6668

16331

Any reimbursement code in KELA

2370

3823

3.24

307.65

7.4

5.6

24.31

24.40

mmol/l

0.47

2272

3640

Asthma (only as main-diagnosis)

4062

8649

2.78

307.65

7.4

5.6

24.89

24.12

mmol/l

27.22

3908

8272

Pure hypercholesterolaemia

4362

14220

2.05

307.65

7.1

6.4

24.41

24.69

mmol/l

4.44

4194

13607

Complications of medical and surgical care

5068

19465

2.51

307.65

9.6

6.3

24.63

24.50

mmol/l

1.52

4868

18655

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1917

3430

3.71

307.65

7.9

5.5

24.67

24.53

mmol/l

0.80

1843

3239

All influenza

1851

6257

3.26

307.65

8.2

5.9

24.89

24.22

mmol/l

10.36

1763

6009

Other heart diseases

2745

3718

5.19

307.65

9.3

5.4

24.52

24.51

mmol/l

0.04

2638

3510

Nerve, nerve root and plexus disorders

5798

19818

1.83

307.65

7.2

6.8

24.57

24.50

mmol/l

0.75

5559

18980

Other disorders of fluid, electrolyte and acid-base balance

2487

8564

3.03

307.65

10.6

6.4

24.22

24.62

mmol/l

3.63

2406

8187

Implicit Sepsis, including avohilmo

5968

15800

2.92

307.65

10.1

5.6

24.48

24.57

mmol/l

0.75

5747

15122

Bacterial pneumonia (organism specified)

3706

11847

3.15

307.65

10.2

6.1

24.94

24.32

mmol/l

14.09

3523

11354

Asthma-related pneumonia or sepsis

2905

10613

3.02

307.65

9.1

6.3

25.25

24.38

mmol/l

24.41

2801

10141

Paroxysmal tachycardia

1057

2164

4.34

307.65

6.9

5.3

24.17

24.61

mmol/l

2.80

1019

2049

Other septicaemia

3240

10539

3.25

307.65

11.7

6.1

24.23

24.52

mmol/l

3.15

3121

10106

ILD differential diagnosis

3724

8738

2.22

307.65

7.7

5.6

24.67

24.13

mmol/l

12.25

3552

8356

Persons encountering health services for specific procedures and health care

6112

17762

2.13

307.65

8.4

6.4

24.55

24.46

mmol/l

0.99

5809

17057

All kidney diseases

5713

18573

2.17

307.65

9.1

6.2

24.04

24.71

mmol/l

25.85

5500

17768

Diabetes, insulin treatment (Kela reimbursement)

5479

17840

1.90

307.65

8.2

6.5

24.22

24.70

mmol/l

12.80

5270

17070

Early onset COPD, excluding more controls

1370

4245

3.56

307.65

9.9

5.8

25.89

24.10

mmol/l

40.00

1328

4067

COPD/asthma related infections

5177

12978

2.08

307.65

8.2

5.8

24.74

24.29

mmol/l

11.99

4954

12403

Malaise and fatigue

3188

10968

2.43

307.65

7.4

6.5

24.67

24.47

mmol/l

2.09

3079

10495

COPD (mode)

2275

5741

3.42

307.65

9.2

5.6

25.71

24.11

mmol/l

50.28

2202

5510

Implicit bacterial Sepsis

3824

10432

3.56

307.65

12.0

5.6

24.49

24.55

mmol/l

0.32

3679

9993

Intracranial trauma

3102

8096

2.73

307.65

8.2

5.9

24.65

24.22

mmol/l

6.87

3004

7699

COPD differential diagnosis

3726

8742

2.22

307.65

7.7

5.6

24.67

24.13

mmol/l

12.28

3554

8360

6086

12978

2.94

307.65

9.4

5.8

24.91

24.29

mmol/l

23.23

5831

12403

Any death

4143

13673

2.28

307.65

10.7

6.2

24.67

24.56

mmol/l

0.75

3944

13157

Respiratory insufficiency

780

1677

5.54

307.65

11.4

5.3

28.03

23.86

mmol/l

88.48

757

1601

Asthma, unspecified (mode), excluding more controls

3200

7215

3.41

307.65

7.5

5.4

25.02

24.18

mmol/l

25.43

3073

6891

Acute tubulo-interstitial nephritis

3714

15266

2.17

307.65

7.9

6.1

24.34

24.70

mmol/l

6.05

3576

14610

All chronic kidney diseases

3405

13052

2.21

307.65

9.1

6.2

23.41

24.76

mmol/l

57.05

3268

12503

Diseases of arteries, arterioles and capillaries

4143

15904

2.02

307.65

9.5

6.4

24.31

24.61

mmol/l

4.87

3997

15236

Antihypertensive medication - note that there are other indications

2339

4641

2.73

307.65

7.2

5.3

24.26

24.39

mmol/l

0.75

2241

4385

Low back pain

4166

14189

2.07

307.65

7.1

7.0

24.69

24.38

mmol/l

5.84

4023

13551

Other heart diseases, wide

5177

12700

2.61

307.65

8.5

6.1

24.55

24.53

mmol/l

0.14

4975

12102

Asthma/COPD (KELA code 203)

5359

18395

2.03

307.65

7.2

6.6

24.97

24.30

mmol/l

29.44

5140

17599

Unstable angina pectoris

2548

7556

2.90

307.65

8.2

6.1

24.50

24.69

mmol/l

1.56

2442

7222

Fever of other and unknown origin

3691

12485

2.74

307.65

9.0

6.5

24.50

24.45

mmol/l

0.36

3566

11939

Coronary revascularization (ANGIO or CABG)

5646

11905

3.14

307.65

8.2

6.3

24.53

24.73

mmol/l

3.18

5440

11396

Complications of procedures, not elsewhere classified

5186

19049

2.33

307.65

9.9

6.1

24.64

24.50

mmol/l

1.63

4995

18222

Other arrhythmias

3178

11177

2.22

307.65

6.4

6.0

24.42

24.55

mmol/l

1.20

3047

10651

Asthma, unspecified (mode)

3334

8321

3.09

307.65

7.4

5.5

25.00

24.13

mmol/l

28.19

3199

7968

Myocardial infarction, strict

2913

8276

2.70

307.65

8.1

6.3

24.24

24.69

mmol/l

7.39

2795

7930

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

6854

17224

2.85

307.65

9.5

5.9

24.89

24.33

mmol/l

22.49

6570

16488

Diabetes medication

5440

17578

1.88

307.65

8.0

6.5

24.24

24.65

mmol/l

9.87

5232

16819

Asthma-related pneumonia

2901

10593

3.02

307.65

9.1

6.3

25.25

24.38

mmol/l

24.39

2797

10122

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3627

17268

2.23

307.65

9.8

6.5

24.64

24.52

mmol/l

1.05

3484

16542

Diabetes, varying definitions

5353

16251

1.99

307.65

8.1

6.3

24.25

24.67

mmol/l

9.87

5160

15534

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1535

4945

3.29

307.65

8.5

6.3

24.58

24.28

mmol/l

2.21

1474

4713

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5149

15676

2.04

307.65

8.3

6.3

24.23

24.71

mmol/l

12.09

4957

14983

Implicit Sepsis

5832

15308

3.07

307.65

10.4

5.6

24.52

24.57

mmol/l

0.35

5612

14661

Hypertensive diseases (excluding secondary)

2642

3686

4.45

307.65

7.7

5.6

24.40

24.52

mmol/l

0.67

2552

3483

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

5563

19732

1.99

307.65

8.7

6.4

24.37

24.56

mmol/l

2.88

5327

18909

Bacterial pneumonia, not elsewhere classified

3375

8954

3.73

307.65

10.3

5.9

25.00

24.25

mmol/l

17.68

3203

8586

Implicit bacterial Sepsis, including avohilmo

4105

11089

3.47

307.65

11.7

5.7

24.50

24.55

mmol/l

0.27

3951

10625

Substance abuse, excluding more controls

3355

12557

2.37

307.65

9.3

6.8

24.46

24.37

mmol/l

0.58

3262

11970

Pacemaker

2740

11379

2.45

307.65

9.4

6.4

24.36

24.52

mmol/l

1.31

2633

10892

Pain in throat and chest

4764

11855

2.50

307.65

6.8

24.62

24.35

mmol/l

4.90

4561

11292

Any gastric operation

3630

8223

2.30

307.65

7.6

5.0

24.31

24.57

mmol/l

3.20

3480

7840

Asthma (mode)

4242

8738

2.69

307.65

7.5

5.6

24.79

24.13

mmol/l

21.58

4081

8356

Hypertension

4072

9783

2.47

307.65

7.7

6.5

24.46

24.58

mmol/l

1.07

3925

9312

Major coronary heart disease event excluding revascularizations

4036

10454

2.76

307.65

8.3

6.3

24.35

24.74

mmol/l

7.49

3881

10007

Coronary atherosclerosis

4305

10311

2.86

307.65

8.3

6.3

24.43

24.73

mmol/l

4.94

4160

9873

Insulin medication

3743

14499

2.28

307.65

8.8

6.6

23.91

24.68

mmol/l

20.69

3595

13885

Asthma (diagnoses ohter than nonallergic)

5085

20945

2.06

307.65

7.4

6.7

24.94

24.39

mmol/l

19.23

4890

20053

Implicit viral Sepsis

1826

5416

3.86

307.65

11.2

5.5

24.64

24.53

mmol/l

0.47

1750

5176

Covid-19 confirmed case

2768

11329

2.67

307.65

8.1

6.5

24.53

24.42

mmol/l

0.72

2696

10813

Symptoms and signs involving the circulatory and respiratory systems

5111

11991

2.23

307.65

6.9

6.8

24.50

24.34

mmol/l

1.99

4909

11420

Other intervertebral disc disorders

4791

13850

2.17

307.65

7.0

24.63

24.41

mmol/l

3.72

4575

13229

COPD

3052

11384

2.35

307.65

8.9

6.7

25.55

24.31

mmol/l

44.24

2950

10908

Valvular operations

1103

3197

3.93

307.65

13.3

5.9

24.38

24.42

mmol/l

0.13

1060

3044

Pneumonia, organism unspecified

6119

16059

2.80

307.65

9.4

5.9

24.94

24.33

mmol/l

24.04

5890

15381

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6086

12978

2.94

307.65

9.4

5.8

24.91

24.29

mmol/l

23.23

5831

12403

Symptoms and signs involving cognition, perception, emotional state and behaviour

5328

19333

1.92

307.65

7.5

6.8

24.54

24.50

mmol/l

0.30

5133

18500

Complications of surgical and medical care, not elsewhere classified

6401

19527

2.32

307.65

9.4

6.1

24.59

24.49

mmol/l

1.24

6166

18676

Heart failure and coronary heart disease

3480

7827

3.51

307.65

9.8

6.2

24.42

24.69

mmol/l

2.87

3373

7491

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

799

1054

6.02

307.65

8.5

6.4

24.95

24.63

mmol/l

1.08

775

999

ILD medications: prednisolone, methylprednisolone, prednisone

5798

17758

1.88

307.65

7.5

6.6

24.64

24.42

mmol/l

4.02

5565

16983

Explicit Sepsis

3678

11159

3.34

307.65

11.5

5.6

24.25

24.53

mmol/l

3.27

3543

10681

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

5927

15673

2.73

307.65

9.8

5.6

24.49

24.56

mmol/l

0.56

5700

14986

Heart failure and antihypertensive medication

1958

2452

5.92

307.65

11.1

5.8

24.80

24.88

mmol/l

0.27

1900

2328

Inflammatory bowel disease treatment related agents

6184

18575

1.92

307.65

7.2

6.7

24.69

24.40

mmol/l

6.68

5939

17772

Oxycodone

2869

9788

2.73

307.65

8.5

6.6

24.99

24.41

mmol/l

12.33

2756

9365

GASTRO-related operations

3630

8223

2.30

307.65

7.6

5.0

24.31

24.57

mmol/l

3.20

3480

7840

Non-invasive ventilation

5467

1994

37.55

307.65

8.8

4.4

24.93

24.59

mmol/l

3.86

5119

1912

Other pulmonary diagnosis

3794

8720

2.27

307.65

7.7

5.6

24.69

24.12

mmol/l

13.63

3622

8339

Disorders of lipoprotein metabolism and other lipidaemias

4578

14750

1.97

307.65

7.4

6.4

24.41

24.68

mmol/l

4.46

4408

14096

Concussion

2595

8048

2.63

307.65

7.2

5.9

24.60

24.23

mmol/l

4.94

2510

7654

Diseases of arteries, arterioles and capillaries (FINNGEN)

1588

2050

5.95

307.65

10.5

5.5

24.34

24.76

mmol/l

3.00

1539

1947

Insulin, combination of fast acting with intermediate-acting or long-acting

3755

17529

2.05

307.65

8.8

6.7

23.92

24.59

mmol/l

16.72

3606

16790

Asthma, including avohilmo

6229

19843

1.79

307.65

7.2

6.8

24.84

24.38

mmol/l

16.55

5983

18994

All-cause Heart Failure

4528

12313

2.82

307.65

9.7

6.4

24.72

24.49

mmol/l

2.69

4382

11786

Cardiovascular diseases

2509

3915

3.56

307.65

7.5

5.2

24.31

24.23

mmol/l

0.39

2412

3693

Bacterial infection, other or unspecified, including avohilmo

3887

13976

2.44

307.65

8.8

6.1

24.44

24.57

mmol/l

1.13

3697

13398

Atrial fibrillation and flutter

1867

2513

5.24

307.65

9.2

5.4

24.50

24.77

mmol/l

1.73

1788

2384

Erysipelas, including avohilmo

4555

15594

2.29

307.65

8.4

6.1

24.75

24.58

mmol/l

2.03

4406

14922

Percutaneous Coronary Intervention

5676

11902

3.17

307.65

8.3

6.3

24.54

24.73

mmol/l

2.95

5469

11393

Major coronary heart disease event

5818

12887

2.93

307.65

8.2

6.3

24.51

24.74

mmol/l

4.26

5603

12326

Atrial fibrillation and flutter with reimbursement

1583

2045

5.38

307.65

8.1

5.4

24.61

24.81

mmol/l

0.95

1534

1944

Insulin, intermediate and long-acting

3461

16552

2.15

307.65

8.8

6.7

23.91

24.60

mmol/l

15.54

3326

15851

Hypothyroidism (congenital or acquired)

870

843

6.04

307.65

8.6

4.0

24.28

24.26

mmol/l

0.05

832

796

Infections, IBD-co-morbidities

967

1335

5.57

307.65

10.6

6.1

24.11

24.62

mmol/l

2.55

927

1265

Parasetamol

3543

7025

2.66

307.65

7.4

6.4

24.47

24.35

mmol/l

0.90

3402

6645

Type 2 diabetes, wide definition

4770

14352

2.22

307.65

8.2

6.4

24.27

24.73

mmol/l

9.77

4593

13732

Tramadol

4223

12568

2.11

307.65

7.6

6.6

24.65

24.41

mmol/l

3.61

4089

11990

Heart failure, strict

4585

12483

2.82

307.65

9.7

6.4

24.71

24.49

mmol/l

2.38

4440

11950

Codeine

4672

13105

2.00

307.65

7.4

6.6

24.59

24.37

mmol/l

3.16

4490

12500

Hypertension, essential

4122

9677

2.54

307.65

7.8

6.5

24.45

24.59

mmol/l

1.32

3979

9206

Emergency coronary revascularization (for ACS)

6173

13662

2.97

307.65

8.1

6.3

24.50

24.69

mmol/l

3.09

5945

13071

Oral corticosteroids

6206

18301

2.08

307.65

7.3

6.7

24.76

24.41

mmol/l

9.36

5962

17511

Hypothyroidism, levothyroxine purchases

860

842

5.98

307.65

8.3

4.0

24.30

24.26

mmol/l

0.10

822

795

Substance abuse

3355

15797

2.08

306.07

9.3

6.9

24.46

24.44

mmol/l

0.13

3262

15093

Poisoning by medicine

1304

4351

3.26

305.33

8.5

7.0

24.56

24.38

mmol/l

0.91

1262

4151

Spinal stenosis

3148

11348

2.17

304.86

7.1

7.0

24.80

24.45

mmol/l

5.68

3035

10866

Asthma, hospital admissions , main diagnosis only

4377

20971

1.89

304.29

7.3

6.7

24.88

24.42

mmol/l

12.45

4209

20070

Lumbar disc prolapse

3477

13050

2.07

302.34

6.9

7.2

24.56

24.44

mmol/l

1.18

3324

12465

Hernia of abdominal wall, postoperative

1215

3900

3.38

300.09

11.0

5.4

24.65

24.69

mmol/l

0.12

1171

3721

Endocrine, nutritional and metabolic diseases

3487

8679

2.10

293.37

7.7

5.9

24.30

24.60

mmol/l

3.81

3348

8258

Coronary artery bypass grafting

1723

4911

2.85

292.21

10.6

6.1

24.30

24.62

mmol/l

2.68

1655

4699

Acute renal failure

1747

7037

2.76

291.60

14.1

6.3

22.87

24.72

mmol/l

40.56

1692

6742

Type 2 diabetes, definitions combined, including avohilmo

4788

15499

1.85

289.94

7.8

6.4

24.43

24.69

mmol/l

3.96

4617

14820

Other postsurgical states

648

1428

5.59

286.97

10.7

6.1

24.56

24.58

mmol/l

0.04

640

1359

Other special examinations and investigations of persons without complaint or reported diagnosis

3413

8562

2.10

286.32

7.3

6.2

24.42

mmol/l

0.02

3260

8127

Pulmonary embolism

2049

8912

2.51

285.84

8.4

6.6

24.72

24.49

mmol/l

1.98

1971

8536

Pulmonary heart disease

2049

8975

2.49

281.26

8.4

6.7

24.72

24.50

mmol/l

1.81

1971

8601

Other (not insulin) diabetes medications

5037

17050

1.80

277.40

7.6

6.5

24.36

24.67

mmol/l

5.80

4845

16315

Non-allergic asthma (mode)

1135

3656

3.33

276.37

7.9

5.5

24.84

24.05

mmol/l

9.47

1097

3496

Hypo-osmolality and hyponatraemia

1345

4830

3.08

275.90

11.0

6.3

24.40

24.72

mmol/l

2.00

1302

4618

Mental and behavioural disorders due to alcohol

2972

14292

2.09

275.82

9.1

7.0

24.32

24.42

mmol/l

0.57

2884

13650

Codeine or tramadol medication

5743

18604

1.73

275.19

7.3

6.8

24.59

24.46

mmol/l

1.65

5524

17794

Obesity related asthma

2064

9147

2.42

272.35

8.4

6.9

25.30

24.44

mmol/l

18.67

2006

8756

Haemorrhage from respiratory passages

2065

8053

2.42

268.46

8.8

6.7

24.62

24.38

mmol/l

1.84

1990

7688

Schizophrenia or delusion, excluding more controls

1630

6428

2.67

268.04

8.0

6.5

25.46

24.44

mmol/l

16.32

1564

6126

Other chronic obstructive pulmonary disease, including avohilmo

3378

14702

2.00

267.84

8.8

6.8

25.47

24.37

mmol/l

40.35

3264

14095

3418

15820

1.97

266.89

9.1

6.9

24.27

24.47

mmol/l

1.98

3316

15126

3299

15530

1.99

266.55

9.2

7.0

24.24

24.47

mmol/l

2.31

3200

14849

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3337

13809

2.01

264.87

7.9

6.7

23.99

24.70

mmol/l

16.97

3193

13245

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1535

6022

2.72

262.78

8.5

6.8

24.58

24.33

mmol/l

1.72

1474

5754

Hypothyroidism, drug reimbursement

492

528

6.85

262.48

7.9

3.9

24.41

24.51

mmol/l

0.18

462

499

Myocardial infarction, without ST-elevation

2739

12393

2.14

261.40

8.0

6.7

24.09

24.57

mmol/l

8.20

2636

11873

Neurological diseases, wide definition

1172

1747

3.51

260.93

8.1

5.8

24.42

24.45

mmol/l

0.07

1124

1644

COPD, hospital admissions

2919

12559

2.09

260.45

8.9

6.7

25.64

24.33

mmol/l

48.38

2822

12041

Hypertensive heart and/or renal disease

1649

4772

2.73

260.23

9.2

6.4

24.67

24.59

mmol/l

0.32

1600

4567

DVT of lower extremities and pulmonary embolism

2663

13248

2.14

259.42

7.9

6.6

24.75

24.49

mmol/l

3.06

2559

12681

COPD, early/later onset

2943

12666

2.09

259.42

9.0

6.7

25.62

24.33

mmol/l

47.37

2847

12142

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1457

2523

3.01

256.67

7.2

6.3

24.29

24.33

mmol/l

0.11

1396

2384

Later onset COPD, excluding more controls

1418

4042

2.94

255.48

8.3

5.4

25.44

24.08

mmol/l

24.40

1373

3867

Diseases of oesophagus, stomach and duodenum

5392

19175

1.72

253.78

8.0

6.6

24.45

24.53

mmol/l

0.81

5177

18356

Neurological diseases

3780

10147

1.93

253.38

7.3

6.3

24.55

24.25

mmol/l

4.60

3622

9664

Viral pneumonia

943

2931

3.60

251.83

9.5

6.0

25.01

24.20

mmol/l

6.50

890

2813

COPD related to multimorbidity

2637

11146

2.15

250.59

9.3

6.6

25.55

24.30

mmol/l

39.29

2550

10684

Any mental disorder

5336

15936

1.73

250.45

7.8

6.5

24.63

24.45

mmol/l

2.56

5149

15213

Certain infectious and parasitic diseases

4523

12875

1.81

250.35

7.8

5.9

24.45

24.53

mmol/l

0.63

4325

12304

Alcohol use disorder, Swedish definition

3121

15017

1.99

250.08

9.3

7.0

24.26

24.46

mmol/l

1.78

3029

14358

Suicide or other Intentional self-harm

1389

5335

2.80

249.80

8.8

6.9

24.70

24.42

mmol/l

1.88

1340

5098

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

973

3098

3.43

247.09

8.7

6.9

24.52

24.37

mmol/l

0.57

943

2957

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2600

12965

2.11

246.38

9.3

7.1

24.31

24.46

mmol/l

0.94

2525

12400

Cardiac arrest

466

693

6.48

244.81

14.1

5.8

23.92

24.55

mmol/l

1.70

447

652

Insulin, fast-acting

2132

10002

2.27

244.25

9.0

6.7

23.93

24.56

mmol/l

8.21

2042

9577

5596

17294

1.69

242.35

7.6

6.4

24.78

24.35

mmol/l

13.02

5384

16532

Syncope and collapse

2515

10351

2.13

242.28

6.3

6.5

24.40

24.47

mmol/l

0.46

2416

9907

Venous thromboembolism

3192

16665

1.94

241.03

7.6

6.7

24.77

24.51

mmol/l

3.34

3061

15975

COPD, hospital admission 2, with asthma infections

2210

9080

2.26

239.14

9.5

6.5

25.78

24.22

mmol/l

49.48

2134

8681

Kela-code for severe mental illness

1964

8989

2.32

238.34

7.8

7.1

25.31

24.43

mmol/l

15.94

1892

8600

Episodal and paroxysmal disorders

5197

15828

1.71

238.00

7.3

6.5

24.62

24.36

mmol/l

4.95

4998

15093

Personality disorders, excluding more controls

1233

4536

2.87

237.45

7.6

6.4

24.89

24.29

mmol/l

5.70

1193

4315

Unspecified mental disorder

2112

9959

2.24

236.92

7.7

7.0

25.24

24.40

mmol/l

15.49

2036

9528

Paralytic ileus and intestinal obstruction

1744

7655

2.46

236.57

10.0

6.3

24.57

24.60

mmol/l

0.09

1671

7323

Conduction disorders

1675

5649

2.53

236.43

7.4

5.9

24.40

24.54

mmol/l

0.71

1614

5378

AV-block

1202

3711

3.02

236.21

8.0

5.9

24.24

24.49

mmol/l

1.30

1150

3528

Epilepsy

1803

7977

2.40

235.99

9.4

6.6

24.72

24.31

mmol/l

4.14

1735

7614

Other soft tissue disorders, not elsewhere classified

4565

15217

1.76

235.16

7.1

6.9

24.63

24.43

mmol/l

2.92

4402

14555

Biguanides

4849

17531

1.73

234.86

7.6

6.6

24.37

24.63

mmol/l

4.10

4651

16781

COPD-related respiratory insufficiency

1000

3392

3.40

234.82

11.9

6.4

26.74

24.20

mmol/l

52.47

973

3244

Alcohol use disorder, ICD-based

2415

12062

2.12

234.23

9.4

7.1

24.31

24.45

mmol/l

0.89

2348

11538

Stroke, including SAH

3646

14677

1.87

233.91

9.0

6.7

24.58

24.56

mmol/l

0.11

3500

14075

Calcific aortic valvular stenosis

2125

9812

2.27

232.86

8.7

6.3

24.40

24.44

mmol/l

0.18

2047

9378

Calcific aortic valvular stenosis, operated

2125

9812

2.27

232.86

8.7

6.3

24.40

24.44

mmol/l

0.18

2047

9378

Calcific aortic valvular stenosis, diagnosis (helper)

2123

9809

2.26

232.23

8.7

6.3

24.40

24.44

mmol/l

0.19

2045

9375

Operations 2 for CAVS

2123

9809

2.26

232.23

8.7

6.3

24.40

24.44

mmol/l

0.19

2045

9375

Hypertensive Heart Disease

1486

4520

2.69

230.99

9.2

6.4

24.93

24.57

mmol/l

2.38

1442

4327

Calcific aortic valvular stenosis, including rheumatic fever

2125

9831

2.26

230.90

8.7

6.3

24.40

24.44

mmol/l

0.17

2047

9397

Diseases of the digestive system

2758

14385

2.01

230.59

9.4

6.5

24.18

24.51

mmol/l

3.91

2671

13756

Intestinal stricture

2020

9534

2.28

230.46

10.3

6.6

24.51

24.53

mmol/l

0.06

1945

9130

Dizziness and giddiness

3924

17619

1.80

228.69

6.7

6.8

24.50

24.51

mmol/l

0.03

3779

16867

Pain in limb

4101

15043

1.79

228.64

7.1

6.9

24.73

24.43

mmol/l

5.61

3964

14390

Abnormal findings on diagnostic imaging of lung

2943

15032

1.96

226.42

7.8

6.9

25.10

24.47

mmol/l

15.70

2823

14420

Symptoms and signs involving the digestive system and abdomen

4876

14615

1.72

226.17

7.5

6.7

24.42

24.51

mmol/l

0.88

4691

13933

Nausea and vomiting

1614

6772

2.48

226.07

8.5

6.1

24.25

24.55

mmol/l

2.16

1560

6461

Abdominal and pelvic pain

4866

14612

1.72

225.96

7.4

6.7

24.47

24.51

mmol/l

0.35

4683

13930

Examination and observation for other reasons

2906

8455

2.01

224.58

8.5

6.2

24.60

24.43

mmol/l

1.61

2848

8029

Alcohol abuse, main dg, excluding more controls

949

3178

3.28

221.93

8.7

6.9

24.45

24.33

mmol/l

0.34

926

3028

Diseases of the respiratory system

2834

7194

2.04

221.90

7.3

5.5

24.61

24.08

mmol/l

9.11

2716

6886

Intestinal infectious diseases

4758

21623

1.69

221.46

8.1

6.6

24.33

24.54

mmol/l

3.19

4578

20689

Sequelae of external causes of morbidity and mortality

1661

7367

2.44

220.88

9.9

6.8

24.77

24.47

mmol/l

2.15

1607

7052

Other antidepressants

5131

16014

1.69

220.60

7.6

6.7

24.68

24.35

mmol/l

7.59

4945

15276

COPD, hospital admissions 3, with asthma pneumonia sepsis

1913

7702

2.31

215.89

9.8

6.4

25.88

24.21

mmol/l

48.42

1849

7359

Insulin, fast-acting or short human

2140

10564

2.15

214.25

9.0

6.8

23.93

24.49

mmol/l

6.53

2050

10109

Other diseases of intestines

4976

17033

1.67

213.23

7.8

6.6

24.33

24.51

mmol/l

2.35

4792

16273

Polyarthropathies

3380

12108

1.86

212.60

7.5

7.0

24.33

24.48

mmol/l

1.29

3241

11584

Osteopathies and chondropathies

3059

15493

1.89

212.06

7.3

6.7

24.75

24.54

mmol/l

2.17

2947

14844

Dorsopathies

4723

14437

1.70

211.70

7.0

24.56

24.37

mmol/l

2.74

4524

13791

Other symptoms and signs involving cognitive functions and awareness

2787

13364

1.95

209.03

7.5

6.8

24.62

24.53

mmol/l

0.54

2681

12795

Other nutritional deficiencies

3268

16995

1.82

205.06

8.2

6.9

24.92

24.44

mmol/l

8.81

3161

16256

Diarrhoea and gastroenteritis of presumed infectious origin

3551

18494

1.78

203.57

8.2

6.5

24.31

24.52

mmol/l

2.56

3418

17681

Mood disorders, excluding more controls

4373

15561

1.70

201.07

8.0

6.5

24.75

24.46

mmol/l

4.92

4235

14853

Convulsions, not elsewhere classified

1253

5012

2.62

200.02

8.9

6.6

24.38

24.34

mmol/l

0.11

1210

4779

Peripheral artery disease

2687

11484

1.96

198.91

8.9

6.3

24.14

24.56

mmol/l

5.71

2583

10994

Other functional intestinal disorders

2507

12082

1.97

198.85

7.3

6.4

24.63

24.55

mmol/l

0.44

2394

11557

Abnormalities of heart beat

1768

8090

2.22

195.92

6.4

6.5

24.36

mmol/l

0.01

1703

7701

Schizophrenia or delusion

1630

7500

2.30

195.10

8.0

7.0

25.46

24.45

mmol/l

16.20

1564

7188

ILD, hospital admission 2, with pulmonary infections

757

2424

3.55

194.33

9.0

5.7

25.05

24.22

mmol/l

6.11

733

2317

Misadventures to patients during surgical and medical care

975

3590

3.00

193.52

12.0

6.1

24.66

24.52

mmol/l

0.59

945

3445

Schizophrenia, schizotypal and delusional disorders

1636

7567

2.29

193.29

8.0

7.0

25.46

24.45

mmol/l

16.11

1569

7254

Bronchitis

5331

20587

1.60

191.82

7.7

6.6

24.80

24.41

mmol/l

10.51

5145

19675

GI-bleeding

2043

10359

2.10

191.37

9.4

6.4

24.10

24.50

mmol/l

4.02

1982

9911

Other headache syndromes

2010

10044

2.08

190.13

6.8

6.5

24.62

24.42

mmol/l

1.86

1944

9594

Injuries to the head

5385

20661

1.59

189.44

7.8

6.7

24.54

24.48

mmol/l

0.43

5223

19729

Obesity

3047

16422

1.81

188.63

8.3

6.8

25.04

24.42

mmol/l

13.14

2946

15714

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1273

5408

2.58

188.46

7.3

7.0

24.62

24.56

mmol/l

0.20

1213

5205

Status post-ami

1498

5037

2.42

187.36

8.3

6.0

24.20

24.62

mmol/l

3.76

1447

4813

Shoulder lesions

3891

13992

1.73

187.33

6.8

7.1

24.61

24.50

mmol/l

1.12

3746

13395

Volume depletion

750

2440

3.47

186.98

10.9

6.1

23.97

24.60

mmol/l

2.88

728

2341

Obesity and other hyperalimentation

3055

16497

1.81

186.84

8.3

6.8

25.04

24.43

mmol/l

13.13

2954

15787

Sequelae with surgical and medical care as external cause

1328

5766

2.51

186.52

9.5

6.8

24.87

24.52

mmol/l

2.45

1288

5520

Deforming dorsopathies

1487

6712

2.35

186.52

7.3

6.8

24.88

24.48

mmol/l

4.15

1432

6424

Allergic asthma (mode), excluding more controls

957

3403

2.87

186.35

7.2

5.4

24.63

24.05

mmol/l

4.77

917

3234

Caries of dentine

1356

5686

2.46

185.75

10.3

6.9

24.47

24.48

mmol/l

0.02

1297

5416

Psychiatric diseases

4556

14135

1.66

184.88

7.6

6.6

24.54

24.47

mmol/l

0.61

4385

13473

Intracranial injury

3107

16786

1.79

184.30

8.1

6.7

24.60

24.46

mmol/l

1.17

3015

16044

Vocal cord dysfunction

598

1432

3.90

184.26

9.0

4.9

25.11

24.82

mmol/l

1.05

562

1354

Malignant neoplasm

4017

14269

1.70

184.10

7.4

6.9

24.62

24.52

mmol/l

0.81

3831

13723

Any event in cancer register

4191

14996

1.68

183.99

7.5

6.8

24.57

24.47

mmol/l

0.98

4000

14405

Other diseases of the digestive system

2018

10343

2.08

183.36

9.4

6.4

24.07

24.49

mmol/l

4.33

1959

9892

Malignant neoplasm, wide definition

4070

14430

1.69

183.06

7.4

6.9

24.59

24.52

mmol/l

0.61

3880

13876

Other acute lower respiratory infections

2856

15455

1.83

182.62

8.3

6.6

25.13

24.37

mmol/l

21.18

2750

14794

Malignant neoplasm, including Hilmo

4061

14409

1.69

182.54

7.4

6.9

24.58

24.52

mmol/l

0.50

3870

13854

Aneurysms, operations, SAH

1088

4363

2.74

182.12

11.3

6.4

24.83

24.55

mmol/l

1.79

1045

4168

Disorders of gallbladder, biliary tract and pancreas

4902

19556

1.61

181.83

7.9

6.7

24.39

24.58

mmol/l

2.79

4720

18728

Malignant neoplasm

4004

14257

1.70

181.77

7.4

6.9

24.61

24.52

mmol/l

0.79

3818

13712

Hernia

4537

19039

1.63

181.41

7.7

6.7

24.56

mmol/l

0.02

4382

18194

Early onset COPD

1370

6102

2.44

180.88

9.9

7.1

25.89

24.31

mmol/l

32.58

1328

5844

malignant neoplasm of female genital organs, including Hilmo

1052

3948

2.77

179.88

6.5

6.0

24.86

24.83

mmol/l

0.08

1014

3778

Stroke, excluding SAH

3345

14256

1.77

179.76

8.4

6.8

24.58

24.55

mmol/l

0.19

3205

13673

Dental caries

1475

6353

2.33

178.90

9.9

6.9

24.48

mmol/l

0.00

1415

6058

ILD, hospital admissions 3, with pneumonia sepsis

676

2140

3.63

177.62

9.5

6.0

25.16

24.09

mmol/l

8.47

654

2058

Cervicobrachial syndrome

1198

5039

2.54

177.61

6.6

7.0

24.79

24.44

mmol/l

3.06

1167

4822

Abnormal findings on examination of blood, without diagnosis

2709

13853

1.86

177.29

7.5

7.2

24.35

24.45

mmol/l

0.62

2588

13306

Atherosclerosis, excluding cerebral and coronary sclerosis

2505

10856

1.92

174.28

8.6

6.2

24.12

24.56

mmol/l

5.83

2410

10383

COPD, hospital admissions 1, only main diagnosis

2150

9805

2.01

172.32

8.8

6.7

25.84

24.28

mmol/l

50.01

2090

9378

Solid cancers

3921

14095

1.68

172.32

7.2

6.9

24.65

24.53

mmol/l

1.13

3741

13559

Statin medication

2735

8487

1.87

171.88

7.1

6.5

24.31

24.72

mmol/l

5.89

2618

8067

Focal epilepsy

1266

5565

2.45

171.18

9.7

6.6

24.66

24.43

mmol/l

1.23

1218

5319

Osteoporosis

1624

7225

2.21

170.50

7.3

6.1

24.89

24.67

mmol/l

1.39

1569

6911

Malignant neoplasm of digestive organs, including Hilmo

2479

10038

1.91

170.14

8.1

7.0

24.36

24.56

mmol/l

1.75

2377

9672

Use of hypnotics and sedatives

5093

19048

1.57

169.09

7.7

6.8

24.68

24.45

mmol/l

3.96

4886

18227

Transient ischemic attack

2946

13694

1.80

168.51

7.0

6.8

24.48

24.56

mmol/l

0.54

2827

13124

Obesity due to excess calories

2276

12407

1.91

168.19

8.3

6.8

24.97

24.41

mmol/l

8.88

2209

11873

Solid cancers, including Hilmo

3962

14295

1.66

167.14

7.3

6.9

24.62

24.53

mmol/l

0.82

3776

13751

Autoimmune diseases excluding thyroid diseases

4954

17459

1.58

166.90

8.0

6.7

24.36

24.50

mmol/l

1.67

4738

16723

Aplastic and other anaemias

2697

14198

1.83

166.19

8.7

6.6

24.07

24.56

mmol/l

7.08

2586

13618

Chronic kidney disease

2010

10226

2.01

165.73

9.8

6.2

22.86

24.71

mmol/l

57.44

1923

9793

Other or unspecified ileus, impaction or obstruction

1216

5346

2.46

165.03

9.7

6.5

24.72

24.62

mmol/l

0.36

1169

5099

Symptoms and signs involving the nervous and musculoskeletal systems

2998

17811

1.75

165.00

7.4

6.8

24.86

24.46

mmol/l

7.28

2893

17049

Oedema, not elsewhere classified

1737

8520

2.09

164.28

8.7

6.3

25.17

24.49

mmol/l

9.15

1678

8148

Alcohol dependence

1537

7422

2.21

164.23

9.4

7.2

24.48

24.39

mmol/l

0.33

1500

7103

malignant neoplasm of female genital organs

937

3585

2.79

163.67

6.6

6.0

24.90

24.81

mmol/l

0.32

903

3435

Allergic asthma (mode)

957

3641

2.68

163.28

7.2

5.6

24.63

24.05

mmol/l

4.92

917

3472

Missing teeth due to accident, extraction or parodontitis

3324

18143

1.70

162.23

7.4

7.0

24.73

24.56

mmol/l

1.90

3196

17414

Alcohol abuse, main dg

949

3762

2.74

161.65

8.7

7.5

24.45

24.40

mmol/l

0.11

926

3601

Unspecified acute lower respiratory infection

986

4007

2.68

159.62

9.9

6.9

25.33

24.39

mmol/l

10.46

947

3843

Autoimmune diseases excluding thyroid diseases, strict definition

4780

16946

1.57

159.44

7.8

6.7

24.34

24.50

mmol/l

1.90

4575

16237

Other respiratory diseases principally affecting the interstitium

1237

5587

2.42

159.36

9.9

6.7

24.96

24.46

mmol/l

4.10

1200

5348

Acute alcohol intoxication

1458

6992

2.22

158.29

8.4

7.0

24.48

24.37

mmol/l

0.42

1419

6685

Endovascular or surgical operations to intracerebral aneurysms

504

1431

4.15

158.15

11.3

7.0

24.94

24.66

mmol/l

0.96

494

1363

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

718

2518

3.22

157.72

10.3

7.0

24.60

24.47

mmol/l

0.40

687

2412

Pain, not elsewhere classified

1378

6476

2.23

155.66

7.0

6.3

24.89

24.49

mmol/l

3.56

1334

6181

Rotator cuff syndrome

3202

13322

1.72

155.14

6.6

7.0

24.59

24.52

mmol/l

0.51

3092

12763

Focal epilepsy, strict definition

1174

5219

2.42

154.88

9.7

6.5

24.69

24.45

mmol/l

1.26

1130

4985

Peripheral arterial reconstruction

1211

5499

2.42

154.60

10.3

6.3

23.96

24.43

mmol/l

3.93

1163

5273

Constipation

4394

19405

1.58

154.05

7.3

6.8

24.78

24.46

mmol/l

6.33

4217

18601

Finngen Rheumatological endpoints

4291

15644

1.60

153.79

6.9

7.0

24.50

24.45

mmol/l

0.37

4094

14964

Personality disorders

1233

5576

2.33

153.37

7.6

7.0

24.89

24.33

mmol/l

5.12

1193

5327

Nutritional anaemias

2688

15084

1.77

152.61

8.9

6.4

24.27

24.53

mmol/l

2.60

2584

14457

Type 1 diabetes, wide definition, subgroup 1

1016

4241

2.54

152.23

9.1

6.3

23.52

24.64

mmol/l

11.54

970

4031

Specific personality disorders

1079

4646

2.45

150.81

8.0

7.1

24.98

24.30

mmol/l

6.40

1046

4433

Anxiety disorders, excluding more controls

3570

14172

1.65

150.74

8.2

6.4

24.71

24.47

mmol/l

3.18

3461

13530

ILD medications: immunosuppressive drugs

2926

15921

1.72

150.60

7.8

6.8

24.31

24.48

mmol/l

1.71

2818

15250

Disorders of adult personality and behaviour

1273

5872

2.27

150.59

8.1

7.0

24.91

24.29

mmol/l

6.38

1230

5603

Other and unspecified nerve root and plexus disorders, also in other diseases

1158

5172

2.39

150.35

6.5

7.2

24.67

24.51

mmol/l

0.75

1090

4955

Implicit fungal Sepsis, including avohilmo

529

1593

3.79

150.06

12.1

5.4

24.62

24.50

mmol/l

0.27

514

1521

Focal epilepsy, mode (most common among epilepsy diagnosis)

1112

4901

2.45

149.73

9.8

6.6

24.62

24.46

mmol/l

0.74

1074

4683

Iron deficiency anaemia

2344

13118

1.83

149.69

9.2

6.3

24.27

24.52

mmol/l

2.18

2258

12554

Malignant neoplasm of digestive organs

2251

9604

1.89

149.50

8.1

6.9

24.36

24.55

mmol/l

1.50

2155

9256

Other symptoms and signs involving the nervous and musculoskeletal systems

2121

11771

1.88

148.64

7.6

6.8

24.93

24.44

mmol/l

8.13

2046

11280

Pain (limb, back, neck, head abdominally)

3245

9761

1.71

148.24

7.0

6.8

24.44

24.40

mmol/l

0.20

3108

9275

Short Achilles tendon (acquired)

276

515

6.71

148.23

7.0

7.8

24.63

24.61

mmol/l

0.02

260

485

Type 1 diabetes

1210

5505

2.31

148.01

9.2

6.4

23.51

24.59

mmol/l

12.91

1154

5242

Fall on same level

5159

18515

1.52

147.05

7.9

6.7

24.57

24.44

mmol/l

1.50

4955

17718

Gastrointestinal diseases

2305

6297

1.88

145.24

7.2

5.8

24.25

24.58

mmol/l

3.34

2200

5996

Other and unspecified anaemias

2459

13536

1.79

142.23

8.6

6.5

24.11

24.56

mmol/l

5.64

2364

12978

Acute alcohol intoxication, ICD10

1130

5131

2.36

141.20

8.7

7.4

24.27

24.43

mmol/l

0.62

1101

4922

Substance use, excluding alcohol

989

4232

2.48

140.93

10.0

7.0

25.15

24.50

mmol/l

5.21

969

4038

Other anaemias

2469

13605

1.78

140.65

8.6

6.5

24.12

24.56

mmol/l

5.49

2374

13045

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1653

8635

2.01

140.65

7.9

6.8

24.77

24.46

mmol/l

2.69

1589

8267

Hypokalaemia

776

3006

2.83

139.12

10.0

6.4

25.30

24.71

mmol/l

2.38

747

2880

Ischaemic Stroke, excluding all haemorrhages

3045

13833

1.69

138.78

7.8

6.9

24.58

24.54

mmol/l

0.23

2921

13271

Fungal Sepsis

365

905

4.82

138.75

14.7

5.3

24.30

24.47

mmol/l

0.30

357

864

Schizophrenia

861

3506

2.64

137.83

8.0

7.5

26.07

24.39

mmol/l

21.12

828

3351

Soft tissue disorders

4512

15303

1.54

137.77

6.8

6.9

24.50

24.43

mmol/l

0.56

4328

14638

Benzodiazepine use

4724

21591

1.51

137.54

7.5

6.8

24.93

24.41

mmol/l

16.25

4571

20640

Carpal tunnel syndrome

2920

15548

1.68

137.51

6.9

24.73

24.57

mmol/l

1.55

2801

14912

Postprocedural musculoskeletal disorders, not elsewhere classified

564

1885

3.46

136.36

8.4

7.0

25.08

24.50

mmol/l

3.12

538

1801

Type 1 diabetes, wide definition

1043

4647

2.36

134.42

9.0

6.4

23.55

24.59

mmol/l

10.57

995

4424

Gastroduodenal ulcer

1571

8197

2.03

134.17

9.5

6.5

24.19

24.48

mmol/l

2.03

1514

7862

Other disorders of skin and subcutaneous tissue

3613

19808

1.59

134.10

8.0

6.7

24.42

24.55

mmol/l

1.05

3474

18978

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

578

1971

3.25

132.12

9.0

5.9

24.93

24.47

mmol/l

1.80

558

1883

Spondylolisthesis/Spondylolysis

987

4409

2.39

128.15

7.1

7.0

24.61

24.50

mmol/l

0.43

954

4222

Intestinal infectious diseases, including avohilmo, including avohilmo

5314

20642

1.47

127.89

7.8

6.6

24.39

24.55

mmol/l

2.12

5110

19755

Mood disorders

4614

20137

1.50

127.69

7.9

6.7

24.71

24.48

mmol/l

3.69

4467

19246

Conductive and sensorineural hearing loss

3907

17171

1.56

127.64

6.5

7.0

24.43

24.60

mmol/l

2.04

3753

16478

Diverticular disease of intestine

3533

14213

1.60

127.24

7.1

6.6

24.47

24.62

mmol/l

1.63

3423

13623

Nephropathy related operations

781

3186

2.71

126.86

17.0

6.8

22.39

24.59

mmol/l

32.95

751

3058

Explicit bacterial Sepsis, including avohilmo

675

2553

2.89

126.63

10.8

5.5

24.38

24.43

mmol/l

0.11

649

2445

Cervical disc disorders

1757

9671

1.90

126.56

7.1

24.68

24.44

mmol/l

2.06

1693

9264

Mood [affective] disorders

4595

20122

1.50

126.15

8.0

6.7

24.72

24.48

mmol/l

3.75

4449

19231

Sensorineural hearing loss

3780

16619

1.56

125.99

6.6

7.0

24.45

24.61

mmol/l

1.70

3625

15957

Mycoses

1482

7757

2.02

125.83

8.9

6.9

24.52

24.48

mmol/l

0.12

1433

7423

ILD-related respiratory insufficiency

347

907

4.86

125.70

11.3

6.7

25.34

24.33

mmol/l

4.04

334

866

Explicit bacterial Sepsis

663

2498

2.90

125.37

10.7

5.5

24.38

24.44

mmol/l

0.14

637

2395

Implicit fungal Sepsis

334

837

4.76

125.25

14.3

5.3

24.34

24.44

mmol/l

0.15

327

797

Interstitial lung disease endpoints

1024

4731

2.37

125.11

8.2

6.6

24.95

24.46

mmol/l

3.56

993

4536

Other interstitial pulmonary diseases

1024

4731

2.37

125.11

8.2

6.6

24.95

24.47

mmol/l

3.55

993

4536

Interstitial lung disease

1024

4731

2.37

125.11

8.2

6.6

24.95

24.46

mmol/l

3.56

993

4536

Viral and other specified intestinal infections

930

3960

2.40

124.88

7.7

6.1

24.24

24.37

mmol/l

0.43

894

3782

Spondylosis

2585

12291

1.70

124.52

6.4

7.0

24.84

24.47

mmol/l

5.99

2493

11757

Infections of the skin and subcutaneous tissue

2748

16850

1.66

124.39

8.5

6.9

24.49

24.47

mmol/l

0.09

2656

16114

Other reaction to severe stress, and adjustment disorders

1493

7811

1.98

124.18

8.8

6.6

24.56

24.45

mmol/l

0.57

1454

7426

ILD, hospital admissions

1009

4651

2.37

124.06

8.1

6.7

24.96

24.48

mmol/l

3.36

978

4458

Emotionally unstable personality disorder

556

1902

3.12

123.84

7.6

7.0

24.77

24.16

mmol/l

2.82

539

1815

Disorders of thyroid, IBD co-morbidities

617

1441

3.04

123.26

6.1

5.7

24.26

24.46

mmol/l

0.62

584

1363

Other disorders of urethra and urinary system

3290

14750

1.60

121.87

7.3

6.6

24.57

24.44

mmol/l

1.07

3169

14102

Other bacterial intestinal infections

1054

4951

2.28

121.41

9.5

6.4

24.17

24.58

mmol/l

2.42

1014

4732

Falls/tendency to fall

4618

15797

1.50

120.96

7.6

6.7

24.45

24.44

mmol/l

0.06

4427

15120

Enterocolitis due to Clostridium difficile

733

2975

2.72

120.26

10.7

6.4

24.31

24.54

mmol/l

0.75

706

2845

Depression

4207

19107

1.51

120.23

8.0

6.7

24.69

24.49

mmol/l

2.66

4074

18255

Hernia of abdominal wall

2350

14270

1.72

120.00

9.1

6.9

24.76

24.48

mmol/l

3.11

2261

13696

Neoplasms

2997

9793

1.64

119.52

7.4

6.9

24.36

mmol/l

0.02

2858

9381

Organic, including symptomatic, mental disorders

2818

12454

1.66

118.95

7.3

7.0

24.52

24.56

mmol/l

0.20

2732

11934

Used for control exclusion in common control thyroid runs

4702

16319

1.48

118.65

7.7

6.7

24.34

24.49

mmol/l

1.75

4502

15627

Problems related to lifestyle

637

2418

2.86

118.38

9.1

6.9

24.82

24.36

mmol/l

1.83

617

2305

Autoimmune diseases

4956

17510

1.47

118.07

7.7

6.7

24.32

24.50

mmol/l

2.44

4750

16767

Other symptoms and signs involving the circulatory and respiratory systems

428

1308

3.63

117.34

7.7

6.9

24.57

24.44

mmol/l

0.26

409

1254

External causes of morbidity and mortality

2646

8020

1.69

117.31

7.3

5.8

24.36

24.42

mmol/l

0.33

2541

7663

Cough

1734

9031

1.85

116.64

6.6

6.7

24.72

24.38

mmol/l

3.42

1670

8612

Cerebral aneurysm, nonruptured

571

2081

3.06

116.39

10.0

6.9

24.79

24.55

mmol/l

0.98

549

1989

Extreme obesity with alveolar hypoventilation

348

950

4.38

116.36

11.5

7.3

28.43

24.45

mmol/l

38.10

339

906

Pain in thoracic spine

783

3295

2.53

116.10

6.7

6.8

24.81

24.38

mmol/l

2.86

761

3148

Certain infectious and parasitic diseases, including avohilmo

3096

9794

1.62

116.01

7.2

6.1

24.40

24.52

mmol/l

0.89

2965

9359

Persons encountering health services for examination and investigation

2775

8562

1.67

115.50

7.3

6.2

24.40

24.42

mmol/l

0.10

2655

8127

Other and unspecified drugs and medicaments

552

1983

3.09

115.31

9.0

6.9

25.01

24.48

mmol/l

2.38

533

1892

Ventral hernia

1316

6836

2.04

114.83

10.5

6.6

24.71

24.50

mmol/l

1.20

1264

6532

Idiopathic pulmonary fibrosis

594

2247

3.01

114.38

7.1

6.5

25.16

24.34

mmol/l

5.01

577

2149

Traumatic subdural haemorrhage

816

3289

2.50

114.27

9.7

5.9

24.57

24.17

mmol/l

1.94

793

3126

ILD, hospital admissions 1, main diag only

903

4125

2.40

113.75

8.0

6.6

24.91

24.49

mmol/l

2.52

878

3951

Diagnoses used for exclusion with ILD

1424

7622

1.98

113.62

9.3

6.8

25.01

24.40

mmol/l

7.18

1347

7305

Benign neoplasm of colon, rectum, anus and anal canal

3282

18341

1.56

113.38

7.2

6.9

24.51

24.59

mmol/l

0.62

3180

17579

Other CVD

1272

6585

2.07

113.32

8.3

6.3

24.40

24.47

mmol/l

0.25

1227

6309

Viral hepatitis, IBD co-morbidity

242

495

5.26

112.68

9.5

6.4

24.63

24.28

mmol/l

0.57

235

466

Other disorders of ear

4235

18854

1.49

112.41

6.5

7.0

24.48

24.56

mmol/l

0.79

4074

18062

Other and unspecified nonorganic psychotic disorders

857

3797

2.38

112.23

8.4

7.1

25.28

24.32

mmol/l

8.08

818

3625

Streptococcal septicaemia, including avohilmo

603

2302

2.89

111.96

10.2

6.1

24.42

24.45

mmol/l

0.05

580

2208

Other mental disorders due to brain damage and dysfunction and to physical disease

801

3504

2.51

111.64

7.6

6.5

24.46

24.58

mmol/l

0.41

786

3353

Dialysis, with operation codes

762

3256

2.55

111.34

17.4

6.6

22.33

24.78

mmol/l

38.87

734

3124

Liquid cancers, including Hilmo

1867

9539

1.80

111.31

8.2

6.9

24.58

24.52

mmol/l

0.23

1781

9187

Alzheimer’s disease (Atypical or mixed), excluding more controls

641

1826

2.88

111.28

5.0

5.8

24.32

24.14

mmol/l

0.53

620

1731

Streptococcal septicaemia

591

2244

2.91

110.95

10.2

6.0

24.42

mmol/l

0.01

568

2151

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1473

8013

1.92

110.54

7.5

7.2

24.47

24.66

mmol/l

1.03

1431

7672

Glucagon-like peptide-1 (GLP-1) analogues

1473

8013

1.92

110.54

7.5

7.2

24.47

24.66

mmol/l

1.03

1431

7672

Undetermined asthma, excluding more controls

590

2212

2.82

110.39

6.6

5.4

24.77

24.11

mmol/l

3.60

572

2105

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

414

1290

3.56

110.13

7.8

7.2

24.46

24.37

mmol/l

0.16

407

1233

Injuries to the thorax

2390

14881

1.67

109.78

8.3

6.9

24.71

24.47

mmol/l

2.47

2305

14236

Other/unspecified dorsalgia

1683

9401

1.83

109.69

6.9

6.8

24.77

24.40

mmol/l

3.72

1622

8988

Type of accident

1471

8026

1.92

109.46

7.7

6.9

24.86

24.47

mmol/l

3.57

1415

7687

Cardiomyopathy

866

3905

2.35

109.45

9.6

6.0

24.26

24.45

mmol/l

0.70

837

3713

Gonarthrosis [arthrosis of knee](FG)

3556

13634

1.54

109.31

6.4

7.1

24.69

24.55

mmol/l

1.46

3395

13060

Injuries to the abdomen, lower back, lumbar spine and pelvis

2068

12255

1.73

108.99

8.5

6.5

24.81

24.46

mmol/l

4.02

1997

11720

Gout

1592

7614

1.89

108.71

8.9

7.0

23.86

24.51

mmol/l

7.32

1537

7305

Acute bronchitis

2026

11884

1.73

108.53

8.1

6.4

25.17

24.39

mmol/l

15.93

1950

11375

Other degenerative diseases of the nervous system

1353

5160

1.99

107.49

6.1

5.9

24.37

24.26

mmol/l

0.46

1307

4921

Disorders of lens

3146

12761

1.58

107.45

8.1

7.2

24.35

24.63

mmol/l

3.24

3025

12243

Nontraumatic intracranial haemmorrhage

1183

6072

2.08

107.39

11.6

6.4

24.74

24.44

mmol/l

1.84

1139

5804

Hyperkalaemia

439

1451

3.43

107.20

11.8

6.8

22.62

24.56

mmol/l

10.57

429

1392

Symptoms and signs involving the urinary system

3656

18753

1.51

107.03

7.4

6.9

24.56

24.55

mmol/l

0.08

3512

17994

L04AD Calcineurin inhibitors

606

2368

2.79

106.69

10.8

7.4

23.14

24.52

mmol/l

12.43

585

2270

Dermatitis

2968

19077

1.57

106.62

7.8

6.8

24.55

24.54

mmol/l

0.05

2856

18279

Gonarthrosis

3050

11161

1.59

106.44

6.4

7.0

24.66

24.55

mmol/l

0.84

2906

10686

Gastric ulcer

1062

5307

2.14

104.20

10.1

6.4

24.42

24.52

mmol/l

0.32

1029

5088

Schizoaffective disorder

434

1439

3.32

103.84

7.7

7.4

26.00

24.41

mmol/l

8.97

420

1376

Secondary hypertension

318

841

3.97

103.66

10.1

5.7

24.05

24.52

mmol/l

0.96

304

795

Viral and other specified intestinal infections, including avohilmo

1152

5640

2.04

103.61

7.6

6.3

24.28

24.36

mmol/l

0.30

1104

5384

Arthrosis

3234

11707

1.55

102.13

6.8

7.1

24.58

24.54

mmol/l

0.23

3080

11197

Emphysema

512

1891

3.02

102.00

8.6

6.6

24.61

24.18

mmol/l

1.58

493

1812

Sequelae of cerebrovascular disease

2000

10331

1.73

101.95

8.3

6.5

24.48

24.45

mmol/l

0.12

1929

9889

Other and unspecified iron deficiency

1747

10219

1.78

101.88

8.9

6.3

24.28

24.52

mmol/l

1.64

1692

9773

Factors influencing health status and contact with health services

1295

3314

2.02

99.99

7.4

5.5

24.42

24.41

mmol/l

0.01

1245

3149

Malignant neoplasm of ovary, including Hilmo

394

1270

3.48

99.81

7.9

6.6

24.45

24.94

mmol/l

1.77

381

1212

Migraine

1850

8470

1.74

99.73

6.2

6.4

24.45

24.38

mmol/l

0.39

1782

8080

Complications of internal orthopaedic prosthetic devices, implants and grafts

1240

6640

1.98

99.07

7.2

6.0

24.93

24.58

mmol/l

2.44

1195

6353

Bacterial intestinal infections, IBD co-morbidities

1031

5194

2.11

98.60

9.5

6.5

24.16

24.52

mmol/l

1.97

992

4975

Transplanted organ and tissue status

544

2096

2.83

98.51

11.2

6.5

23.00

24.59

mmol/l

14.30

526

2000

Cholelithiasis, broad definition with cholecystitis

3955

18384

1.47

98.32

7.1

6.7

24.50

24.57

mmol/l

0.62

3806

17606

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

361

1110

3.53

97.24

8.5

8.1

24.93

24.29

mmol/l

2.11

354

1060

Obesity, other/unspecified

1436

8042

1.85

97.17

8.1

6.8

24.87

24.41

mmol/l

4.22

1390

7686

All influenza (not pneumonia)

713

3114

2.43

97.11

7.8

6.2

24.76

24.25

mmol/l

3.29

679

2994

Acute sinusitis

2205

12536

1.64

96.83

8.1

6.8

24.53

24.47

mmol/l

0.31

2115

11960

Coxarthrosis

2501

10299

1.62

96.21

6.7

7.0

24.69

24.57

mmol/l

0.88

2393

9876

Coxarthrosis [arthrosis of hip](FG)

2709

12174

1.58

95.21

6.7

7.1

24.66

24.56

mmol/l

0.66

2598

11673

Vascular disorders of the intestines

505

1929

2.93

94.56

10.0

6.3

23.89

24.65

mmol/l

3.37

487

1836

Subarachnoid haemorrhage

634

2689

2.57

94.30

13.1

6.4

24.80

24.53

mmol/l

0.94

611

2574

Delirium, not induced by alcohol and other psychoactive substances

804

3764

2.31

94.02

9.8

6.5

24.43

24.49

mmol/l

0.13

787

3604

Other bacterial intestinal infections, including avohilmo

1187

6382

1.95

92.76

9.2

6.6

24.17

24.55

mmol/l

2.47

1142

6108

Lung cancer and mesothelioma

933

3884

2.14

92.10

7.0

5.6

25.44

24.01

mmol/l

24.05

887

3726

L04AA Selective immunosuppressants

1041

5372

2.04

92.08

9.1

7.3

23.69

24.56

mmol/l

9.61

1002

5130

Lung diseases due to external agents

855

4142

2.22

91.79

10.7

6.4

25.21

24.33

mmol/l

8.21

808

3969

Myocarditis

218

488

4.84

91.41

7.3

6.3

24.29

24.41

mmol/l

0.17

206

463

Other arthrosis

2492

10786

1.59

91.34

7.2

7.1

24.72

24.56

mmol/l

1.35

2390

10330

Neurotic, stress-related and somatoform disorders

3686

17752

1.46

91.13

8.2

6.7

24.69

24.53

mmol/l

1.60

3571

16945

Symptoms and signs concerning food and fluid intake

581

2387

2.61

91.02

9.6

6.2

24.67

24.46

mmol/l

0.58

559

2278

Anxiety disorders

3731

17949

1.46

90.68

8.2

6.7

24.69

24.53

mmol/l

1.62

3615

17128

Undetermined asthma

590

2437

2.55

90.56

6.6

5.5

24.77

24.09

mmol/l

3.73

572

2331

Cutaneous abscess, furuncle and carbuncle

1226

6702

1.91

90.50

9.5

7.2

24.50

24.44

mmol/l

0.21

1183

6409

Hypotension

1085

5748

2.02

90.42

7.8

6.3

24.39

24.46

mmol/l

0.23

1050

5507

Chronic ulcer of skin, not elsewhere classified

478

1823

2.93

89.79

10.6

6.8

24.53

24.43

mmol/l

0.19

458

1743

Depression or dysthymia

2814

10131

1.55

89.48

7.7

6.8

24.61

24.40

mmol/l

2.15

2724

9635

Benign neoplasms

4202

16304

1.43

89.09

7.1

6.9

24.35

24.44

mmol/l

0.82

4034

15583

Benign neoplasm: Colon

2762

17452

1.54

89.06

7.3

7.0

24.52

24.57

mmol/l

0.31

2676

16728

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1025

5234

2.00

88.67

7.5

6.5

24.71

24.20

mmol/l

4.42

992

4995

Post-traumatic stress disorder

348

1101

3.35

88.43

7.1

6.0

24.28

24.02

mmol/l

0.58

334

1047

Diseases of the musculoskeletal system and connective tissue

2021

6162

1.68

87.74

6.5

7.2

24.40

24.35

mmol/l

0.24

1931

5870

Abnormal serum enzyme levels

1665

9708

1.74

87.39

7.0

7.6

24.36

24.39

mmol/l

0.12

1574

9333

Injury, poisoning and certain other consequences of external causes

2071

6374

1.66

86.77

7.1

5.8

24.36

24.41

mmol/l

0.21

1993

6063

Visual disturbances

2254

14625

1.59

86.72

7.2

6.7

24.57

24.50

mmol/l

0.43

2151

14023

Other cataract

2121

9985

1.63

86.69

6.8

7.2

24.28

24.62

mmol/l

3.50

2046

9556

Unspecified misadventure during surgical and medical care

402

1432

3.18

86.38

13.9

7.1

24.96

24.41

mmol/l

2.17

390

1369

Other pleural conditions

647

2882

2.45

86.28

9.4

6.1

25.13

24.15

mmol/l

7.61

629

2759

Other diseases of pericardium

286

826

3.89

86.22

12.4

7.0

24.75

24.39

mmol/l

0.90

278

787

Non-selective monoamine reuptake inhibitors

1717

10020

1.70

86.13

7.1

6.5

25.07

24.44

mmol/l

9.57

1658

9578

Colorectal cancer, including Hilmo

1444

7861

1.80

85.17

7.9

6.8

24.30

24.52

mmol/l

1.41

1390

7575

Cholelithiasis

3729

18082

1.44

84.74

6.7

24.51

24.58

mmol/l

0.47

3593

17314

Senile cataract

2877

11820

1.52

84.18

8.1

7.2

24.41

24.63

mmol/l

1.97

2759

11335

Other disorders of the musculoskeletal system and connective tissue

819

4029

2.18

84.17

7.9

6.9

24.90

24.54

mmol/l

2.19

785

3850

Disorders of other endocrine glands

1932

11980

1.64

83.92

7.9

6.6

24.55

24.53

mmol/l

0.11

1856

11463

Other diseases of urinary system

4286

17422

1.41

83.74

7.3

6.8

24.44

24.45

mmol/l

0.08

4119

16678

Diabetic maculopathy, excluding more controls

579

2476

2.51

83.72

9.3

6.3

23.62

24.65

mmol/l

6.26

552

2367

Anxiety (asthma-related co-morbidities)

2237

10956

1.59

83.59

8.4

6.5

24.65

24.47

mmol/l

1.41

2168

10454

Sub-endpoint used in defining T1D endpoints

1332

7517

1.81

83.21

8.9

6.7

23.63

24.46

mmol/l

8.96

1269

7192

Colorectal cancer

1312

7219

1.83

83.01

8.0

6.8

24.30

24.51

mmol/l

1.29

1261

6946

Chronic pancreatitis

719

3394

2.29

82.73

11.6

6.8

24.16

24.58

mmol/l

1.86

694

3249

Cardiomyopathies, Primary/intrinsic

604

2646

2.44

82.35

9.7

5.9

24.08

24.37

mmol/l

0.93

580

2519

Other gastritis (incl. Duodenitis)

1155

6407

1.90

82.15

8.4

6.7

24.48

24.54

mmol/l

0.22

1123

6143

Other complications of surgical and medical care, not elsewhere classified

518

2130

2.62

81.67

9.8

6.0

24.66

24.50

mmol/l

0.40

506

2027

Hyperlipidaemia, other/unspecified

1884

10667

1.65

81.56

6.8

6.4

24.33

24.66

mmol/l

3.20

1821

10211

Disorders of eyelid, lacrimal system and orbit

3890

20578

1.41

81.42

6.9

24.66

24.49

mmol/l

2.20

3737

19721

Viral pneumonia (known virus, not influenza)

236

633

4.44

80.95

10.1

7.0

25.13

24.40

mmol/l

1.62

228

612

Diseases of the skin and subcutaneous tissue

4235

15382

1.41

80.88

7.5

6.5

24.42

24.50

mmol/l

0.64

4055

14700

Acute upper respiratory infections of multiple and unspecified sites

3247

16577

1.46

80.73

7.3

6.6

24.62

24.46

mmol/l

1.59

3148

15819

Retention of urine

1876

9552

1.65

80.64

7.7

7.1

24.31

24.41

mmol/l

0.49

1801

9159

Enlarged lymph nodes

715

3375

2.23

80.40

6.6

6.8

24.60

24.49

mmol/l

0.34

676

3221

Injuries to the hip and thigh

2419

14481

1.54

80.31

7.3

6.6

24.85

24.44

mmol/l

5.89

2329

13869

Status epilepticus

261

753

3.96

79.41

19.0

6.0

25.24

24.29

mmol/l

3.21

247

719

Iron deficiency anaemia secondary to blood loss (chronic)

897

4648

2.05

79.40

10.6

6.3

24.25

24.55

mmol/l

1.37

857

4446

Bipolar affective disorders

748

3604

2.16

79.29

7.1

6.7

24.87

24.32

mmol/l

3.13

723

3425

Other retinal disorders

3121

16613

1.47

78.81

8.1

6.8

24.28

24.59

mmol/l

4.19

3002

15913

Gonarthrosis,primary

4183

18449

1.40

78.76

6.3

7.1

24.71

24.54

mmol/l

2.15

4007

17704

Visual disturbances and blindness

2393

16032

1.53

78.75

7.3

6.7

24.59

24.50

mmol/l

0.57

2284

15375

Peripheral artery operations in Hilmo

746

3636

2.20

78.55

11.3

6.0

23.73

24.41

mmol/l

4.31

722

3475

Acute upper respiratory infections

4552

20217

1.37

77.91

7.5

6.6

24.64

24.47

mmol/l

2.46

4390

19328

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

4382

20743

1.38

77.83

7.7

6.6

24.37

24.54

mmol/l

2.27

4219

19848

Other and unspecified dermatitis

2357

15815

1.53

77.18

7.6

6.7

24.52

24.55

mmol/l

0.14

2267

15145

Toxic effects of substances chiefly nonmedicinal as to source

572

2519

2.42

77.12

7.0

7.1

24.26

24.43

mmol/l

0.51

562

2414

Malignant neoplasm of corpus uteri, including Hilmo

517

2193

2.57

76.91

5.7

6.1

25.09

24.91

mmol/l

0.58

500

2097

Cardiomyopathy (excluding other)

618

2815

2.34

76.79

9.8

5.8

24.09

24.37

mmol/l

0.93

594

2681

Polyarthrosis

1044

5130

1.92

76.76

6.0

6.7

25.01

24.68

mmol/l

2.19

1021

4921

Autoimmune diseases related-to ILD

3617

21832

1.41

76.42

7.8

6.7

24.55

24.49

mmol/l

0.45

3479

20891

Migraine with aura

866

4466

2.00

75.25

7.0

6.0

24.30

24.24

mmol/l

0.21

837

4246

Intestinal adhesions without obstruction

527

2279

2.52

75.17

11.6

6.5

24.43

24.70

mmol/l

0.77

510

2170

Congenital malformations, deformations and chromosomal abnormalities

2260

14286

1.53

74.92

8.5

6.9

24.60

24.44

mmol/l

1.24

2151

13681

Ulcer of oesophagus

450

1823

2.74

74.78

9.7

6.6

24.71

24.43

mmol/l

0.78

435

1750

Unspecified fall

2373

15746

1.52

74.77

7.9

6.7

24.69

24.47

mmol/l

1.87

2285

15088

Sleep apnoea

4133

19190

1.38

74.58

7.4

7.0

24.99

24.45

mmol/l

16.49

4007

18335

Diseases of peritoneum

571

2561

2.41

74.55

13.0

6.6

23.58

24.60

mmol/l

5.98

546

2445

Candidiasis

697

3370

2.19

74.32

10.5

6.7

24.57

24.45

mmol/l

0.35

674

3216

Acute peritonitis

407

1573

2.87

74.31

15.4

7.0

23.25

24.52

mmol/l

5.89

393

1499

Fracture of rib(s), sternum and thoracic spine

1587

9867

1.68

74.29

8.5

6.9

24.74

24.44

mmol/l

2.47

1538

9457

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1250

7079

1.80

74.26

6.3

7.0

24.67

24.52

mmol/l

0.72

1196

6816

Malignant neoplasm of corpus uteri

478

1997

2.61

73.67

5.7

5.9

25.13

24.92

mmol/l

0.67

463

1911

Exclusions for E4_PCOS_BROAD

783

3953

2.08

73.61

9.0

6.8

24.59

24.45

mmol/l

0.43

751

3779

Vascular syndromes of brain in cerebrovascular disorders

330

1156

3.27

73.60

7.2

6.6

24.64

24.41

mmol/l

0.43

321

1104

Candidiasis, including avohilmo

1306

7734

1.75

73.02

8.9

6.6

24.65

24.50

mmol/l

0.73

1261

7409

Disorders of synovium and tendon

2258

12806

1.53

73.02

6.8

7.1

24.46

24.49

mmol/l

0.19

2169

12248

Cervicalgia

939

5062

1.94

72.54

6.4

6.7

24.79

24.45

mmol/l

2.33

906

4849

Pneumonitis due to solids and liquids

531

2345

2.47

72.33

12.9

6.4

25.39

24.33

mmol/l

6.64

500

2247

Pneumonia due to Streptococcus pneumoniae

263

808

3.63

72.03

10.1

6.9

24.49

24.19

mmol/l

0.53

250

779

Amputation

611

2864

2.31

71.75

11.4

6.3

23.78

24.43

mmol/l

2.99

589

2747

Azathioprine

645

3060

2.22

71.75

7.5

6.8

24.19

24.37

mmol/l

0.52

627

2922

Combinations of oral blood glucose lowering drugs

1387

8417

1.72

71.70

7.2

7.0

23.88

24.65

mmol/l

9.70

1343

8076

Disorders of choroid and retina

3728

19101

1.40

71.66

7.7

6.8

24.30

24.60

mmol/l

4.84

3590

18313

Alzheimer disease, excluding more controls

906

3062

2.01

71.24

5.9

24.48

24.26

mmol/l

0.95

874

2913

Later onset COPD

1596

8022

1.68

71.12

8.1

6.2

25.39

24.23

mmol/l

21.72

1539

7673

ILD medications: azathioprine

645

3072

2.21

71.03

7.5

6.7

24.19

24.41

mmol/l

0.70

627

2933

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

449

1856

2.64

70.87

10.6

6.7

24.60

24.51

mmol/l

0.19

436

1770

Injuries to the shoulder and upper arm

3809

21665

1.38

70.62

6.9

24.58

24.53

mmol/l

0.34

3672

20735

Genitourinary diseases

2344

7820

1.54

70.14

7.8

6.8

24.35

24.60

mmol/l

2.10

2242

7484

Arthropathies

3550

12911

1.41

70.11

6.4

6.9

24.38

24.44

mmol/l

0.38

3377

12343

Disorders of mineral metabolism

460

1925

2.58

70.10

8.1

6.7

24.67

24.63

mmol/l

0.06

444

1842

Abnormal findings on diagnostic imaging of other body structures

738

3731

2.10

70.01

6.9

24.50

24.54

mmol/l

0.10

714

3578

Glaucoma suspect

1780

11521

1.60

69.97

6.1

6.7

24.50

24.62

mmol/l

0.71

1688

11044

Glomerular diseases

909

4937

1.94

69.59

9.9

6.9

23.07

24.47

mmol/l

17.92

876

4732

Abnormal findings on antenatal screening of mother

270

850

3.33

69.00

4.5

6.6

23.08

23.79

mmol/l

2.64

257

805

Migraine without aura

642

3067

2.16

68.94

6.0

5.9

24.31

24.16

mmol/l

0.54

620

2915

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

4210

19909

1.36

68.57

7.4

6.9

24.68

24.48

mmol/l

2.74

4049

19061

Parkinson's disease, excluding more controls

674

3036

2.16

68.35

5.8

25.58

24.20

mmol/l

17.83

641

2886

Gout, FINNGEN

1592

10058

1.64

68.20

8.9

6.9

23.86

24.49

mmol/l

7.06

1537

9643

Nonorganic sleeping disorders, excluding more controls

770

3959

2.01

67.95

7.7

6.2

24.67

24.34

mmol/l

1.63

744

3767

Sleep apnoea, including avohilmo

4267

19349

1.36

67.87

7.0

24.96

24.42

mmol/l

17.40

4137

18483

Accidents

3259

11649

1.43

67.75

7.2

6.6

24.42

24.46

mmol/l

0.17

3125

11136

Superficial injury of head

1141

6652

1.78

67.58

7.2

6.6

24.51

24.48

mmol/l

0.07

1118

6331

Rheumatoid arthritis

1425

7763

1.68

67.52

7.3

6.9

24.73

24.57

mmol/l

0.84

1355

7446

Selective serotonin reuptake inhibitors

4138

16020

1.36

66.74

7.4

6.7

24.78

24.35

mmol/l

10.13

3984

15282

Other external causes of accidental injury

3251

11649

1.42

66.65

7.2

6.6

24.45

24.46

mmol/l

0.04

3119

11136

Other joint disorders

3424

12901

1.41

66.55

6.5

6.9

24.42

24.44

mmol/l

0.12

3278

12334

Transport accidents

1910

10458

1.55

66.39

7.7

6.6

24.52

24.45

mmol/l

0.33

1821

9990

Gastro-oesophageal reflux disease

2931

17691

1.43

66.20

7.2

6.7

24.51

24.57

mmol/l

0.39

2805

16953

Other disorders of adrenal gland

274

912

3.34

65.82

10.7

7.2

24.36

24.46

mmol/l

0.14

268

876

Colorectal adenocarcinoma

1091

6284

1.80

65.51

7.7

6.8

24.33

24.51

mmol/l

0.81

1051

6049

Pleural effusion

846

4591

1.95

65.32

9.1

6.1

25.08

24.21

mmol/l

8.24

817

4394

Mental and behavioural disorders due to opioids

201

549

4.03

65.30

9.0

8.0

25.51

24.49

mmol/l

3.21

195

520

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

808

4319

1.98

65.24

7.2

7.0

24.74

24.47

mmol/l

1.16

771

4159

Hydrocephalus

448

1928

2.54

64.84

9.9

6.5

24.63

24.41

mmol/l

0.56

436

1835

Fentanyl

575

2726

2.24

64.56

8.1

5.7

25.39

24.31

mmol/l

8.48

540

2611

Diaphragmatic hernia

1674

10907

1.59

63.83

7.2

6.5

24.44

24.57

mmol/l

0.73

1617

10427

Kidney transplant status

303

1086

3.09

63.81

11.0

7.7

21.99

24.59

mmol/l

19.68

295

1043

Pneumonia due to other infectious organisms, not elsewhere classified

221

661

3.79

63.62

11.3

7.1

24.39

24.24

mmol/l

0.22

213

636

Dysphagia

1176

7070

1.73

62.55

7.8

6.4

25.04

24.55

mmol/l

4.13

1131

6749

Disorders of calcium metabolism

362

1433

2.75

62.42

8.1

6.5

24.68

24.60

mmol/l

0.10

348

1369

Nonischemic cardiomyopathy

491

2218

2.36

62.39

9.6

6.5

24.56

24.62

mmol/l

0.10

466

2128

Phobic anxiety disorders

471

2071

2.36

62.16

9.0

6.1

24.55

24.15

mmol/l

1.31

453

1969

Symptoms and signs involving the skin and subcutaneous tissue

3081

21283

1.39

61.86

6.9

24.55

24.51

mmol/l

0.21

2961

20394

All anxiety disorders

2262

12094

1.48

61.68

8.4

6.6

24.64

24.48

mmol/l

1.13

2193

11549

Left ventricular outflow tract obstruction (LVOTO), broad definition

504

2319

2.33

61.60

13.0

7.5

24.40

24.50

mmol/l

0.25

490

2220

Diseases of the eye and adnexa

2964

10596

1.42

61.47

7.1

6.8

24.24

24.47

mmol/l

2.31

2833

10128

Malignant neoplasm of ovary

276

962

3.18

61.15

8.5

6.6

24.52

24.88

mmol/l

0.86

265

919

Familial hypercholesterolemia, with ischemic heart disease

494

2268

2.35

61.05

8.6

6.0

24.28

24.53

mmol/l

0.78

481

2169

Ascites

429

1857

2.50

61.01

9.2

6.6

23.71

24.68

mmol/l

4.76

413

1777

Colectomy operation

883

4963

1.88

60.85

11.1

6.7

23.99

24.55

mmol/l

4.08

850

4747

Diseases of liver

1581

10278

1.59

60.83

9.8

7.1

23.70

24.58

mmol/l

12.99

1518

9862

Other pulmonary heart/vessel disease

307

1144

3.01

60.68

10.7

6.6

25.32

24.45

mmol/l

2.28

301

1090

Osteoporosis with pathological fracture (FG)

422

1827

2.51

60.16

7.4

5.9

25.44

24.86

mmol/l

2.31

403

1746

Brain meningioma

291

1055

3.05

59.99

8.5

7.2

25.17

24.68

mmol/l

1.86

286

1007

Fracture of lumbar spine and pelvis

1160

7030

1.72

59.82

8.4

6.4

24.97

24.51

mmol/l

3.51

1119

6726

Other systemic involvement of connective tissue (FG)

1118

6578

1.73

59.74

6.3

6.6

24.77

24.55

mmol/l

1.23

1078

6302

Neuromuscular dysfunction of bladder

503

2347

2.30

59.64

7.5

6.9

24.96

24.50

mmol/l

1.86

477

2234

Psychotic depression

296

1077

2.95

59.57

8.8

6.6

24.77

24.27

mmol/l

1.54

287

1023

Diabetic retinopathy, excluding more controls

1313

4497

1.71

59.56

10.0

6.8

23.91

24.43

mmol/l

3.78

1275

4316

Neuralgia and neuritis, unspecified

301

1113

2.96

59.53

7.3

7.5

24.71

24.51

mmol/l

0.41

287

1059

Serous carcinoma of ovary, including Hilmo

217

673

3.68

59.26

8.4

6.3

24.57

24.81

mmol/l

0.43

211

644

Insulin, fast-acting (human)

588

2896

2.12

59.22

9.5

6.5

23.55

24.51

mmol/l

5.75

563

2759

Cerebral cysts

302

1121

2.92

58.96

13.9

7.3

23.99

24.32

mmol/l

0.66

291

1070

Endocarditis

216

668

3.61

58.63

18.3

6.4

23.99

24.44

mmol/l

0.84

211

635

Secondary right heart disease

284

1036

3.09

58.60

11.1

6.5

25.41

24.47

mmol/l

2.42

278

987

Noninfective enteritis and colitis

1923

13092

1.50

58.22

8.0

6.8

24.20

24.50

mmol/l

2.82

1850

12523

Pain in joint

2202

9306

1.48

58.20

6.8

6.9

24.50

24.44

mmol/l

0.37

2122

8839

Use of disulfiram, acamprosate or naltrexone

446

2001

2.39

58.03

9.0

8.0

24.73

24.51

mmol/l

0.50

439

1920

Leisure time condition

846

4746

1.86

57.93

7.2

6.8

24.87

24.46

mmol/l

2.33

803

4549

Aortic valve malfunction, age under 60 years

475

2191

2.33

57.85

12.9

7.6

24.43

24.51

mmol/l

0.19

462

2095

Aortic aneurysm

1199

7275

1.69

57.41

11.4

6.5

24.63

24.38

mmol/l

1.52

1160

6962

Brain meningioma, including Hilmo

295

1103

2.94

57.32

8.5

7.0

25.18

24.69

mmol/l

1.91

290

1054

Alzheimer’s disease (Atypical or mixed)

690

3623

2.01

57.19

4.9

5.7

24.35

24.38

mmol/l

0.07

665

3463

Parkinson's disease, strict definition, excluding more controls

612

2886

2.08

57.07

5.5

5.9

25.56

24.18

mmol/l

16.87

581

2744

Other metabolic disorders

536

2592

2.16

56.70

7.0

6.3

24.78

24.63

mmol/l

0.46

514

2474

Dental operations

2695

9898

1.43

56.63

6.7

24.51

24.52

mmol/l

0.00

2581

9487

Acidosis

169

463

4.32

56.33

15.1

6.9

20.42

24.38

mmol/l

10.57

163

442

Postprocedural disorders of digestive system, not elsewhere classified

227

748

3.45

56.14

11.8

7.2

24.33

24.50

mmol/l

0.22

221

718

Assault

535

2595

2.15

56.10

8.5

7.6

24.36

24.39

mmol/l

0.05

522

2478

Other specific joint derangements/joint disorders

2776

12497

1.41

56.07

6.8

7.0

24.51

24.45

mmol/l

0.40

2666

11946

Fracture of femur

1421

8264

1.61

56.04

7.7

6.2

24.93

24.50

mmol/l

3.73

1372

7902

severe traumatic brain injury, does not include concussion

1161

7210

1.68

55.04

10.5

6.7

24.68

24.39

mmol/l

1.64

1129

6899

Dermatophytosis

699

3768

1.96

55.02

7.5

6.9

24.60

24.46

mmol/l

0.37

674

3611

Panic disorder

517

2487

2.16

54.99

9.8

5.9

24.64

24.21

mmol/l

1.73

496

2364

Caries of enamel

2281

20838

0.70

54.44

6.5

7.2

24.59

24.53

mmol/l

0.37

2200

19961

Familial hypercholesterolemia

762

4238

1.89

54.23

7.7

6.6

24.50

24.59

mmol/l

0.30

748

4052

Certain disorders involving the immune mechanism

839

4805

1.82

53.63

8.8

7.0

24.52

24.53

mmol/l

0.02

790

4599

Medical observation and evaluation for suspected diseases and conditions

2379

8559

1.44

53.55

7.7

6.2

24.41

24.42

mmol/l

0.07

2284

8124

Other condition

661

3523

1.97

53.45

8.6

6.9

24.82

24.43

mmol/l

1.97

646

3367

Other arthritis (FG)

1279

8153

1.62

53.32

6.6

7.0

24.52

24.55

mmol/l

0.10

1235

7823

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

2405

15765

1.41

52.93

8.4

6.8

24.60

24.47

mmol/l

1.03

2291

15105

Care involving dialysis

409

1842

2.39

52.90

13.0

6.3

22.09

24.39

mmol/l

19.61

390

1777

Other anxiety disorders

1597

9053

1.53

52.35

8.4

6.6

24.65

24.42

mmol/l

1.67

1554

8624

Any dementia, excluding more controls

1816

8524

1.51

52.19

5.5

6.5

24.49

24.48

mmol/l

0.04

1743

8165

Urinary track infection

1904

6462

1.50

52.04

7.3

5.7

24.46

24.60

mmol/l

0.75

1834

6135

Artrosis, including avohilmo

3403

14033

1.35

51.69

6.6

7.4

24.56

24.46

mmol/l

0.84

3250

13403

Cholecystectomy

3018

19186

1.36

51.68

7.1

6.8

24.42

24.56

mmol/l

1.18

2901

18382

Use of biperiden

302

1205

2.75

51.67

8.1

7.1

25.81

24.52

mmol/l

5.80

294

1158

Somatoform disorder

658

3534

1.94

51.55

7.9

6.3

24.76

24.45

mmol/l

1.35

638

3361

Cellulitis

994

6022

1.71

51.48

8.5

7.1

24.54

24.43

mmol/l

0.37

960

5763

Asthma and allergy, excluding more controls

367

1551

2.41

51.46

6.5

5.2

24.60

24.07

mmol/l

1.95

353

1474

Elevated blood glucose level

433

2018

2.30

51.39

8.5

6.9

23.93

24.48

mmol/l

1.76

419

1930

Fracture of lower leg, including ankle

2321

16433

1.42

51.36

8.9

6.6

24.65

24.54

mmol/l

0.61

2227

15735

L04AX Other immunosuppressants

2252

16159

1.42

51.34

7.1

7.0

24.53

24.54

mmol/l

0.06

2166

15485

Examination and encounter for administrative purposes

445

2098

2.27

51.33

8.5

6.3

24.54

24.34

mmol/l

0.59

433

1993

Suppurative and necrotic conditions of lower respiratory tract

345

1475

2.57

51.11

14.3

7.2

25.38

24.49

mmol/l

3.32

331

1409

Vascular diseases of the intestine

261

981

2.97

50.71

11.6

6.1

23.62

24.49

mmol/l

2.36

254

941

Second line medication for Crohn's disease

2303

16613

1.41

50.69

7.1

7.0

24.52

24.53

mmol/l

0.09

2215

15919

Seropositive rheumatoid arthritis

1062

6530

1.67

50.56

7.1

6.8

24.72

24.58

mmol/l

0.57

1013

6262

Glaucoma

2618

16378

1.39

50.37

6.2

6.9

24.41

24.57

mmol/l

1.34

2503

15707

Infective dermatitis

558

2875

2.05

50.29

8.0

6.7

24.52

24.48

mmol/l

0.09

531

2752

Diseases of the ear and mastoid process

4553

17890

1.29

50.26

6.7

7.0

24.44

24.52

mmol/l

0.76

4372

17137

Extrapyramidal and movement disorders

1790

12420

1.48

50.21

6.2

6.8

25.17

24.48

mmol/l

12.75

1723

11906

Viral haemorrhagic fevers, not elsewhere classified/unspecified

407

1872

2.34

50.18

8.3

7.5

24.36

24.45

mmol/l

0.19

389

1787

Postprocedural endocrine and metabolic disorders, not elsewhere classified

487

2380

2.14

50.16

7.2

6.3

24.77

24.64

mmol/l

0.36

466

2274

Arthropod-borne viral fevers and viral haemorrhagic fevers

485

2387

2.17

50.11

7.9

7.2

24.40

24.43

mmol/l

0.07

465

2277

Benign neoplasm of other and ill-defined parts of digestive system

851

5003

1.78

49.96

7.7

6.8

24.51

24.61

mmol/l

0.33

820

4795

Tobacco use

293

1168

2.73

49.95

9.0

7.6

25.13

24.46

mmol/l

1.79

281

1117

Speech and linguistic disorders, excluding more controls

265

923

2.81

49.84

7.0

6.0

24.41

24.12

mmol/l

0.50

248

866

Acute pancreatitis

921

5526

1.74

49.81

9.6

6.8

24.30

24.54

mmol/l

0.96

890

5294

Glomerular disorders in diseases classified elsewhere

584

3072

2.02

49.75

11.4

7.0

22.61

24.48

mmol/l

19.04

565

2938

Reimbursement for rheumatic diseases

2311

16649

1.41

49.73

7.1

6.8

24.70

24.56

mmol/l

1.08

2215

15965

Soft tissue disorders related to use, overuse and pressure

1197

7647

1.62

49.69

6.9

24.63

24.55

mmol/l

0.29

1153

7331

Dialysis

236

850

3.09

49.55

13.9

7.1

21.96

24.79

mmol/l

17.27

230

817

Occupational exposure to risk-factors

225

797

3.20

49.21

6.7

7.9

24.32

24.41

mmol/l

0.14

219

759

Special screening examination for infectious and parasitic diseases

108

2996

0.26

49.02

4.7

6.4

24.24

24.34

mmol/l

0.10

101

2842

Mental and behavioural disorders due to sedatives or hypnotics

322

1349

2.55

48.90

8.4

7.4

25.16

24.42

mmol/l

2.59

311

1293

Other sleep disorders

509

2559

2.09

48.82

6.3

6.7

24.69

24.34

mmol/l

1.30

493

2440

Dissociative [conversion] disorders

179

549

3.52

48.62

7.4

6.2

24.59

24.07

mmol/l

0.99

172

522

Disorders of lacrimal system

1850

12750

1.46

48.61

6.6

24.71

24.59

mmol/l

0.75

1770

12205

Cervicocranial syndrome

470

2298

2.15

48.60

6.4

6.9

24.69

24.40

mmol/l

1.11

456

2198

Lyme disease

514

9740

0.51

48.58

6.6

7.2

24.69

24.59

mmol/l

0.34

505

9327

Lyme disease, including avohilmo

514

9740

0.51

48.58

6.6

7.2

24.69

24.59

mmol/l

0.34

505

9327

Shock, not elsewhere classified

195

6.30

48.54

37.8

6.7

22.80

24.17

mmol/l

1.41

185

Diabetic nephropathy, excluding more controls

780

3653

1.84

48.37

10.0

7.0

23.25

24.34

mmol/l

9.26

749

3504

Open wound of head

2389

16411

1.40

48.32

7.2

6.8

24.50

24.49

mmol/l

0.04

2307

15678

Gout, idiopatic and unspecified

1303

8578

1.58

48.27

8.9

6.9

23.87

24.45

mmol/l

5.09

1266

8213

Brachial plexus disorders

374

1675

2.35

48.24

5.6

7.2

24.50

24.40

mmol/l

0.24

357

1602

Acute and transient psychotic disorders

485

2408

2.11

48.12

7.8

7.1

25.61

24.39

mmol/l

7.82

461

2299

Primary gonarthrosis, bilateral

2379

14556

1.40

48.12

6.1

7.1

24.81

24.55

mmol/l

2.99

2283

13970

Unspecified haematuria

2011

11629

1.45

48.11

7.4

7.2

24.33

24.47

mmol/l

0.80

1920

11159

Early lumbar disc prolapse, operated

336

1434

2.44

48.03

6.7

7.9

24.57

24.38

mmol/l

0.47

320

1372

Spirochaetal infections, other/unspecified, including avohilmo

522

9799

0.52

47.83

6.6

7.2

24.68

24.59

mmol/l

0.32

513

9383

Previous suicide attempt

162

6.54

47.77

7.9

9.3

23.99

24.37

mmol/l

0.36

153

Artificial opening status

305

1271

2.62

47.52

18.5

6.4

24.37

24.45

mmol/l

0.12

296

1206

Acute gastritis

394

1827

2.31

47.50

8.4

6.3

24.79

24.51

mmol/l

0.65

386

1748

Other and unspecified injuries of head

396

1844

2.30

47.18

6.7

6.9

24.35

24.44

mmol/l

0.18

387

1752

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

651

3474

1.89

47.05

12.0

6.9

24.41

24.45

mmol/l

0.10

623

3317

Liquid cancers

1339

8399

1.56

46.90

8.6

6.8

24.50

24.52

mmol/l

0.05

1276

8091

Malignant neoplasm of urinary organs

535

2797

2.04

46.70

6.7

7.0

24.21

24.49

mmol/l

1.02

512

2697

Pyothorax

278

1126

2.74

46.58

15.3

7.3

25.45

24.49

mmol/l

3.17

268

1075

Other spirochaetal diseases

530

9815

0.53

46.43

6.6

7.2

24.72

24.59

mmol/l

0.51

521

9398

Other blood glucose lowering drugs, excl. Insulins

765

4459

1.80

46.40

6.9

6.5

24.53

24.66

mmol/l

0.40

734

4258

Cholecystitis

702

3993

1.84

46.27

9.6

6.2

24.49

24.56

mmol/l

0.17

678

3816

Other disorders of glucose regulation and pancreatic internal secretion

407

1928

2.24

46.20

7.3

6.9

23.82

24.43

mmol/l

1.77

396

1842

Arterial embolism and thrombosis

329

1435

2.48

46.11

12.0

5.8

24.00

24.34

mmol/l

0.79

313

1374

Other spirochaetal diseases, including avohilmo

541

9938

0.53

46.11

6.5

7.2

24.73

24.58

mmol/l

0.59

531

9518

Other noninfective gastroenteritis and colitis

1030

6464

1.64

45.99

8.4

6.6

24.12

24.54

mmol/l

2.80

988

6181

Systemic connective tissue disorders

1493

10172

1.51

45.92

6.9

6.5

24.61

24.59

mmol/l

0.07

1442

9735

Inguinal hernia

2555

12565

1.38

45.63

7.1

7.0

24.47

mmol/l

0.03

2459

12013

Pneumocystosis, including avohilmo

163

507

3.89

45.58

12.6

7.7

24.34

24.54

mmol/l

0.26

156

487

Pneumocystosis

163

507

3.89

45.58

12.6

7.7

24.34

24.54

mmol/l

0.26

156

487

Asthma and allergy

367

1634

2.28

45.56

6.5

5.3

24.60

24.02

mmol/l

2.25

353

1557

Other symptoms and signs involving the digestive system and abdomen

679

3828

1.84

45.43

8.1

6.0

24.44

24.72

mmol/l

1.21

657

3660

Diseases of the myoneural junction and muscle

618

3410

1.91

45.37

9.5

6.9

24.49

24.47

mmol/l

0.04

602

3261

Malignant neoplasm of colon, including Hilmo

923

5661

1.69

45.30

7.7

6.6

24.09

24.50

mmol/l

2.78

889

5441

Other viral diseases

1042

6563

1.62

44.84

8.2

6.9

24.42

24.38

mmol/l

0.11

998

6285

Intracerebral haemorrhage

659

3731

1.86

44.31

10.8

6.2

24.70

24.45

mmol/l

0.88

631

3578

Causalgia

111

266

4.84

44.03

7.6

9.9

25.12

24.46

mmol/l

0.99

106

256

Injuries to the neck

915

5643

1.67

43.96

7.9

7.0

24.81

24.38

mmol/l

2.90

879

5394

Sleep disorders (combined)

4518

18817

1.27

43.95

6.9

6.8

24.72

24.41

mmol/l

6.44

4366

17957

Abnormal involuntary movements

620

3450

1.88

43.95

7.1

6.9

24.86

24.44

mmol/l

2.13

601

3312

Cytomegalovirus infection, IBD co-morbidity

153

461

3.80

43.94

13.1

8.5

23.43

24.58

mmol/l

2.69

143

442

Polyneuropathies and other disorders of the peripheral nervous system

1061

6811

1.62

43.92

10.3

7.0

24.61

24.46

mmol/l

0.59

1036

6515

Sequelae of injuries, of poisoning and of other consequences of external causes

973

6101

1.65

43.86

10.2

7.0

24.76

24.49

mmol/l

1.38

924

5843

Other specified and unspecified personality disorders

363

1676

2.28

43.60

7.1

7.4

25.32

24.35

mmol/l

4.46

358

1605

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1330

8949

1.53

43.39

7.2

6.7

24.59

24.61

mmol/l

0.06

1261

8584

Other specified/unspecified arthritis

1092

7046

1.59

43.31

6.6

7.0

24.56

24.58

mmol/l

0.06

1055

6757

Fall involving bed

237

924

2.89

43.29

8.1

5.8

25.11

24.48

mmol/l

1.42

226

886

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

732

4303

1.79

43.28

10.3

7.3

23.33

24.52

mmol/l

10.17

712

4127

Cytomegaloviral disease

153

465

3.74

43.24

13.1

8.3

23.43

24.65

mmol/l

2.94

143

445

Viral infections characterized by skin and mucous membrane lesions

1726

12197

1.45

43.19

7.7

6.9

24.49

24.51

mmol/l

0.09

1660

11685

Cytomegaloviral disease, including avohilmo

154

471

3.71

43.07

13.0

8.3

23.43

24.69

mmol/l

3.16

144

451

Dermatitis and eczema

4595

21838

1.26

43.07

7.6

6.8

24.52

24.50

mmol/l

0.14

4414

20905

Other disorders of lacrimal gland

1509

10427

1.48

43.04

6.8

6.7

24.75

24.62

mmol/l

0.75

1446

9970

Other viral diseases, not elsewhere classified

709

4101

1.78

42.89

7.2

6.8

24.58

24.37

mmol/l

0.78

683

3924

Malignant neoplasm of kidney, except renal pelvis

483

2514

2.05

42.79

6.7

6.8

24.30

24.50

mmol/l

0.59

463

2423

Malignant neoplasm of brain

201

718

3.09

42.71

14.1

6.8

25.39

24.56

mmol/l

2.27

187

690

Injuries to the knee and lower leg

4836

21101

1.25

42.44

7.8

6.7

24.60

24.47

mmol/l

1.38

4655

20193

Lesion of ulnar nerve

605

3375

1.87

42.38

8.1

7.2

24.56

24.49

mmol/l

0.14

581

3230

Malignant neoplasm of urinary organs, including Hilmo

597

3338

1.89

42.13

6.7

6.8

24.19

24.46

mmol/l

0.99

573

3217

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

672

3750

1.80

42.04

11.9

7.0

24.42

24.41

mmol/l

0.01

643

3578

Decubitus ulcer and pressure area

367

1745

2.27

41.96

15.7

6.6

24.27

24.42

mmol/l

0.22

354

1669

Other and unspecified polyneuropathies, also in other diseases

938

5919

1.65

41.91

9.6

7.0

24.53

24.46

mmol/l

0.19

917

5666

Unspecified kidney failure

558

3074

1.92

41.34

9.9

5.8

22.84

24.73

mmol/l

15.63

537

2951

Cardiac murmurs and other cardiac sounds

343

1559

2.26

41.18

7.9

6.5

24.78

24.33

mmol/l

1.35

328

1489

Other skin changes

940

5952

1.64

41.16

7.2

6.8

24.44

24.50

mmol/l

0.21

898

5701

Oxicams

1139

4176

1.60

41.11

6.2

7.5

24.52

24.34

mmol/l

0.80

1099

3993

Myocardial infarction, with ST-elevation

894

5611

1.67

40.93

8.2

6.7

24.06

24.35

mmol/l

1.42

858

5374

Extracorporeal dialysis

330

1522

2.35

40.81

14.1

7.1

22.14

24.47

mmol/l

15.64

313

1461

Acute pancreatitis (for exclusion)

921

5818

1.64

40.69

9.6

6.8

24.30

24.48

mmol/l

0.63

890

5575

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

521

2831

1.95

40.40

6.7

6.9

24.32

24.48

mmol/l

0.43

501

2735

Congenital malformations of heart and great arteries

501

2588

1.96

40.36

12.1

7.0

24.77

24.37

mmol/l

1.70

483

2471

Any dementia

1968

9912

1.41

39.98

5.4

6.5

24.47

24.53

mmol/l

0.25

1887

9506

Other and unspecified effects of external causes

985

6322

1.60

39.84

7.4

6.8

24.30

24.41

mmol/l

0.37

952

6030

Coxarthrosis, primary

2738

17445

1.33

39.81

6.5

6.9

24.65

24.57

mmol/l

0.53

2624

16748

Malignant neoplasm of colon

770

4696

1.71

39.51

7.7

6.6

24.09

24.51

mmol/l

2.42

741

4516

Sulfasalazine

1083

7118

1.56

39.47

7.0

6.8

24.72

24.44

mmol/l

1.66

1036

6805

Strabismus

1000

6444

1.59

39.43

9.0

6.8

24.68

24.46

mmol/l

1.07

961

6161

Disorders of ocular muscles, binocular movement, accommodation and refraction

1780

12727

1.41

39.41

8.2

6.7

24.61

24.45

mmol/l

1.01

1720

12171

Somnolence, stupor and coma

237

958

2.69

39.36

11.1

7.0

24.91

24.41

mmol/l

1.02

231

914

Fibromyalgia

340

1590

2.23

39.36

6.1

6.7

24.73

24.46

mmol/l

0.70

321

1509

Malignant neoplasm of brain, including Hilmo

254

1061

2.58

39.20

13.8

6.7

25.32

24.52

mmol/l

2.88

237

1019

Hypoglycaemia, other or unspecified

329

1532

2.29

39.18

7.5

6.9

23.84

24.37

mmol/l

1.21

320

1461

Abdominal aortic aneurysm (AAA)

528

2880

1.92

39.15

10.8

5.7

24.44

24.26

mmol/l

0.49

510

2756

Umbilical hernia

1150

7684

1.54

39.12

7.6

7.1

24.80

24.42

mmol/l

2.85

1113

7352

Total colectomy

222

876

2.77

38.87

13.8

7.2

23.90

24.45

mmol/l

1.01

215

842

Total colectomy operation

222

876

2.77

38.87

13.8

7.2

23.90

24.45

mmol/l

1.01

215

842

Disturbances of skin sensation

1029

6714

1.57

38.78

6.7

7.0

24.52

24.49

mmol/l

0.07

988

6429

Focal brain injury

299

1341

2.36

38.76

11.8

5.7

24.96

24.06

mmol/l

3.65

292

1272

Gout, strict definition

953

6161

1.62

38.66

9.5

6.9

23.87

24.45

mmol/l

3.72

932

5903

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

366

1786

2.19

38.64

7.0

6.3

24.70

24.50

mmol/l

0.41

350

1707

Presence of other functional implants

2514

13045

1.34

38.58

6.6

6.2

24.51

24.65

mmol/l

0.96

2409

12519

Sequelae of other external causes

287

1276

2.41

38.39

12.0

7.3

24.25

24.42

mmol/l

0.25

277

1211

Functional dyspepsia

1072

7091

1.55

38.07

6.7

6.4

24.69

24.60

mmol/l

0.32

1022

6796

Postmenopausal osteoporosis with pathological fracture

364

1796

2.19

37.93

7.1

5.9

25.36

24.84

mmol/l

1.84

347

1721

Fall on same level involving ice and snow

2353

17832

1.34

37.88

6.9

6.8

24.53

24.55

mmol/l

0.11

2265

17075

Malignant neoplasm of eye, brain and central nervous system

234

960

2.64

37.68

12.8

6.8

25.35

24.55

mmol/l

2.58

220

923

Invasive ventilation

364

1793

2.17

37.65

17.2

7.2

25.67

24.36

mmol/l

5.97

340

1713

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

522

2901

1.90

37.64

8.4

6.9

24.56

24.49

mmol/l

0.17

501

2796

Migraine with aura and triptan purchases

487

2621

1.91

37.62

6.8

6.5

24.05

24.31

mmol/l

1.07

472

2498

Noninfectious colitis NAS

584

3341

1.82

37.58

8.0

6.4

23.99

24.51

mmol/l

2.23

562

3198

Alcohol-induced chronic pancreatitis

336

1614

2.24

37.43

12.1

7.3

23.99

24.45

mmol/l

1.09

326

1553

Assault by bodily force

305

1396

2.29

37.43

9.2

7.9

24.52

24.40

mmol/l

0.24

300

1337

Other/unspecified cytomegaloviral diseases

128

383

3.82

37.21

13.2

9.1

23.54

24.52

mmol/l

1.82

120

367

Disorders of parathyroid gland

921

5869

1.61

37.14

7.0

6.3

24.59

24.73

mmol/l

0.49

886

5613

Amputation of toe

396

2029

2.10

37.04

10.7

6.8

23.64

24.43

mmol/l

2.93

381

1945

Left ventricular outflow tract obstruction, narrow definition

239

997

2.58

37.00

16.7

7.4

24.59

24.50

mmol/l

0.15

231

959

Ulcer of lower limb, not elsewhere classified

733

4498

1.71

36.88

9.2

6.8

24.17

24.51

mmol/l

1.20

710

4310

Mental retardation, excluding more controls

149

464

3.31

36.88

8.7

6.6

26.14

24.37

mmol/l

4.82

143

439

Hydronephrosis

524

2925

1.88

36.87

8.6

6.1

23.40

24.73

mmol/l

10.49

500

2810

Impingement syndrome of shoulder

975

6372

1.58

36.86

7.5

7.4

24.62

24.54

mmol/l

0.30

921

6101

Problems related to social environment

168

590

3.13

36.83

7.4

7.1

25.58

24.36

mmol/l

2.73

161

564

Malignant neoplasm of rectum, including Hilmo

597

3476

1.80

36.58

8.2

6.8

24.50

24.49

mmol/l

0.03

575

3349

Haemorrhoids and perianal venous thrombosis

1450

10177

1.45

36.54

5.9

6.5

24.59

mmol/l

0.02

1396

9735

Benign neoplasm of meninges

485

2661

1.92

36.40

8.1

6.9

24.78

24.62

mmol/l

0.51

474

2537

Disorders of continuity of bone

414

2149

2.02

36.36

7.2

24.87

24.50

mmol/l

1.08

400

2052

Duodenal ulcer

546

3107

1.85

36.22

8.6

6.4

23.86

24.41

mmol/l

2.26

524

2985

Other and unspecified myopathies

452

2435

1.97

36.11

9.5

6.8

24.41

24.42

mmol/l

0.01

441

2332

Disorders of skin appendages

1819

13291

1.39

36.07

7.5

6.9

24.40

24.47

mmol/l

0.31

1740

12721

Other disorders of skin and subcutaneous tissue, not elsewhere classified

651

3889

1.75

36.05

9.7

6.7

24.62

24.52

mmol/l

0.23

623

3720

Other diseases of anus and rectum

1291

8930

1.48

35.99

7.6

6.4

24.58

24.57

mmol/l

0.03

1245

8545

Flat foot [pes planus] (acquired)

409

2125

2.02

35.87

6.8

7.1

24.71

24.65

mmol/l

0.14

392

2035

Paracetamol or NSAID medication

569

1574

1.86

35.77

6.8

7.1

24.27

24.13

mmol/l

0.30

540

1490

Glomerulonephritis

446

2394

1.96

35.77

8.5

7.0

23.51

24.46

mmol/l

4.74

426

2288

Hypothyroidism, strict autoimmune

2814

14333

1.31

35.64

6.6

24.59

24.48

mmol/l

0.81

2704

13735

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1309

7863

1.47

35.58

6.3

6.5

24.33

24.62

mmol/l

2.13

1260

7514

Nonorganic sleeping disorders

770

4797

1.65

35.49

7.7

6.7

24.67

24.36

mmol/l

1.53

744

4585

Gonarthrosis, primary, with knee surgery

2582

15527

1.32

35.43

6.3

7.1

24.66

24.55

mmol/l

0.79

2480

14906

Visual field defects

415

2187

2.01

35.39

8.3

6.9

24.68

24.52

mmol/l

0.40

396

2080

Non-allergic asthma

396

2049

2.04

35.37

7.0

6.9

24.71

24.49

mmol/l

0.51

382

1958

Other diseases of blood and blood-forming organs, wide

921

6006

1.58

35.32

9.1

7.0

24.72

24.54

mmol/l

0.64

888

5755

Recurrent or chronic depression

1303

6228

1.48

35.18

8.2

6.7

24.55

24.48

mmol/l

0.30

1265

5932

DVT of lower extremities

851

5467

1.61

35.03

7.6

7.0

24.75

24.48

mmol/l

1.22

815

5228

Agranulocytosis

494

2755

1.88

35.00

9.1

6.9

24.62

24.53

mmol/l

0.19

478

2631

Other diseases of pancreas

416

2204

2.00

34.96

9.9

6.4

23.99

24.64

mmol/l

2.41

404

2108

Protozoal diseases

186

715

2.91

34.91

12.1

7.8

24.45

24.54

mmol/l

0.11

178

688

Haemorrhage, not elsewhere classified

213

868

2.66

34.86

10.2

6.8

24.58

24.46

mmol/l

0.15

203

830

Alcohol withdrawal state with delirium

356

1794

2.13

34.83

10.6

7.7

24.27

24.49

mmol/l

0.46

349

1724

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

329

1605

2.17

34.75

12.4

6.7

25.23

24.47

mmol/l

3.30

307

1540

Other systemic involvement of connective tissue

1129

7704

1.51

34.65

6.3

6.4

24.75

24.59

mmol/l

0.79

1089

7379

Rheumatoid arthritis, including avohilmo

1535

11071

1.42

34.62

7.1

6.7

24.71

24.60

mmol/l

0.52

1463

10616

Exclusions for E4_PCOS_CONSORTIUM

2443

11651

1.33

34.42

7.2

6.3

24.65

24.57

mmol/l

0.45

2349

11129

Hypopituitarism

310

1483

2.21

34.29

10.6

7.4

24.58

24.44

mmol/l

0.30

297

1422

Postprocedural disorders of nervous system

251

1103

2.38

33.94

5.9

7.1

24.31

24.30

mmol/l

0.02

240

1054

Adenocarcinoma and papilloma adenocarcinoma of rectum

493

2781

1.87

33.87

8.2

6.9

24.62

24.50

mmol/l

0.31

475

2679

Procreative management

1106

6166

1.51

33.79

6.8

7.3

24.62

24.54

mmol/l

0.28

1039

5904

Cholangitis (primary sclerosing, PSC)

307

1477

2.21

33.79

9.4

6.1

23.80

24.55

mmol/l

2.75

297

1409

Malignant neoplasm of rectum

495

2798

1.87

33.75

8.2

6.8

24.54

24.50

mmol/l

0.08

475

2692

Recurrent aphthous stomatitis , including avohilmo

591

3498

1.75

33.70

7.0

6.8

24.51

24.47

mmol/l

0.09

568

3349

Acute alcohol intoxication ICD-9

198

796

2.74

33.67

8.0

6.6

25.18

24.51

mmol/l

1.37

192

762

Abnormal spermatozoa

174

4201

0.39

33.63

4.0

7.8

24.26

24.32

mmol/l

0.07

161

4027

Cystitis

3260

15410

1.27

33.55

7.2

6.7

24.43

24.45

mmol/l

0.07

3145

14736

Artificial joint operation, meniscal resection

3855

20016

1.25

33.47

6.5

7.1

24.71

24.54

mmol/l

2.05

3696

19192

Protozoal diseases, including avohilmo

187

738

2.82

33.23

12.1

7.7

24.45

24.57

mmol/l

0.15

179

708

Benign neoplasm: Cerebral meninges

439

2412

1.92

32.88

8.2

6.8

24.80

24.59

mmol/l

0.75

429

2296

Congenital malformations of aortic and mitral valves

208

864

2.60

32.66

17.6

7.4

24.70

24.46

mmol/l

0.47

201

829

Other embolism and thrombosis

570

3377

1.76

32.62

8.3

6.7

24.68

24.48

mmol/l

0.60

546

3230

Corns and callosities

326

1628

2.13

32.53

7.9

7.3

24.44

24.50

mmol/l

0.10

313

1550

Chronic viral hepatitis

209

866

2.56

32.53

9.4

8.5

24.59

24.41

mmol/l

0.26

202

828

Other symptoms and signs involving general sensations and perceptions

221

948

2.52

32.34

7.5

6.9

25.01

24.38

mmol/l

1.63

212

899

Cardiomyopathy, other and unspecified

319

1578

2.13

32.30

10.4

6.3

24.20

24.49

mmol/l

0.64

313

1506

Other problems related to primary support group, including family circumstances

344

1688

2.05

32.24

7.7

7.0

24.71

24.33

mmol/l

1.22

334

1615

Other viral diseases, including avohilmo

1255

8738

1.45

32.23

7.9

6.8

24.38

24.39

mmol/l

0.01

1205

8359

Gestational [pregnancy-induced] hypertension

675

4155

1.66

32.11

6.7

6.4

24.25

24.39

mmol/l

0.47

648

3959

Gout, unspecified

1014

6910

1.52

32.00

9.1

6.8

23.86

24.47

mmol/l

4.40

985

6631

Diplopia

581

3483

1.74

31.85

7.2

6.8

24.69

24.51

mmol/l

0.62

556

3336

Stomatitis and related lesions

764

4885

1.61

31.82

7.5

6.8

24.45

24.48

mmol/l

0.07

734

4673

Paralytic ileus

216

927

2.54

31.78

12.6

6.9

24.67

24.59

mmol/l

0.09

210

876

Other disorders of nervous system

322

1615

2.12

31.77

7.4

6.8

25.18

24.55

mmol/l

2.83

315

1540

Congenital malformations of the circulatory system

526

2970

1.78

31.73

12.7

7.0

24.83

24.37

mmol/l

2.20

508

2837

Unknown and unspecified causes of morbidity

278

1313

2.22

31.65

8.1

6.4

24.37

24.57

mmol/l

0.36

273

1255

Pregnancy hypertension

1148

7101

1.47

31.57

6.4

6.5

24.36

24.56

mmol/l

1.17

1103

6783

Polycystic ovarian syndrome, consortium definition

2291

10054

1.32

31.55

6.7

6.0

24.77

24.57

mmol/l

1.62

2192

9618

Appendectomy

2343

17297

1.31

31.55

7.5

7.0

24.47

24.52

mmol/l

0.28

2255

16556

Cardiodefibrillation

1646

12182

1.38

31.53

7.4

7.0

24.41

24.51

mmol/l

0.48

1584

11682

Superficial injury of thorax

657

4070

1.67

31.50

7.6

6.8

24.87

24.41

mmol/l

2.39

630

3894

Hypothermia

132

448

3.38

31.49

11.5

7.3

23.26

24.24

mmol/l

1.20

126

428

Tubulo-interstitial nephritis, not specified as acute or chronic

303

1488

2.15

31.36

6.7

6.0

24.57

24.67

mmol/l

0.16

292

1419

Fibrosis and cirrhosis of liver

385

2065

1.98

31.29

9.5

6.8

23.56

24.55

mmol/l

4.30

368

1985

Other and unspecified abdominal hernia

221

965

2.49

31.24

8.3

6.5

24.99

24.54

mmol/l

0.88

212

918

Radiculopathy

660

4099

1.67

31.22

6.2

6.9

24.65

24.41

mmol/l

0.95

641

3935

Injury of intra-abdominal organs

136

467

3.20

31.12

21.2

7.7

24.07

24.49

mmol/l

0.55

130

446

Hypothyreosis and Thyroxine purchase for inclusion criteria

3578

19019

1.25

31.11

6.9

6.8

24.60

24.46

mmol/l

1.44

3423

18225

Viral pneumonia (unknown virus, not influenza)

309

1536

2.13

31.06

10.7

7.1

24.51

24.34

mmol/l

0.29

295

1475

Early lumbar disc prolapse operation

347

1785

2.01

31.04

7.0

7.8

24.60

24.37

mmol/l

0.68

331

1706

Other and unspecified local infections of skin and subcutaneous tissue

430

2390

1.88

30.79

8.8

6.9

24.43

mmol/l

0.01

412

2284

Colon adenocarcinoma

607

3721

1.71

30.76

7.2

6.5

24.10

24.54

mmol/l

2.16

585

3585

Hypothyroidism, other/unspecified

3457

18404

1.25

30.71

6.9

6.8

24.59

24.46

mmol/l

1.29

3306

17632

Benign neoplasm: Stomach

452

2560

1.86

30.70

6.9

6.6

24.65

24.57

mmol/l

0.19

437

2445

Type 1 diabetes, definitions combined

278

1318

2.17

30.70

7.0

6.3

22.76

24.45

mmol/l

6.51

265

1256

Other aneurysm

284

1380

2.21

30.70

11.8

6.5

24.47

24.48

mmol/l

0.02

274

1323

Cerebral palsy and other paralytic syndromes

468

2671

1.83

30.55

9.5

6.8

24.68

24.43

mmol/l

0.65

442

2556

Other other unspecified disorders of the circulatory system

199

839

2.59

30.53

11.1

7.0

24.47

24.38

mmol/l

0.14

189

803

Type 1 diabetes, strict (exclude DM2)

275

1303

2.17

30.43

7.0

6.3

22.71

24.44

mmol/l

6.65

262

1243

Rheumatism, unspecified

506

2952

1.78

30.39

6.0

6.7

25.04

24.67

mmol/l

1.48

485

2819

Pneumonia derived septicemia

182

737

2.68

30.31

11.1

7.5

24.65

24.43

mmol/l

0.27

171

699

Acute posthaemorrhagic anaemia

198

835

2.58

30.30

10.0

6.7

24.15

24.53

mmol/l

0.58

187

795

Clear cell adenocarcinoma of kidney

257

1212

2.30

30.28

6.1

6.9

24.24

24.53

mmol/l

0.63

246

1169

Other enthesopathies

1093

7592

1.47

30.28

6.0

7.1

24.59

24.51

mmol/l

0.35

1046

7269

Other viral hepatitis

243

1109

2.31

30.27

9.9

8.1

24.57

24.42

mmol/l

0.23

236

1062

Dementia

2024

10561

1.34

30.15

5.5

6.8

24.47

24.56

mmol/l

0.45

1946

10109

Childhood asthma (age<16), excluding more controls

262

935

2.23

30.10

7.6

5.1

24.18

23.68

mmol/l

1.49

249

886

Other viral hepatitis, including avohilmo

253

1178

2.26

29.96

9.6

8.1

24.60

24.40

mmol/l

0.34

245

1131

Drug-induced neutropenia

326

1678

2.06

29.90

9.5

7.5

24.70

24.60

mmol/l

0.17

316

1603

Injury of other and unspecified intrathoracic organs

316

1610

2.09

29.87

12.6

7.1

25.06

24.41

mmol/l

2.41

305

1538

Zoster [herpes zoster]

821

5424

1.57

29.86

8.2

6.7

24.79

24.58

mmol/l

0.86

792

5193

Ovarian cyst

1128

4440

1.48

29.83

6.5

24.34

24.55

mmol/l

1.10

1088

4243

Behavioural disorders, excluding more controls

172

4.58

29.65

7.6

6.2

24.63

24.05

mmol/l

0.59

161

Hyperkinetic disorders, excluding more controls

260

1132

2.18

29.42

4.4

5.4

24.00

23.80

mmol/l

0.44

253

1066

Bicuspidal aortic valve syndrome

193

815

2.57

29.41

18.4

7.5

24.69

24.51

mmol/l

0.34

187

783

Type 1 diabetes, strict definition, subgroup 1

188

770

2.52

29.34

7.2

6.2

22.46

24.36

mmol/l

5.52

178

728

Hyperparathyroidism

792

5157

1.57

29.21

6.9

6.3

24.44

24.74

mmol/l

1.39

763

4924

Other extrapyramidal and movement disorders in other diseases

1038

7214

1.48

29.18

6.2

7.0

25.03

24.49

mmol/l

4.93

1006

6916

Artificial joint re-operation

357

1917

1.99

29.16

6.3

25.15

24.56

mmol/l

2.39

341

1832

Benign neoplasm: Transverse colon

528

3174

1.75

29.09

8.5

6.9

24.69

24.51

mmol/l

0.50

516

3042

Osteomyelitis

313

1607

2.07

28.97

10.1

7.2

24.48

24.43

mmol/l

0.07

300

1537

Diseases of oral cavity, salivary glands and jaws

2437

9786

1.30

28.95

6.7

6.6

24.46

24.54

mmol/l

0.46

2337

9342

Disorders of muscles

419

2353

1.85

28.83

8.5

7.3

24.41

24.44

mmol/l

0.05

409

2249

Primary coxarthrosis, bilateral

1300

9433

1.42

28.75

6.4

6.7

24.78

24.56

mmol/l

1.37

1243

9051

Other/unspecified seropositive rheumatoid arthritis

1053

7360

1.47

28.67

7.1

6.7

24.71

24.58

mmol/l

0.52

1004

7059

Degenerative diseases of the nervous system

1781

9689

1.35

28.64

5.3

6.5

24.35

24.51

mmol/l

0.91

1717

9275

Social phobias

254

1199

2.19

28.60

8.6

6.3

24.29

24.15

mmol/l

0.21

243

1139

185

4.95

28.57

6.4

5.9

25.54

24.26

mmol/l

1.82

173

Pleural plaque

486

2877

1.78

28.48

6.5

6.2

24.90

23.95

mmol/l

6.91

474

2748

Amiodarone users

496

2953

1.77

28.45

7.5

6.8

24.04

24.47

mmol/l

1.74

475

2833

Childhood asthma (age<16)

262

958

2.17

28.39

7.6

5.4

24.18

23.69

mmol/l

1.46

249

910

Xerosis cutis

123

426

3.30

28.37

8.0

6.9

23.83

24.65

mmol/l

1.17

118

405

Seropositive rheumatoid arthritis, wide

1061

7442

1.46

28.34

7.1

6.7

24.72

24.59

mmol/l

0.56

1012

7135

Varicose veins

2522

15078

1.28

28.32

6.7

24.83

24.49

mmol/l

4.59

2423

14434

Disorders of the thyroid gland

3714

19819

1.23

28.29

6.9

24.54

24.46

mmol/l

0.66

3555

18996

Other disorders of eyelid

1917

13897

1.33

28.28

7.0

6.7

24.79

24.57

mmol/l

2.00

1848

13311

Other viral diseases, not elsewhere classified, including avohilmo

893

6006

1.51

28.26

7.0

6.9

24.49

24.38

mmol/l

0.38

861

5742

Superficial injury of hip and thigh

676

4333

1.61

28.12

6.6

6.3

24.77

24.43

mmol/l

1.53

652

4151

Other epidermal thickening

224

1028

2.33

27.99

8.1

7.7

23.79

24.38

mmol/l

1.39

215

980

Evidence of alcohol involvement determined by blood alcohol level

278

3.83

27.84

9.0

9.1

23.99

24.61

mmol/l

0.76

266

Primary_lymphoid and hematopoietic malignant neoplasms

1061

7479

1.46

27.78

8.8

6.9

24.57

24.47

mmol/l

0.37

1009

7169

Asthma mixed form (mode), excluding more controls

177

729

2.54

27.71

4.5

5.3

25.45

23.99

mmol/l

4.31

172

694

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1029

7209

1.47

27.69

7.1

6.8

24.73

24.60

mmol/l

0.51

982

6915

Sulfonylureas

1502

8860

1.38

27.67

7.3

6.3

24.02

24.65

mmol/l

6.70

1435

8488

Sarcoidosis

546

3346

1.70

27.55

7.0

6.9

24.72

24.49

mmol/l

0.70

512

3197

Other local infections of skin and subcutaneous tissue

441

2554

1.80

27.47

8.7

6.9

24.44

24.45

mmol/l

0.02

423

2440

Chronic periodontitis, including avohilmo

3981

21099

1.22

27.47

7.1

6.9

24.50

24.55

mmol/l

0.37

3815

20207

Hypertensive Renal Disease

185

788

2.52

27.47

8.0

6.6

22.87

24.50

mmol/l

4.57

177

747

Other diseases of biliary tract

409

2324

1.85

27.43

9.6

6.1

23.80

24.69

mmol/l

4.11

397

2228

Periodontitis

3985

21102

1.22

27.41

7.1

6.9

24.49

24.55

mmol/l

0.52

3819

20209

Mixed and other personality disorders

281

1407

2.08

27.39

7.5

7.6

25.07

24.39

mmol/l

1.80

271

1351

Speech and linguistic disorders

267

1250

2.12

27.37

7.0

6.6

24.39

24.16

mmol/l

0.39

249

1191

Arterial embolism and thrombosis of lower extremity artery

195

855

2.47

27.35

12.5

5.8

23.96

24.37

mmol/l

0.75

185

818

Pneumothorax

326

1733

1.99

27.15

11.9

6.7

25.53

24.14

mmol/l

8.48

312

1657

Disorders of psychological development

331

1619

1.95

26.98

6.7

6.8

24.28

24.10

mmol/l

0.32

313

1534

D07AA Corticosteroids, weak (group I)

520

3145

1.70

26.97

7.6

6.7

24.74

24.28

mmol/l

1.69

500

3001

Migraine without aura and triptan purchases

458

2680

1.75

26.82

6.2

6.6

24.24

24.32

mmol/l

0.21

441

2557

Dementia in Alzheimer disease

907

5208

1.50

26.75

4.8

6.3

24.26

24.50

mmol/l

1.09

885

4984

Car occupant injured in other and unspecified transport accidents

661

4254

1.59

26.74

8.5

6.8

24.52

24.35

mmol/l

0.58

626

4065

Other or ill-defined heart diseases

210

950

2.32

26.70

9.7

6.7

24.70

24.36

mmol/l

0.57

201

908

Methotrexate

517

3143

1.70

26.64

7.2

6.5

24.68

24.50

mmol/l

0.52

499

3002

Benign neoplasm of other and unspecified endocrine glands

552

3425

1.67

26.53

8.1

6.9

25.09

24.52

mmol/l

3.08

531

3269

Other disorders of kidney and ureter

582

3663

1.66

26.52

9.6

6.9

24.23

24.52

mmol/l

0.90

554

3505

Fracture of skull and facial bones

824

5574

1.52

26.47

10.2

6.9

24.61

24.45

mmol/l

0.60

802

5312

Oesophagitis

263

1314

2.13

26.34

9.9

6.5

24.03

24.52

mmol/l

1.27

250

1261

Hyperplasia of prostate

1653

7009

1.36

26.25

7.0

8.0

24.45

24.37

mmol/l

0.36

1588

6751

295

1527

2.03

26.24

6.5

6.2

24.75

24.43

mmol/l

0.75

289

1455

Trochanteric bursitis

572

3583

1.65

26.20

6.3

6.7

24.77

24.68

mmol/l

0.23

553

3425

Type 1 diabetes, strict definition

197

867

2.34

26.19

7.0

6.4

22.64

24.37

mmol/l

5.09

187

822

Right hemicolectomy

294

1537

2.04

26.04

12.4

6.5

23.88

24.51

mmol/l

1.75

278

1469

Ulcerative colitis, NAS

512

3126

1.69

25.96

8.0

6.7

24.01

24.49

mmol/l

2.08

492

2990

Inflammatory bowel disease

1134

8160

1.42

25.93

7.8

7.1

24.25

24.47

mmol/l

1.26

1092

7797

Myalgia

824

5590

1.51

25.91

6.4

6.8

24.75

24.46

mmol/l

1.47

789

5346

Family history of malignant neoplasm

370

2063

1.85

25.90

5.9

6.1

24.61

24.53

mmol/l

0.19

347

1961

Dilated cardiomyopathy

548

3431

1.67

25.70

9.7

7.1

24.04

24.43

mmol/l

1.36

525

3289

Idiopathic gout

478

2897

1.74

25.69

8.4

7.0

23.71

24.49

mmol/l

3.69

465

2778

Periapical abscess

1766

13603

1.32

25.67

7.5

7.2

24.59

24.53

mmol/l

0.27

1689

13029

Disorders of sclera, cornea, iris and ciliary body

2103

16566

1.29

25.57

7.1

6.9

24.52

mmol/l

0.02

2020

15869

Mental retardation

149

588

2.66

25.30

8.7

8.0

26.14

24.31

mmol/l

5.22

143

560

Other fall from one level to another

848

5820

1.49

25.27

9.1

7.0

24.58

24.36

mmol/l

0.90

810

5574

Convergence insufficiency and excess

193

4.21

25.25

6.6

7.0

23.75

24.65

mmol/l

1.26

184

Lesion of lateral popliteal nerve

236

1152

2.18

25.22

11.6

7.1

24.47

24.49

mmol/l

0.02

229

1098

Other diseases of oesophagus

426

2507

1.77

25.19

7.3

6.3

24.78

24.47

mmol/l

0.87

414

2399

Scoliosis

292

1525

1.99

25.17

8.4

6.6

25.05

24.33

mmol/l

2.81

278

1463

Cirrhosis of liver, NAS

283

1483

2.04

25.00

9.5

7.3

23.29

24.56

mmol/l

4.97

276

1418

Diseases of pulp and periapical tissues, including avohilmo

4052

17532

1.21

24.96

7.0

6.7

24.37

24.50

mmol/l

1.35

3881

16773

Viral warts

374

2121

1.83

24.96

6.3

7.2

24.06

24.43

mmol/l

0.96

359

2032

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

364

2058

1.86

24.96

7.2

6.4

24.34

24.49

mmol/l

0.28

353

1971

Hypercalcemia

229

1114

2.22

24.95

7.2

6.6

25.09

24.44

mmol/l

1.44

219

1063

Immunodeficiencies

205

951

2.29

24.88

13.7

7.1

24.87

24.36

mmol/l

1.02

191

908

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3217

20714

0.82

24.86

7.2

6.8

24.50

24.49

mmol/l

0.05

3090

19810

Ulcerative colitis

879

6094

1.48

24.85

7.6

7.0

24.17

24.52

mmol/l

2.07

841

5826

Other strabismus

729

4859

1.53

24.60

8.6

6.5

24.55

24.43

mmol/l

0.38

701

4641

Mental retardation, wide definition

160

663

2.53

24.55

8.5

8.0

26.11

24.48

mmol/l

4.62

153

632

505

3115

1.67

24.53

9.0

6.5

24.58

24.39

mmol/l

0.52

483

2971

Diseases of male genital organs

2079

8180

1.30

24.34

7.1

8.1

24.46

24.40

mmol/l

0.28

1997

7849

Diseases of salivary glands

1208

8881

1.39

24.32

6.9

24.60

24.55

mmol/l

0.16

1172

8502

Dislocation, sprain and strain of joints and ligaments at neck level

513

3182

1.66

24.31

5.9

7.0

24.51

24.29

mmol/l

0.77

489

3041

Alzheimer disease

1594

8690

1.34

24.30

5.0

6.3

24.39

24.50

mmol/l

0.52

1536

8309

Asthma and opportunity respiratory infection

227

1111

2.19

24.25

8.1

6.7

25.54

24.28

mmol/l

4.48

218

1060

Carcinoma in situ of endometrium

101

6.36

24.22

6.2

7.7

24.59

25.61

mmol/l

1.52

Coagulation defects, purpura and other haemorrhagic conditions

750

5077

1.52

24.17

9.8

6.8

24.54

24.48

mmol/l

0.15

718

4872

Alzheimer’s disease (Late onset), excluding more controls

632

2641

1.60

24.14

4.9

5.8

24.33

24.22

mmol/l

0.31

615

2511

Superficial injury of abdomen, lower back and pelvis

601

3881

1.59

24.14

6.2

6.7

24.59

24.35

mmol/l

0.91

579

3712

Toxic effect of ethanol

167

720

2.46

24.05

9.0

7.6

24.17

24.45

mmol/l

0.34

160

689

Bronchiectasis

353

2000

1.86

24.04

7.7

6.5

25.48

24.27

mmol/l

5.86

338

1915

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1979

15020

1.29

24.03

7.5

7.2

24.83

24.50

mmol/l

4.02

1885

14407

Hypocalcemia

131

510

2.83

23.97

10.5

6.5

23.96

24.48

mmol/l

0.57

126

489

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

324

1793

1.91

23.96

7.2

6.3

23.67

24.47

mmol/l

3.10

308

1728

Fracture of shoulder and upper arm

1435

10839

1.35

23.90

7.0

6.7

24.73

24.57

mmol/l

0.83

1381

10373

Mycoses, including avohilmo

3552

22577

1.21

23.82

7.5

6.9

24.61

24.49

mmol/l

1.13

3426

21603

Pneumococcal septicemia

170

747

2.46

23.77

11.0

7.6

24.69

24.49

mmol/l

0.24

159

710

Use of pramipexole

908

6410

1.46

23.63

6.6

6.9

24.93

24.57

mmol/l

2.14

870

6151

Dementia, including avohilmo

2116

11441

1.29

23.57

5.7

6.9

24.47

24.57

mmol/l

0.54

2038

10972

Heartburn

414

2458

1.74

23.40

7.1

6.7

24.78

24.66

mmol/l

0.34

399

2355

Outcome of delivery

1365

0.30

23.36

2.3

6.7

23.79

24.28

mmol/l

0.78

1306

1409

9159

1.35

23.33

6.5

6.2

24.49

24.56

mmol/l

0.28

1348

8768

Persistent mood disorders

678

4524

1.54

23.32

8.0

6.5

24.97

24.48

mmol/l

2.40

656

4311

Other/unspecified rheumatoid arthritis

519

3278

1.65

23.31

8.0

6.4

24.76

24.64

mmol/l

0.29

494

3130

Other ill-defined and unspecified causes of mortality

457

2809

1.71

23.23

8.8

6.4

24.70

24.37

mmol/l

0.99

452

2686

Other infectious diseases, including avohilmo

396

2341

1.77

23.11

9.3

6.8

24.16

24.41

mmol/l

0.60

377

2235

Meniscus derangement

2108

11080

1.28

23.11

6.5

7.1

24.75

24.55

mmol/l

1.74

2023

10607

Injuries to the elbow and forearm

2672

18700

1.24

22.97

6.8

24.62

24.53

mmol/l

0.56

2563

17923

Malignant neoplasm of pancreas, including Hilmo

408

2441

1.75

22.89

8.8

6.4

24.23

24.45

mmol/l

0.56

392

2350

Normal-pressure hydrocephalus

262

1382

2.04

22.88

5.5

6.0

24.52

24.46

mmol/l

0.09

256

1317

Erythema intertrigo

143

594

2.64

22.86

9.5

6.7

24.85

24.61

mmol/l

0.24

137

568

Secondary uncertain malignant neoplasm

586

3822

1.59

22.83

6.7

24.61

24.52

mmol/l

0.20

559

3676

Colon adenocarcinoma, helper endpoint

607

4005

1.58

22.66

7.2

6.5

24.10

24.52

mmol/l

1.99

585

3844

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1045

6234

1.41

22.61

7.0

6.9

25.46

24.47

mmol/l

13.97

989

6013

Thoracic aortic aneurysm

633

4219

1.56

22.42

11.9

6.5

24.75

24.43

mmol/l

1.53

611

4036

Subjective visual disturbances

952

6837

1.42

22.24

7.3

6.8

24.61

24.53

mmol/l

0.28

910

6548

Exposure to unspecified smoke, fire and flames

190

4.15

22.17

3.9

9.8

24.36

24.47

mmol/l

0.08

180

1030

7017

1.41

21.95

6.1

24.61

24.60

mmol/l

0.02

988

6710

Vitreous haemorrhage

445

2751

1.69

21.94

8.7

7.0

24.03

24.51

mmol/l

1.65

428

2634

Superficial injury of lower leg

935

6706

1.42

21.89

6.9

6.5

24.73

24.48

mmol/l

1.19

905

6398

Communicating hydrocephalus

125

499

2.77

21.87

13.8

7.3

24.65

24.35

mmol/l

0.33

119

479

Volvulus

152

661

2.49

21.86

9.8

6.3

24.84

24.65

mmol/l

0.22

147

627

Benign neoplasm: Colon, unspecified

1098

8113

1.39

21.85

7.7

7.0

24.36

24.53

mmol/l

0.78

1052

7769

Asthma mixed form (mode)

177

811

2.27

21.81

4.5

5.6

25.45

23.94

mmol/l

4.55

172

778

Inflammatory diseases of the central nervous system

333

1905

1.82

21.79

10.6

7.0

24.68

24.43

mmol/l

0.63

320

1816

Other congenital malformations of the digestive system

166

739

2.35

21.73

8.7

7.0

24.12

24.43

mmol/l

0.45

159

704

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

202

976

2.14

21.62

8.7

7.2

24.48

24.35

mmol/l

0.22

196

930

Intestinal malabsorption

205

1008

2.15

21.47

12.3

7.1

23.77

24.47

mmol/l

1.38

193

966

Heterophoria

280

1524

1.91

21.43

6.3

6.6

24.49

24.35

mmol/l

0.30

266

1449

Type1 diabetes, definitions combined, early onset

157

689

2.34

21.07

7.9

7.4

22.74

24.22

mmol/l

3.20

149

650

Intussusception

112

429

2.84

21.06

5.8

7.0

24.70

24.63

mmol/l

0.06

101

408

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

258

1387

1.97

21.03

7.5

6.1

23.49

24.43

mmol/l

3.16

243

1335

5-aminosalicylic acid

688

4703

1.49

20.94

7.2

6.8

24.17

24.37

mmol/l

0.72

660

4491

Purpura and other haemorrhagic conditions

536

3492

1.59

20.94

9.0

6.7

24.45

24.47

mmol/l

0.04

513

3354

Oesophageal varices

205

1023

2.15

20.88

8.8

6.9

23.28

24.32

mmol/l

2.68

200

978

Caries of dentine, including avohilmo

3145

13370

1.22

20.85

6.7

6.8

24.47

24.52

mmol/l

0.33

3016

12776

Dermatitis due to substances taken internally

226

1161

2.04

20.84

8.0

6.4

24.69

24.49

mmol/l

0.33

217

1103

Paralytic strabismus

310

1766

1.84

20.80

9.7

6.7

24.94

24.43

mmol/l

1.61

297

1683

Pleural plaque with presence of asbestos

377

2280

1.75

20.73

6.3

6.8

24.90

24.24

mmol/l

2.94

366

2178

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

479

2626

1.61

20.71

5.9

6.8

24.04

24.01

mmol/l

0.06

461

2500

Brain glioblastoma and astrocytoma

102

377

2.99

20.70

7.7

7.9

24.93

24.68

mmol/l

0.41

365

Unspecified nephritic syndrome

120

482

2.73

20.64

10.4

7.9

24.04

24.51

mmol/l

0.75

114

461

Amputation of ankle bones

132

556

2.62

20.64

12.7

7.2

23.39

24.33

mmol/l

1.45

127

531

Ill-defined and unknown causes of mortality

480

3073

1.63

20.62

8.6

6.4

24.75

24.40

mmol/l

1.09

475

2942

Benign neoplasm: Sigmoid colon

820

5837

1.45

20.57

6.9

7.1

24.43

24.55

mmol/l

0.40

797

5588

Anaemia in chronic diseases classified elsewhere

137

587

2.56

20.55

11.0

7.2

22.54

24.59

mmol/l

4.92

127

561

False labour

677

2822

1.51

20.55

5.0

6.4

23.81

24.26

mmol/l

2.53

644

2693

Phlebitis and thrombophlebitis (not including DVT)

872

6261

1.43

20.53

6.9

6.8

24.64

24.48

mmol/l

0.61

830

5993

Orchitis and epididymitis

415

2566

1.68

20.43

9.1

8.0

24.40

24.30

mmol/l

0.19

401

2462

Irregular menses

1327

7566

1.33

20.41

7.0

6.2

24.52

24.49

mmol/l

0.10

1274

7235

Viral hepatitis

259

1400

1.93

20.36

9.6

8.0

24.56

24.41

mmol/l

0.25

251

1345

Viral hepatitis, including avohilmo

269

1472

1.90

20.31

9.4

7.9

24.59

24.46

mmol/l

0.21

260

1416

Coxarthrosis, primary, with hip surgery

2007

15006

1.26

20.17

6.4

6.8

24.62

24.56

mmol/l

0.30

1926

14401

Fracture of neck

290

1638

1.87

20.16

12.5

6.8

25.41

24.41

mmol/l

4.09

282

1566

Hepatic failure, not elsewhere classified

185

901

2.20

20.13

16.7

7.5

23.17

24.62

mmol/l

4.25

177

868

Adhesive capsulitis of shoulder

624

4230

1.51

20.08

7.5

7.2

24.54

mmol/l

0.01

597

4052

Diabetic retinopathy

1671

8158

1.30

20.05

9.3

7.6

23.93

24.34

mmol/l

3.25

1611

7841

Other diseases of intestine

641

4376

1.51

20.02

11.8

6.8

24.35

24.66

mmol/l

1.10

620

4181

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1108

14090

0.74

19.98

6.6

24.82

24.58

mmol/l

1.53

1061

13493

Adenocarcinoma and ductal carcinoma of pancreas

188

925

2.18

19.95

10.5

6.4

24.39

24.56

mmol/l

0.29

179

892

Other follicular disorders

275

1527

1.87

19.83

7.5

24.47

24.37

mmol/l

0.16

265

1467

Manic episode

124

511

2.58

19.81

7.6

8.0

25.59

24.50

mmol/l

1.80

119

484

Malignant neoplasm of pancreas

334

1972

1.78

19.80

8.7

6.4

24.26

24.51

mmol/l

0.56

321

1892

Diseases of pulp and periapical tissues and dental caries

2687

11349

1.23

19.79

6.6

6.8

24.46

24.55

mmol/l

0.56

2579

10839

Malignant neoplasm of endocrine gland

263

1444

1.90

19.72

6.3

7.0

25.00

24.61

mmol/l

1.10

250

1379

Conduct disorder

236

3.37

19.68

7.6

9.9

24.69

24.52

mmol/l

0.14

223

Foreign body in alimentary tract

234

1244

1.98

19.63

11.4

7.2

24.70

24.38

mmol/l

0.64

227

1188

Hallux valgus (acquired)

1178

6331

1.35

19.59

6.0

6.8

24.65

24.62

mmol/l

0.09

1134

6063

Myocardial infarction, unclassifiable

1024

6788

1.38

19.56

7.8

6.2

24.05

24.43

mmol/l

2.36

978

6506

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

138

600

2.43

19.51

12.8

8.1

23.50

24.72

mmol/l

2.08

130

574

Chronic apical periodontitis

4290

20682

1.17

19.50

7.2

6.8

24.39

24.51

mmol/l

1.30

4126

19789

Attention to artificial openings

195

978

2.12

19.49

10.9

6.4

24.67

24.44

mmol/l

0.30

185

943

Malignant neoplasm of endocrine gland, including Hilmo

296

1691

1.82

19.43

6.3

7.2

25.01

24.57

mmol/l

1.41

282

1613

Other secondary gonarthrosis

239

1286

1.96

19.42

7.5

7.3

24.52

24.48

mmol/l

0.05

229

1231

Lateral epicondylitis

457

2917

1.61

19.40

5.7

7.3

24.45

24.50

mmol/l

0.13

436

2784

Other diseases of upper respiratory tract

4315

19328

1.17

19.39

7.2

6.9

24.56

24.46

mmol/l

1.05

4134

18525

Embolic stroke with flimmer

138

606

2.46

19.38

7.8

6.0

24.51

24.23

mmol/l

0.38

128

579

Degeneration of macula and posterior pole

2115

13257

1.25

19.37

6.9

6.7

24.49

24.60

mmol/l

0.65

2032

12697

Spondyloarthritis

649

4464

1.49

19.31

7.8

6.6

24.80

24.45

mmol/l

1.64

626

4266

Behavioural disorders

234

3.35

19.28

7.6

9.4

24.63

24.45

mmol/l

0.14

219

Pyogenic arthritis

283

1603

1.84

19.27

8.8

7.3

24.63

24.45

mmol/l

0.33

275

1540

Other diseases of arteries and capillaries

369

2248

1.71

19.25

9.3

6.3

24.21

24.51

mmol/l

0.82

356

2155

Other and unspecified visual disturbances

420

2641

1.65

19.23

6.4

6.8

24.36

24.49

mmol/l

0.33

394

2521

Alzheimer disease, including avohilmo

1733

9532

1.28

19.17

5.2

6.4

24.36

24.53

mmol/l

1.00

1670

9120

Hypothyroidism, strict autoimmune, 3 medication purchases required

3089

17437

1.20

19.16

6.4

6.7

24.60

24.46

mmol/l

1.39

2970

16698

Trigger finger

527

3487

1.55

19.07

7.2

7.0

24.55

24.58

mmol/l

0.07

508

3331

Sequelae of injuries of neck and trunk

143

642

2.39

19.06

13.0

7.5

25.52

24.40

mmol/l

2.99

136

612

Pruritus

430

2723

1.63

18.99

8.7

6.2

24.21

24.53

mmol/l

1.15

413

2594

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

3431

22696

1.19

18.99

7.0

6.9

24.47

24.51

mmol/l

0.26

3296

21734

Pre-eclampsia

517

3401

1.55

18.97

5.6

6.5

24.27

24.50

mmol/l

0.71

492

3242

Benign neoplasm: Rectum

775

5550

1.44

18.86

7.0

7.2

24.45

24.55

mmol/l

0.33

752

5312

Other bursopathies

511

3374

1.56

18.80

7.2

7.3

24.75

24.54

mmol/l

0.56

490

3223

Open wound of lower leg

594

4050

1.51

18.65

9.8

6.7

24.55

24.47

mmol/l

0.20

575

3876

Temporomandibular joint disorders, including avohilmo

1356

10179

1.31

18.65

5.9

6.8

24.50

24.49

mmol/l

0.05

1306

9726

Other factor of the environment

254

3.35

18.61

8.4

6.4

24.27

24.34

mmol/l

0.05

242

Spondylopathies in diseases classified elsewhere

277

3.27

18.53

5.3

6.5

25.28

24.68

mmol/l

0.63

269

Other obstructive and reflux uropathy

165

789

2.20

18.51

9.5

6.2

23.27

24.52

mmol/l

2.97

160

752

Zoster [herpes zoster], including avohilmo

2058

16199

1.24

18.50

7.3

6.7

24.65

24.56

mmol/l

0.52

1981

15528

Other congenital malformations of the digestive system, including avohilmo

182

895

2.11

18.50

8.3

6.9

24.14

24.35

mmol/l

0.31

175

853

Unspecific neurodegenerative disorder

1922

10623

1.26

18.47

5.3

6.7

24.39

24.55

mmol/l

1.02

1849

10185

Benign neoplasm: Adrenal gland

336

2026

1.74

18.45

7.8

6.8

25.35

24.52

mmol/l

3.50

328

1940

Alcoholic liver disease

435

2794

1.62

18.39

10.9

7.3

23.01

24.52

mmol/l

9.06

425

2691

Calcific tendinitis of shoulder

224

1198

1.95

18.34

7.3

7.7

24.63

24.53

mmol/l

0.18

216

1143

Iridocyclitis

827

5999

1.41

18.34

7.0

7.1

24.37

24.54

mmol/l

0.62

791

5743

Allergic conjunctivitis

1187

14826

0.76

18.19

6.7

24.82

24.57

mmol/l

1.74

1137

14199

Malignant neoplasm of thyroid gland

244

1345

1.89

18.12

6.0

7.0

24.92

24.64

mmol/l

0.64

233

1283

Mental disorders, not otherwise specified

254

1414

1.85

18.08

7.3

7.1

24.81

24.27

mmol/l

1.34

247

1345

Non-Hodgkin lymphoma, all, including Hilmo

544

3679

1.53

17.99

9.6

6.9

24.70

24.48

mmol/l

0.62

515

3537

Malignant neoplasm of bronchus and lung, including Hilmo

921

5672

1.39

17.99

7.1

6.9

25.44

24.47

mmol/l

11.93

875

5469

Other (seronegative) rheumatoid arthritis, wide

724

5160

1.44

17.96

8.1

6.7

24.76

24.62

mmol/l

0.43

691

4939

Urticaria and erythema

1185

9082

1.32

17.95

7.1

6.7

24.55

24.48

mmol/l

0.25

1126

8696

Fracture of foot, except ankle

826

6006

1.40

17.92

7.4

6.8

24.55

24.47

mmol/l

0.26

795

5730

Other noninfective disorders of lymphatic vessels and lymph nodes

163

790

2.19

17.87

8.6

7.4

25.23

24.36

mmol/l

2.18

157

755

Other shoulder lesions

338

2049

1.70

17.82

5.9

7.3

24.78

24.46

mmol/l

0.90

325

1948

Diseases of inner ear

2145

16881

1.23

17.74

6.0

6.9

24.62

24.56

mmol/l

0.31

2054

16195

Other disorders of bone

655

4592

1.46

17.63

6.5

7.0

24.55

24.46

mmol/l

0.23

624

4389

Mental and behavioural disorders due to cannabinoids

357

2.76

17.61

7.7

9.1

25.20

24.30

mmol/l

1.20

333

Malnutrition

115

489

2.56

17.55

8.4

7.0

24.38

24.40

mmol/l

0.01

109

466

Event of undetermined intent

240

1330

1.88

17.53

9.1

7.8

24.43

24.44

mmol/l

0.00

230

1269

Benign neoplasm: Rectum, anus and anal canal

849

6247

1.40

17.51

6.9

7.1

24.49

24.54

mmol/l

0.17

824

5976

Acute nasopharyngitis (common cold)

419

2666

1.60

17.48

7.4

7.5

24.70

24.51

mmol/l

0.51

403

2560

Fitting and adjustment of other devices

883

10434

0.73

17.35

5.9

6.4

24.40

24.48

mmol/l

0.26

839

10033

Early complications of trauma

196

1026

2.02

17.32

11.8

7.6

24.70

24.45

mmol/l

0.34

184

979

!Aliquae complicationes praecoces traumatis

196

1026

2.02

17.32

11.8

7.6

24.70

24.45

mmol/l

0.34

184

979

Other arterial embolism and thrombosis

141

656

2.31

17.32

12.9

5.7

24.00

24.47

mmol/l

0.67

136

630

Congenital malformations and deformations of the musculoskeletal system

249

1387

1.84

17.30

7.3

7.4

24.83

24.24

mmol/l

1.85

239

1321

Crohn disease

431

2789

1.59

17.30

8.4

6.8

24.24

24.48

mmol/l

0.68

416

2667

Hypertrophic disorders of skin

198

1036

1.99

17.25

9.4

7.0

24.25

24.33

mmol/l

0.13

191

985

Chronic sinusitis

1505

11939

1.28

17.24

7.1

7.0

24.63

24.50

mmol/l

0.75

1439

11443

Parkinson's disease, including avohilmo

708

5081

1.44

17.13

5.9

6.8

25.56

24.45

mmol/l

13.19

674

4872

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

656

4631

1.45

17.12

7.6

7.0

24.38

24.50

mmol/l

0.38

633

4425

Malignant neoplasm of thyroid gland, including Hilmo

260

1488

1.81

17.04

6.1

7.0

24.88

24.59

mmol/l

0.73

249

1419

Disorders of vestibular function (Vertigo)

1841

14594

1.25

17.01

5.9

6.8

24.65

24.58

mmol/l

0.39

1766

13997

Impotence

275

1611

1.80

16.98

6.1

7.7

24.27

24.35

mmol/l

0.14

257

1547

Secondary thrombocytopenia

269

3.18

16.93

15.7

7.3

25.17

24.52

mmol/l

0.57

256

Papulosquamous disorders

1472

11703

1.28

16.90

7.2

7.1

24.72

24.55

mmol/l

0.94

1417

11226

Dental caries, including avohilmo

2941

12698

1.20

16.88

6.7

6.9

24.51

24.54

mmol/l

0.15

2822

12128

Abnormal results of function studies

328

2008

1.69

16.77

7.1

24.34

24.45

mmol/l

0.19

310

1926

Anankastic personality disorder

133

607

2.29

16.77

5.3

8.7

24.30

24.37

mmol/l

0.08

127

577

Pre-eclampsia or eclampsia

554

3796

1.49

16.73

5.7

6.5

24.31

24.53

mmol/l

0.76

527

3621

Seborrhoeic keratosis

1016

7725

1.34

16.71

6.3

6.7

24.50

24.59

mmol/l

0.31

979

7394

Budesonide

469

3114

1.54

16.70

6.4

6.7

23.95

24.40

mmol/l

1.85

449

2974

Unspecified jaundice

212

1152

1.93

16.66

8.0

6.8

23.68

24.63

mmol/l

2.94

200

1111

Vascular dementia (mixed)

123

554

2.43

16.61

6.5

5.8

24.83

24.21

mmol/l

0.74

114

528

Anterior Iridocyclitis

721

5209

1.41

16.47

7.1

7.0

24.40

24.55

mmol/l

0.45

687

4990

Primary hyperparathyroidism

435

2869

1.57

16.32

4.6

6.7

24.56

24.65

mmol/l

0.22

415

2741

Embedded teeth, including avohilmo

241

1361

1.81

16.28

6.9

7.3

24.62

24.06

mmol/l

1.22

226

1305

Other intracranial haemorrhages

169

864

2.10

16.27

9.8

5.9

24.66

24.40

mmol/l

0.38

163

825

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1088

8375

1.32

16.18

7.4

24.41

24.50

mmol/l

0.36

1057

8005

Immunodeficiency with predominantly antibody defects

108

461

2.50

16.15

15.4

8.4

25.31

24.64

mmol/l

0.94

100

442

Acute and subacute iridocyclitis

680

4884

1.42

16.10

6.9

24.49

24.54

mmol/l

0.13

651

4675

Benign neoplasm: Small intestine

190

1014

2.00

16.09

9.3

6.8

24.25

24.44

mmol/l

0.24

181

968

Oter anti-inflammatory and antirheumatic agents, non-steroids

970

3991

1.36

16.08

6.7

7.4

24.52

24.36

mmol/l

0.58

933

3820

Acute appendicitis, no complications

1870

15231

1.23

16.04

6.8

7.2

24.51

24.48

mmol/l

0.10

1797

14561

Systemic atrophies primarily affecting the central nervous system

196

1056

1.97

16.03

5.9

7.3

26.65

24.51

mmol/l

7.14

188

1014

Osteonecrosis

261

1531

1.78

15.92

7.9

6.9

24.70

24.60

mmol/l

0.17

253

1468

Primary adrenocortical insufficiency

202

3.42

15.86

12.3

9.1

23.39

24.49

mmol/l

1.12

194

Generalized skin eruption due to drugs and medicaments

163

826

2.08

15.85

8.1

7.1

24.76

24.40

mmol/l

0.55

155

793

Diabetic retinopathy, strict definition

774

5065

1.40

15.83

10.7

7.6

23.65

24.23

mmol/l

3.08

747

4865

Amenorrhoea

167

845

2.03

15.83

8.3

6.4

23.95

24.09

mmol/l

0.22

161

804

Complications of other internal prosthetic devices, implants and grafts

181

952

2.00

15.82

8.0

5.8

24.87

24.38

mmol/l

0.92

172

902

Other inflammatory liver diseases

261

1532

1.78

15.82

8.3

6.7

24.12

24.54

mmol/l

0.87

249

1468

Benign neoplasm: Descending colon

316

1959

1.69

15.72

8.5

6.7

24.29

24.48

mmol/l

0.40

307

1875

Parkinson's disease

675

4882

1.42

15.65

5.8

6.7

25.59

24.45

mmol/l

13.37

642

4686

Toxic effect of other and unspecified substances

192

3.40

15.61

14.0

9.4

24.29

25.01

mmol/l

0.65

184

Sequelae of injuries of head

215

1198

1.88

15.61

16.7

7.4

24.74

24.51

mmol/l

0.40

202

1147

Retinal vascular occlusion

531

3685

1.49

15.56

5.9

6.3

24.44

24.58

mmol/l

0.34

511

3529

Persistent delusional disorders

295

1796

1.71

15.55

8.2

6.9

25.67

24.35

mmol/l

6.08

287

1716

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

185

987

1.97

15.48

7.9

7.7

24.48

24.53

mmol/l

0.07

180

948

Other disorders of binocular movement

372

2.64

15.45

6.8

7.7

23.81

24.21

mmol/l

0.53

351

Generalized epilepsy

141

681

2.16

15.44

8.5

6.9

24.61

24.36

mmol/l

0.29

135

648

Nummular dermatitis

346

2199

1.63

15.36

8.8

6.7

24.57

24.49

mmol/l

0.14

335

2101

Benign neoplasm: Duodenum

138

672

2.23

15.35

10.6

6.4

24.25

24.39

mmol/l

0.16

133

646

Malignant neoplasm of respiratory system and intrathoracic organs

903

5653

1.35

15.31

7.0

25.43

24.46

mmol/l

11.61

856

5454

Acute appendicitis

2451

19184

1.20

15.31

6.9

7.2

24.49

mmol/l

0.00

2361

18352

Female infertility, associated with anovulation

168

861

1.99

15.31

5.7

6.1

24.08

23.83

mmol/l

0.44

162

822

Diabetic nephropathy

786

5785

1.39

15.28

9.9

8.0

23.22

24.20

mmol/l

7.91

755

5560

Necrotizing fasciitis

129

4.30

15.25

16.5

9.7

25.11

24.35

mmol/l

0.54

119

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

595

2609

1.45

15.19

7.2

5.8

23.46

23.98

mmol/l

3.22

568

2487

Vascular dementia

446

2898

1.53

15.05

5.4

5.9

24.65

24.37

mmol/l

0.72

421

2773

Other ulcerative colitis

214

1203

1.85

15.03

7.0

23.77

24.40

mmol/l

1.71

202

1153

Retinal vascular disorders

536

3752

1.47

15.00

5.9

6.3

24.45

24.57

mmol/l

0.27

516

3595

Coeliac disease

402

2648

1.56

15.00

7.3

6.4

24.51

24.50

mmol/l

0.02

386

2530

Sequelae of injuries of upper limb

357

2297

1.60

14.92

7.5

7.1

24.64

24.46

mmol/l

0.41

339

2197

Vitamin deficiency, wide

191

1041

1.92

14.89

7.8

7.0

23.75

24.31

mmol/l

0.95

184

986

Vitamin deficiency

191

1041

1.92

14.89

7.8

7.0

23.75

24.31

mmol/l

0.95

184

986

Disorder of lipoprotein metabolism, unspecified

514

3569

1.48

14.89

7.9

6.7

23.98

24.60

mmol/l

3.11

498

3413

Diabetic maculopathy

572

3836

1.46

14.85

9.3

7.6

23.60

24.20

mmol/l

2.47

545

3682

Malignant neoplasm of rectosigmoid junction, including Hilmo

145

726

2.14

14.83

9.0

6.4

23.98

24.45

mmol/l

0.70

138

704

Weight loss

408

2711

1.56

14.82

6.8

6.7

24.72

24.46

mmol/l

0.60

388

2592

Non-small cell lung cancer, including Hilmo

645

4375

1.42

14.75

7.3

6.6

25.38

24.42

mmol/l

9.43

615

4221

Hypertrophic scar

177

942

1.95

14.73

9.8

7.2

24.25

24.30

mmol/l

0.08

171

896

Thiazolidinediones

457

3115

1.52

14.70

7.2

6.7

23.90

24.63

mmol/l

3.30

435

2978

Vitamin D deficiency

310

2.76

14.69

7.6

8.1

24.23

24.24

mmol/l

0.01

294

Follow-up examination after treatment for malignant neoplasms

395

2608

1.56

14.67

7.9

6.0

24.86

24.49

mmol/l

1.13

376

2490

Papilloedema, unspecified

415

2.49

14.48

6.3

8.0

22.93

24.50

mmol/l

2.57

397

Appendicitis, broad definition

2613

19971

1.18

14.46

6.9

7.1

24.51

24.50

mmol/l

0.03

2516

19109

Other disorders of optic [2nd] nerve and visual pathways

242

1427

1.76

14.45

7.6

6.9

24.09

24.41

mmol/l

0.60

228

1360

Preterm labour and delivery

665

4837

1.40

14.43

6.6

24.58

24.67

mmol/l

0.29

639

4612

Secondary malignant neoplasm of respiratory and digestive organs

101

445

2.49

14.42

5.5

6.2

24.61

24.41

mmol/l

0.17

429

Kela reimbursement Agammaglobulinemia (D80-84)

122

4.01

14.39

27.1

10.7

25.15

24.90

mmol/l

0.17

114

Diseases of appendix

2634

20084

1.18

14.36

6.9

7.1

24.52

24.50

mmol/l

0.08

2535

19219

Injury of muscle and tendon at shoulder and upper arm level

1423

11505

1.26

14.29

6.7

7.5

24.49

24.50

mmol/l

0.01

1367

11034

Conjunctivitis (acute, non atopic), including avohilmo

3045

21291

0.86

14.28

6.4

7.0

24.57

24.51

mmol/l

0.44

2943

20370

Other obstetric conditions, not elsewhere classified

609

2719

1.43

14.27

7.2

5.8

23.50

24.00

mmol/l

3.05

581

2594

Disorders of speech understanding and production

144

708

2.08

14.23

7.1

7.0

24.32

24.30

mmol/l

0.02

129

673

Excessive, frequent and irregular menstruation

1106

4569

1.31

14.23

7.0

6.4

24.58

24.53

mmol/l

0.14

1062

4364

Secondary parkinsonism+Parkinsonism in other disease

143

724

2.12

14.22

7.6

7.0

25.82

24.33

mmol/l

4.07

138

697

Epidural haemorrhage

147

3.66

14.21

11.9

6.4

24.76

23.89

mmol/l

0.66

139

Other diseases of liver

640

4651

1.41

14.20

8.5

7.1

23.94

24.63

mmol/l

4.04

614

4458

Other and unspecified tonsillitis

926

5870

1.33

14.19

6.5

7.0

24.55

24.29

mmol/l

1.44

890

5597

Other necrotizing vasculopathies (FG)

243

1444

1.76

14.17

8.5

6.9

24.03

24.46

mmol/l

0.91

235

1383

Keratitis

1267

10120

1.27

14.03

7.4

7.0

24.62

24.51

mmol/l

0.48

1219

9688

Non-follicular lymphoma

401

2691

1.55

14.03

10.8

6.7

24.75

24.48

mmol/l

0.66

380

2580

Inflammatory diseases of female pelvic organs

1852

10464

1.22

14.03

6.3

6.2

24.47

24.64

mmol/l

1.20

1778

10013

Other specified/unspecified systemic involvement of connective tissue

209

1193

1.82

14.00

7.4

6.8

25.07

24.40

mmol/l

1.62

200

1136

Suggestive for eosinophilic asthma

343

2222

1.59

13.99

5.4

7.0

24.39

24.43

mmol/l

0.07

327

2118

Lesion of radial nerve

158

829

2.01

13.97

8.3

7.4

25.46

24.40

mmol/l

2.61

150

788

Benign neoplasm: Caecum

458

3161

1.50

13.92

7.8

6.7

24.78

24.55

mmol/l

0.75

451

3027

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

226

1328

1.79

13.84

7.3

6.1

23.45

24.42

mmol/l

3.03

216

1285

Fall on and from stairs and steps

958

7425

1.31

13.67

6.7

6.9

24.30

24.52

mmol/l

1.00

920

7117

Benign neoplasm: Ascending colon

590

4273

1.42

13.64

7.7

7.0

24.46

24.58

mmol/l

0.34

576

4102

Disorders resulting from impaired renal tubular function

161

860

1.98

13.60

12.5

7.7

22.89

24.45

mmol/l

4.07

154

827

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

303

1902

1.62

13.54

6.9

7.1

24.79

24.34

mmol/l

1.47

292

1817

Redundant prepuce, phimosis and paraphimosis

761

5632

1.35

13.48

7.8

8.1

24.72

24.37

mmol/l

1.65

730

5408

IBD patients in KELA-register

718

5351

1.36

13.46

6.9

7.0

24.11

24.50

mmol/l

2.21

688

5113

Generalized anxiety disorder

403

2705

1.51

13.45

7.9

6.0

24.67

24.19

mmol/l

1.69

392

2576

Corneal ulcer

630

4607

1.39

13.43

6.9

24.43

24.50

mmol/l

0.19

608

4411

Abnormal blood-pressure reading, without diagnosis

157

829

1.97

13.43

7.4

6.6

24.77

24.56

mmol/l

0.28

149

791

Lifestyle-related condition

234

3.02

13.42

8.0

6.5

24.45

24.50

mmol/l

0.04

223

Congenital malformations of the nervous system

288

2.71

13.39

10.4

8.4

24.53

24.23

mmol/l

0.27

272

Diffuse large B-cell lymphoma, helper endpoint

214

1252

1.80

13.36

12.0

6.1

24.67

24.63

mmol/l

0.05

203

1203

Diffuse large B-cell lymphoma

214

1252

1.80

13.36

12.0

6.1

24.67

24.63

mmol/l

0.05

203

1203

Diffuse large B-cell lymphoma, including Hilmo

214

1252

1.80

13.36

12.0

6.1

24.67

24.63

mmol/l

0.05

203

1203

Malignant neoplasm of bronchus and lung

795

5030

1.35

13.36

7.1

6.8

25.43

24.45

mmol/l

10.45

756

4848

Embolic stroke

212

1235

1.80

13.34

7.5

6.3

24.46

24.37

mmol/l

0.14

197

1182

Acute generalized exanthematous pustulosis

176

970

1.90

13.34

7.9

7.0

24.80

24.38

mmol/l

0.78

168

930

Infections of genitourinary tract in pregnancy

249

1506

1.69

13.29

6.0

6.9

24.17

24.53

mmol/l

0.89

242

1436

Inflammatory disease of uterus

360

2377

1.54

13.19

5.5

6.3

24.08

24.43

mmol/l

1.09

346

2265

Nail disorders

299

1902

1.62

13.18

9.0

7.1

24.32

24.46

mmol/l

0.21

290

1817

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

561

4041

1.42

13.18

7.8

6.9

24.35

24.51

mmol/l

0.48

540

3866

Abnormal findings on diagnostic imaging of central nervous system

182

1016

1.86

13.15

8.4

7.0

24.57

24.29

mmol/l

0.47

176

976

Enthesopathies of lower limb, excluding foot

707

5277

1.36

13.12

7.5

7.1

24.77

24.43

mmol/l

1.95

688

5058

Wet age-related macular degeneration

785

5754

1.35

13.10

6.9

6.0

24.29

24.58

mmol/l

1.30

751

5490

Follicular cysts of skin and subcutaneous tissue

652

4818

1.38

13.08

7.6

7.1

24.61

24.48

mmol/l

0.38

619

4612

Olecranon bursitis

259

1603

1.68

12.96

9.5

7.4

24.52

24.51

mmol/l

0.01

251

1535

Cluster headache, wide,, including avohilmo

178

991

1.86

12.94

6.4

7.7

24.41

24.42

mmol/l

0.02

172

952

Spondylopathies (FG)

418

2861

1.49

12.93

6.8

7.2

24.78

24.36

mmol/l

1.61

402

2738

Cluster headache, strict, including avohilmo

165

898

1.91

12.90

6.4

8.1

24.34

24.46

mmol/l

0.16

159

862

Seborrhoeic dermatitis

382

2580

1.52

12.85

8.8

6.7

24.91

24.46

mmol/l

1.53

363

2471

Pre-eclampsia or poor fetal growth

701

5213

1.35

12.80

6.1

6.3

24.19

24.39

mmol/l

0.79

666

4972

Papillary adenocarcinoma of thyroid gland

178

996

1.86

12.77

6.6

6.8

24.86

24.71

mmol/l

0.23

169

955

Polycystic ovarian syndrome, broad definition

220

1300

1.72

12.70

5.7

5.6

23.93

23.82

mmol/l

0.19

210

1235

Specific development disorders of speech and language

170

901

1.87

12.66

7.0

6.7

24.38

24.24

mmol/l

0.15

155

854

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

110

529

2.24

12.64

7.3

6.8

23.91

24.58

mmol/l

1.12

102

511

Lichen planus

489

3473

1.45

12.62

5.9

7.0

24.25

24.61

mmol/l

1.24

469

3320

Necrosis of pulp, including avohilmo

1971

16423

1.20

12.59

7.4

7.1

24.56

24.49

mmol/l

0.34

1883

15725

Malignant neoplasm of small intestine, including Hilmo

140

734

2.03

12.58

7.0

6.6

23.88

24.57

mmol/l

1.43

129

711

Nonhereditary hypogammaglobulinemia

186

3.19

12.57

19.4

9.7

25.16

24.84

mmol/l

0.20

178

Excessive vomiting in pregnancy

198

1143

1.77

12.55

4.5

6.8

24.59

24.41

mmol/l

0.28

189

1092

Dissection of aorta

148

791

1.98

12.53

17.4

6.2

25.02

24.53

mmol/l

0.90

143

756

Polyhydramnios

113

543

2.14

12.49

4.5

6.4

23.70

24.16

mmol/l

0.60

105

513

Spirochaetal infections, other/unspecified

121

2311

0.51

12.35

8.5

7.3

24.94

24.60

mmol/l

0.68

121

2212

Inflammatory bowel disease, strict (require KELA)

718

5424

1.34

12.33

6.9

7.1

24.11

24.46

mmol/l

1.88

688

5182

Other disorders of central nervous system

222

2.94

12.24

9.5

8.4

25.35

24.74

mmol/l

0.66

211

Recurrent dislocation of patella

126

635

2.04

12.23

5.3

7.8

24.03

24.07

mmol/l

0.03

119

610

Meralgia paraesthetica

137

718

2.01

12.20

6.7

8.4

24.59

24.44

mmol/l

0.16

132

687

Parkinson's disease, strict definition

612

4543

1.38

12.20

5.5

6.7

25.56

24.43

mmol/l

12.42

581

4363

Lesion of sciatic nerve

190

1104

1.81

12.19

7.9

5.9

24.64

24.24

mmol/l

0.85

185

1057

Open wound of ankle and foot

367

2485

1.52

12.15

10.0

6.6

24.41

24.34

mmol/l

0.11

356

2373

Fracture of forearm

1941

14719

1.20

12.14

6.6

24.68

24.60

mmol/l

0.42

1856

14105

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

213

1280

1.74

12.11

6.1

6.3

24.95

24.51

mmol/l

0.66

206

1231

Use of rotigotine

267

2.81

12.06

4.1

7.1

26.24

24.73

mmol/l

3.16

252

Malignant neoplasm of stomach, including Hilmo

255

1602

1.65

12.03

7.8

6.2

24.52

24.46

mmol/l

0.10

243

1541

Vitamin B12 deficiency anaemia

414

2884

1.48

11.93

6.8

6.3

24.27

24.51

mmol/l

0.53

394

2757

Benign paroxysmal vertigo

1097

8802

1.27

11.89

5.8

6.8

24.69

24.62

mmol/l

0.31

1060

8423

Hypoparathyroidism

148

804

1.94

11.87

7.4

6.4

25.75

24.47

mmol/l

3.30

141

769

Disorders of optic nerve and visual pathways

308

2021

1.57

11.85

7.4

7.1

23.94

24.44

mmol/l

1.32

289

1929

Other hearing loss

1131

8820

1.26

11.82

6.1

6.6

24.44

24.54

mmol/l

0.39

1079

8438

Amputation of foot

133

704

2.02

11.76

10.8

7.4

23.24

24.33

mmol/l

2.16

128

667

Abnormal weight loss

369

2524

1.51

11.76

6.8

6.6

24.72

24.48

mmol/l

0.50

351

2411

Other infectious diseases

296

1934

1.58

11.76

9.3

6.9

24.02

24.46

mmol/l

1.19

280

1848

Benign neoplasm of brain and other parts of central nervous system

241

1505

1.66

11.65

8.6

7.1

25.35

24.49

mmol/l

3.12

234

1436

Other peripheral vascular diseases

280

1808

1.59

11.63

5.9

6.5

24.66

24.51

mmol/l

0.29

268

1724

Exposure to other specified factors

2866

21460

1.15

11.63

7.8

6.9

24.67

24.49

mmol/l

1.93

2774

20533

Other necrotizing vasculopathies

284

1848

1.59

11.56

8.3

6.6

23.94

24.48

mmol/l

1.41

274

1764

Herpesviral [herpes simplex] infections

394

2732

1.48

11.55

7.2

6.9

24.29

24.42

mmol/l

0.29

384

2612

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1326

12530

0.81

11.53

5.4

6.9

24.42

24.48

mmol/l

0.28

1261

11998

Thrombocytopenia, unspecified

279

1808

1.60

11.52

9.3

6.7

24.48

24.45

mmol/l

0.04

263

1726

Use of ropinirole

166

948

1.86

11.50

6.0

7.2

25.59

24.53

mmol/l

4.05

157

909

Bell's palsy

402

2802

1.47

11.47

8.6

7.0

24.43

24.44

mmol/l

0.02

385

2677

Other hammer toe(s) (acquired)

615

4176

1.37

11.46

6.4

6.6

24.79

24.70

mmol/l

0.24

590

4005

Toxic effect of alcohol

428

2.29

11.43

8.7

8.0

23.90

24.56

mmol/l

0.70

407

Tularaemia, including avohilmo

409

2.33

11.43

5.4

8.1

24.76

24.57

mmol/l

0.18

390

Barrett oesophagus

215

1317

1.71

11.36

8.3

7.0

24.53

24.51

mmol/l

0.03

205

1262

Agoraphobia

367

2.34

11.34

14.2

6.7

25.18

24.09

mmol/l

1.19

348

Acquired absence of organs, not elsewhere classified

268

2.70

11.31

11.7

6.1

23.88

24.54

mmol/l

0.63

254

Neuroendocrine tumor and carcinoma of pancreas

135

3.55

11.20

10.4

5.5

25.38

24.64

mmol/l

0.67

130

Malignant neoplasm of other and unspecified parts of biliary tract

382

2.39

11.20

7.6

6.6

23.61

24.53

mmol/l

1.36

371

Trigeminal neuralgia

209

1271

1.70

11.19

6.5

7.2

24.71

24.47

mmol/l

0.44

199

1214

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

239

1500

1.63

11.15

6.3

6.9

24.18

24.58

mmol/l

0.85

233

1426

Biological medication for rheuma

504

3669

1.40

11.08

6.7

7.2

24.53

24.43

mmol/l

0.28

489

3504

Psoriatic and enteropathic arthropathies

371

2563

1.48

11.07

6.5

7.3

24.69

24.44

mmol/l

0.55

357

2453

Laparoscopic right hemicolectomy

253

1625

1.63

11.07

7.4

6.5

24.14

24.52

mmol/l

1.03

248

1549

Neovascular glaucoma

172

999

1.80

11.06

8.9

6.6

23.70

24.40

mmol/l

1.36

165

956

Disturbance of activity and attention

254

1574

1.60

11.02

4.4

6.8

23.96

23.84

mmol/l

0.23

247

1490

Iron deficiency

372

2.31

11.01

4.0

7.0

23.52

24.12

mmol/l

0.64

355

Alcoholic gastritis

321

2.50

10.98

8.5

7.0

24.75

24.55

mmol/l

0.17

307

Thyroiditis, ILD-related definition

344

2346

1.50

10.96

7.2

6.4

24.32

24.50

mmol/l

0.43

331

2236

Urticaria

884

6980

1.28

10.86

6.6

6.7

24.49

24.50

mmol/l

0.02

834

6675

Other noninflammatory disorders of uterus, except cervix

726

3709

1.33

10.84

6.2

6.5

25.06

24.79

mmol/l

1.19

701

3545

Conjunctivitis (acute, non atopic)

916

7240

1.28

10.81

7.1

6.8

24.49

mmol/l

0.00

881

6930

Divergent concomitant strabismus

239

1514

1.62

10.80

10.0

6.8

24.64

24.44

mmol/l

0.31

228

1446

Other diseases of peritoneum

168

976

1.80

10.77

6.9

6.3

24.26

24.48

mmol/l

0.30

157

934

Symptoms and signs involving speech and voice

1202

9845

1.24

10.76

6.9

6.8

24.86

24.52

mmol/l

2.59

1162

9431

Glaucoma secondary to other eye disorders

172

1007

1.79

10.76

8.9

7.1

23.70

24.37

mmol/l

1.29

165

963

Melanocytic naevi, other sites/unspecified

286

1889

1.56

10.76

6.4

7.3

24.43

24.46

mmol/l

0.06

274

1804

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1739

9956

1.20

10.75

6.4

6.8

24.27

24.57

mmol/l

2.71

1659

9585

Use of memantine

1258

8325

1.24

10.71

4.4

6.2

24.37

24.49

mmol/l

0.53

1205

7963

Use of other anti-dementia drugs

1258

8325

1.24

10.71

4.4

6.2

24.37

24.49

mmol/l

0.53

1205

7963

Irritable bowel syndrome

839

6597

1.29

10.70

5.9

6.4

24.71

24.63

mmol/l

0.25

807

6295

Myelodysplastic syndrome, including Hilmo

141

783

1.90

10.67

5.9

6.3

24.23

24.41

mmol/l

0.19

136

756

Chronic tubulo-interstitial nephritis

134

729

1.92

10.63

6.2

6.0

23.91

24.70

mmol/l

1.37

124

703

Viral infections of the central nervous system

240

1530

1.62

10.60

7.1

7.0

25.25

24.43

mmol/l

2.80

231

1467

Polycystic ovarian syndrome

118

612

1.97

10.58

6.3

5.4

23.64

23.71

mmol/l

0.07

112

584

Injury of nerves and spinal cord at neck level

103

517

2.13

10.58

9.7

7.4

25.73

24.45

mmol/l

3.02

494

Ovarian dysfunction

164

944

1.77

10.54

6.4

5.9

23.94

24.02

mmol/l

0.10

156

898

Seronegative rheumatoid arthritis

391

2758

1.45

10.50

7.8

6.8

24.74

24.56

mmol/l

0.42

371

2641

Chronic gastritis

1022

8257

1.26

10.48

5.7

6.3

24.37

24.57

mmol/l

0.92

982

7917

Left bundle-branch block

239

1528

1.61

10.39

5.1

5.7

24.50

24.60

mmol/l

0.15

233

1459

Secondary and unspecified malignant neoplasm of lymph nodes

314

2138

1.51

10.28

7.3

6.5

24.59

24.53

mmol/l

0.10

297

2055

Seropositive rheumatoid arthritis, strict definition

514

3810

1.38

10.28

7.0

6.9

24.44

24.57

mmol/l

0.30

493

3646

Abscess of anal and rectal regions

284

1891

1.54

10.27

7.5

7.1

24.28

24.62

mmol/l

0.80

273

1801

Monoamine oxidase A inhibitors

376

2644

1.45

10.27

7.8

6.9

25.26

24.38

mmol/l

5.46

371

2511

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1789

10249

1.19

10.26

6.3

6.8

24.25

24.56

mmol/l

3.14

1709

9870

Excessive earwax

2457

19429

1.16

10.17

6.4

7.1

24.58

24.55

mmol/l

0.16

2371

18627

Superficial injury of forearm

323

2211

1.49

10.16

7.1

24.54

24.37

mmol/l

0.37

312

2109

Other benign neoplasms of connective and other soft tissue

339

2348

1.48

10.13

7.5

7.0

24.60

24.51

mmol/l

0.18

331

2250

Polymyalgia rheumatica

555

4183

1.36

10.07

6.2

24.97

24.58

mmol/l

1.74

537

4000

Adverse effects, not elsewhere classified

570

4296

1.35

10.06

6.7

24.59

24.40

mmol/l

0.62

547

4095

Mouth breathing

1371

11433

1.21

10.04

6.7

7.5

24.77

24.49

mmol/l

2.22

1312

10952

Postpartum care and examination

269

1093

1.57

10.03

5.0

6.6

23.49

24.14

mmol/l

2.05

255

1045

Infective bursitis

130

719

1.91

9.99

10.3

7.7

24.55

mmol/l

0.00

123

684

Perforation of tympanic membrane

344

2395

1.47

9.99

6.5

6.7

24.23

24.47

mmol/l

0.51

328

2290

Haemorrhage in early pregnancy

649

4835

1.32

9.96

5.3

6.8

24.35

24.60

mmol/l

1.15

621

4621

Other and unspecified mononeuropathies, also in other diseases

119

640

1.96

9.92

7.7

7.1

25.25

24.24

mmol/l

2.00

113

613

Nontoxic multinodular goitre

679

5265

1.31

9.88

6.9

6.4

24.81

24.73

mmol/l

0.22

656

5039

Mixed conductive and sensorineural hearing loss

455

3335

1.40

9.86

7.1

6.9

24.58

24.61

mmol/l

0.06

440

3183

Other diseases of lip and oral mucosa

1445

12146

1.20

9.84

7.2

6.9

24.46

24.58

mmol/l

0.62

1391

11655

Meningitis

176

1061

1.72

9.84

10.2

7.4

25.04

24.49

mmol/l

1.43

168

1016

Injuries to unspecified part of trunk, limb or body region

364

2569

1.45

9.82

9.1

6.8

24.62

24.47

mmol/l

0.34

353

2456

Other female pelvic inflammatory diseases

454

3321

1.39

9.81

6.5

6.4

24.24

24.74

mmol/l

2.29

433

3174

Right bundle-branch block

130

719

1.88

9.81

7.6

6.5

25.25

24.33

mmol/l

1.54

125

685

Salpingitis and oophoritis

500

3714

1.37

9.79

7.9

6.6

24.94

24.80

mmol/l

0.35

475

3543

Glaucoma, exfoliation

452

3318

1.40

9.77

5.1

6.1

24.37

24.62

mmol/l

0.70

430

3176

Female genital prolapse

907

4010

1.27

9.74

5.6

6.7

24.76

24.75

mmol/l

0.03

861

3832

Autoimmune hepatitis, wide definition

159

936

1.76

9.69

6.5

6.4

24.15

24.54

mmol/l

0.52

150

895

Other neurotic disorders

181

1105

1.70

9.69

6.1

6.3

25.07

24.45

mmol/l

0.97

172

1055

Diabetes mellitus in pregnancy

621

2992

1.33

9.67

6.2

6.5

23.54

24.23

mmol/l

4.49

593

2859

Malignant neoplasm of head and neck, including Hilmo

379

2705

1.44

9.65

9.6

6.8

25.14

24.49

mmol/l

2.68

359

2605

Arthropathies in other diseases classified elsewhere

135

761

1.85

9.64

10.8

8.4

24.28

24.39

mmol/l

0.10

128

730

Other/unspecified synovitis and tenosynovitis

371

2633

1.44

9.64

7.5

7.1

24.39

24.49

mmol/l

0.20

358

2517

Other symptoms and signs involving the urinary system

402

2900

1.42

9.63

6.7

7.1

24.61

24.43

mmol/l

0.44

391

2776

L01XE Protein kinase inhibitors

211

1343

1.64

9.63

5.5

6.6

24.67

24.47

mmol/l

0.34

199

1283

Internal derangement of knee

1230

10101

1.22

9.61

6.7

7.1

24.55

24.53

mmol/l

0.06

1182

9683

Malignant neoplasm of breast, including Hilmo

1165

6121

1.23

9.58

5.6

6.2

25.13

24.76

mmol/l

3.25

1123

5857

Malignant neoplasm of breast, HER2-negative, including Hilmo

1165

6122

1.23

9.58

5.6

6.2

25.13

24.76

mmol/l

3.25

1123

5858

Congenital malformations of the urinary system

187

1152

1.68

9.57

10.0

7.5

23.31

24.41

mmol/l

3.67

175

1099

1732

13331

1.18

9.55

6.2

6.7

24.41

24.56

mmol/l

0.95

1657

12787

Use of levodopa decarboxylase inhibitor

583

4467

1.34

9.46

5.3

6.7

25.66

24.44

mmol/l

13.71

553

4286

Impacted cerumen

224

3400

0.64

9.44

5.8

6.8

24.75

24.50

mmol/l

0.59

212

3252

Hyperkinetic disorders

261

1687

1.53

9.41

4.4

6.7

23.98

23.84

mmol/l

0.29

254

1595

Atopic dermatitis

1290

12283

0.83

9.39

6.6

6.8

24.46

24.47

mmol/l

0.06

1239

11753

Other diseases of stomach and duodenum

242

1594

1.57

9.37

10.3

6.4

24.29

24.64

mmol/l

0.64

230

1524

Panhypopituitarism

390

2.22

9.36

15.3

7.4

24.05

24.14

mmol/l

0.10

373

Tuberculosis, IBD comorbidity

272

1837

1.53

9.35

8.1

6.3

24.95

24.45

mmol/l

1.18

258

1764

Metatarsalgia

302

2076

1.49

9.34

7.1

24.71

24.52

mmol/l

0.49

291

1982

Burns and corrosions

434

3180

1.39

9.33

8.6

7.2

24.36

24.41

mmol/l

0.10

419

3040

Other enthesopathy of foot (+metatarsalgia)

320

2224

1.47

9.33

6.8

7.0

24.67

24.50

mmol/l

0.43

309

2124

Menorrhagia

968

4345

1.26

9.32

6.6

6.5

24.72

24.62

mmol/l

0.34

921

4148

Viral infections of the central nervous system, including avohilmo

250

1657

1.55

9.32

7.0

7.2

25.22

24.43

mmol/l

2.78

241

1585

Sicca syndrome [Sjögren]

284

1934

1.51

9.32

7.0

6.7

24.70

24.61

mmol/l

0.18

272

1845

Pain associated with micturition

420

3067

1.40

9.29

6.2

6.5

24.88

24.46

mmol/l

1.71

398

2923

Paraplegia, diplegia of upper limbs

486

2.07

9.28

11.3

6.7

25.61

24.32

mmol/l

2.32

465

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

541

4068

1.35

9.27

6.5

6.2

24.31

24.49

mmol/l

0.47

511

3917

Lichen simplex chronicus

136

779

1.83

9.26

8.8

6.6

24.30

24.51

mmol/l

0.24

128

743

Malignant neoplasm of breast, HER2-negative

1144

6067

1.23

9.22

5.5

6.2

25.15

24.76

mmol/l

3.34

1102

5806

Primary open-angle glaucoma

1281

10321

1.21

9.20

5.9

6.6

24.33

24.60

mmol/l

1.70

1223

9887

Malignant neoplasm of breast

1145

6073

1.23

9.20

5.5

6.2

25.15

24.76

mmol/l

3.32

1103

5812

Acute laryngitis and tracheitis

280

1869

1.50

9.13

9.1

6.4

24.67

24.28

mmol/l

0.95

271

1772

Fracture at wrist and hand level

1163

9621

1.22

9.11

6.9

7.4

24.65

24.51

mmol/l

0.60

1108

9201

Fistulae involving female genital tract

334

2.30

9.11

10.2

7.6

24.61

24.62

mmol/l

0.01

324

Fibroblastic disorders

852

6858

1.26

9.10

7.0

24.36

24.40

mmol/l

0.11

823

6571

Hepatocellular carcinoma, including Hilmo

133

763

1.84

9.10

8.2

6.6

23.26

24.67

mmol/l

3.31

127

733

Benign lipomatous neoplasm

1033

8487

1.23

9.09

6.5

7.1

24.59

24.57

mmol/l

0.08

989

8133

Effects of foreign body entering through natural orifice

806

6446

1.27

9.08

8.6

7.4

24.73

24.41

mmol/l

1.85

768

6181

Malignant neoplasm of liver and intrahepatic bile ducts

140

815

1.80

9.08

8.0

6.5

23.22

24.59

mmol/l

3.10

130

787

Malignant neoplasm of small intestine

103

547

2.00

9.06

7.2

6.8

24.20

24.54

mmol/l

0.44

532

Peritonsillar abscess

612

4729

1.31

9.06

6.8

7.4

24.73

24.36

mmol/l

2.05

593

4521

Exposure to other and unspecified inanimate mechanical forces

256

1718

1.53

9.01

7.9

7.3

24.84

24.39

mmol/l

1.19

244

1641

Diffuse brain injury

111

600

1.91

8.98

20.1

5.9

25.07

23.92

mmol/l

2.34

106

567

Hypermetropia

226

1476

1.57

8.97

6.2

6.6

24.35

24.51

mmol/l

0.23

218

1409

Tuberculosis, wide

280

1919

1.50

8.96

8.1

6.4

24.95

24.42

mmol/l

1.33

266

1839

Malignant neoplasm of skin, including Hilmo

1914

11064

1.17

8.96

6.5

6.9

24.28

24.57

mmol/l

2.94

1827

10659

Injuries to the ankle and foot

2392

17933

1.15

8.96

7.4

7.0

24.53

24.49

mmol/l

0.19

2309

17144

Other and unspecified mononeuropathies of upper limb

109

589

1.93

8.95

7.9

8.6

24.50

24.42

mmol/l

0.08

104

566

Malignant neoplasm of oral cavity, including Hilmo

174

1075

1.68

8.94

11.1

6.5

25.35

24.71

mmol/l

1.79

166

1038

Spontaneous rupture of synovium and tendon

300

2083

1.48

8.93

6.9

7.4

24.56

24.54

mmol/l

0.03

294

1985

Panniculitis affecting regions of neck and back

126

713

1.83

8.87

9.8

6.8

24.74

24.59

mmol/l

0.18

119

688

Multiple myeloma, including Hilmo

185

1165

1.65

8.85

7.8

6.4

24.06

24.58

mmol/l

0.92

174

1120

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

248

1664

1.54

8.84

7.3

6.5

24.61

24.59

mmol/l

0.03

240

1595

Viral warts, including avohilmo

648

5064

1.30

8.81

6.3

7.0

24.21

24.42

mmol/l

0.72

618

4846

Malignant neoplasm of skin

1836

10709

1.17

8.80

6.5

6.9

24.33

24.57

mmol/l

1.99

1751

10317

Malignant neoplasm of stomach

212

1379

1.59

8.75

8.0

6.0

24.66

24.49

mmol/l

0.29

202

1332

Disorders of refraction and accommodation

822

6584

1.26

8.75

7.2

6.7

24.60

24.45

mmol/l

0.54

796

6288

Tuberculosis, wide, including avohilmo

282

1946

1.49

8.72

8.0

6.5

24.92

24.42

mmol/l

1.19

268

1865

Infarction of spleen

163

3.00

8.71

13.9

6.2

24.14

24.56

mmol/l

0.20

156

Benign neoplasm: Pituitary gland, craniopharyngeal duct

182

1143

1.65

8.71

8.7

7.1

24.41

24.43

mmol/l

0.03

170

1089

Gingivitis and periodontal diseases

3783

17590

1.12

8.67

7.3

6.9

24.41

24.54

mmol/l

1.27

3616

16840

Juvenile arthritis (FINNGEN)

106

570

1.91

8.66

6.1

8.2

24.37

23.98

mmol/l

0.50

101

541

Other menopausal disorders

492

3630

0.75

8.65

5.4

7.0

24.99

24.76

mmol/l

0.80

473

3473

Other and unspecified vascular occlusions

386

2823

1.41

8.63

5.8

6.3

24.68

24.56

mmol/l

0.22

369

2707

Other specified/unspecified soft tissue disorders

176

1099

1.66

8.62

6.6

6.9

24.63

24.43

mmol/l

0.30

170

1042

Crohn's disease NAS

200

1286

1.60

8.59

6.3

6.8

24.29

24.46

mmol/l

0.27

192

1230

Convalescence

174

1084

1.65

8.57

21.2

6.0

24.92

24.35

mmol/l

1.12

165

1042

Injury of blood vessels at abdomen, lower back and pelvis level

3.88

8.54

10.1

11.3

24.43

24.71

mmol/l

0.13

Gout due to impairment of renal function

274

2.44

8.54

10.9

6.1

23.77

24.33

mmol/l

0.52

261

Residual foreign body in soft tissue

173

1078

1.65

8.51

7.9

8.0

24.70

24.48

mmol/l

0.35

166

1024

Contact with machinery

408

3017

1.39

8.47

5.9

7.6

23.92

24.50

mmol/l

2.46

394

2892

Polyarthritis, unspecified

134

784

1.78

8.46

7.2

8.0

24.66

24.40

mmol/l

0.28

125

752

Bronchitis, not specified as acute or chronic

278

1921

1.48

8.45

8.1

6.8

24.75

24.22

mmol/l

1.45

265

1838

Dislocation, sprain and strain of joint and ligaments of hip

147

884

1.73

8.43

6.3

6.7

24.95

24.33

mmol/l

1.41

142

844

Acne vulgaris

167

1027

1.65

8.41

6.9

7.0

23.81

23.80

mmol/l

0.01

161

979

Congenital malformations of the urinary system, including avohilmo

195

1254

1.60

8.40

9.7

7.4

23.39

24.40

mmol/l

3.35

182

1196

Non-small cell lung cancer

423

3112

1.37

8.38

7.7

6.5

25.40

24.46

mmol/l

5.86

402

3001

Other benign neoplasms of skin

1349

11448

1.19

8.36

6.6

6.7

24.52

24.55

mmol/l

0.12

1290

10963

Collagenous colitis

315

2235

1.44

8.35

9.2

6.4

24.01

24.54

mmol/l

1.58

305

2133

Burns and corrosions of external body surface, specified by site

344

2476

1.42

8.33

7.5

7.2

24.33

24.39

mmol/l

0.10

331

2369

Abnormalities of gait and mobility

459

3464

1.36

8.32

6.1

6.6

24.81

24.46

mmol/l

1.06

439

3318

Localized swelling, mass and lump of skin and subcutaneous tissue

1109

9259

1.21

8.27

6.9

7.0

24.56

24.50

mmol/l

0.21

1074

8873

Presbycusis

585

4507

1.31

8.26

4.9

6.0

24.36

24.53

mmol/l

0.52

550

4307

Acute suppurative otitis media

631

4610

1.29

8.23

7.2

6.7

24.00

24.24

mmol/l

0.90

605

4388

Tumor necrosis factor alpha inhibitors

434

3243

1.36

8.22

6.7

7.2

24.49

24.44

mmol/l

0.12

420

3092

Multiple myeloma and malignant plasma cell neoplasms

198

1292

1.59

8.18

7.6

6.4

24.03

24.38

mmol/l

0.59

187

1237

Congenital malformations of cardiac septa

184

1135

1.61

8.18

9.5

7.1

24.62

24.36

mmol/l

0.41

177

1089

Tooth eruption problems

300

2034

1.44

8.15

7.3

6.6

24.30

23.89

mmol/l

0.99

282

1945

Other and unspecified injuries of lower leg

242

1640

1.51

8.13

6.4

6.7

24.88

24.37

mmol/l

1.32

235

1572

Lichen simplex chronicus and prurigo

228

1531

1.53

8.12

8.6

6.6

24.30

24.55

mmol/l

0.46

214

1459

Femoral hernia

167

1048

1.65

8.10

8.3

6.5

24.46

mmol/l

0.01

160

997

Endometriosis ASRM stages 1,2

413

3073

1.36

8.03

5.6

6.4

24.11

24.52

mmol/l

1.80

395

2936

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

125

732

1.80

8.02

6.4

6.2

23.83

24.47

mmol/l

0.85

116

706

Multiple myeloma

125

732

1.80

8.02

6.4

6.2

23.83

24.47

mmol/l

0.85

116

706

Diseases of tongue

219

1461

1.54

8.01

8.3

6.4

25.14

24.39

mmol/l

2.48

206

1386

Struck by thrown, projected or falling objec

180

1151

1.61

8.00

5.3

7.1

24.40

24.44

mmol/l

0.04

167

1107

Ganglion

602

4724

1.29

7.96

6.4

6.9

24.57

24.50

mmol/l

0.18

574

4524

Drug-induced cataract

492

1.97

7.92

9.9

8.1

24.36

24.50

mmol/l

0.13

474

Malignant neoplasm of bladder

287

2025

1.46

7.92

8.0

6.5

23.57

24.31

mmol/l

1.91

276

1954

Retinal breaks without detachment

328

4499

0.72

7.91

6.7

7.2

24.48

24.60

mmol/l

0.25

308

4307

Primary biliary cholangitis, wide definition

435

2.03

7.91

7.2

6.0

24.24

24.71

mmol/l

0.48

415

Injury of eye and orbit

435

3274

1.35

7.91

8.1

7.1

24.66

24.40

mmol/l

0.76

421

3115

Unspecified dementia

454

3084

1.35

7.90

4.2

5.9

24.43

24.42

mmol/l

0.02

432

2948

Erythema multiforme

479

1.98

7.85

8.1

7.3

25.12

24.61

mmol/l

0.65

461

Orthopaedic devices associated with adverse incidents

510

0.20

7.84

6.1

6.3

27.10

24.62

mmol/l

1.29

490

Haemolytic anaemias

133

796

1.74

7.81

10.4

7.2

24.09

24.45

mmol/l

0.47

128

764

Endometriosis of pelvic peritoneum

402

2717

1.36

7.77

5.4

7.1

24.11

24.56

mmol/l

1.99

385

2594

Non-Hodgkin lymphoma, all

185

1203

1.60

7.76

10.1

6.5

24.46

24.47

mmol/l

0.01

174

1159

Diabetic neuropathy

514

3973

1.32

7.75

8.5

8.2

23.92

24.15

mmol/l

0.61

494

3828

Other and unspecified follicular disorders

144

881

1.69

7.72

7.4

7.8

24.46

24.45

mmol/l

0.01

138

847

Rare circulating lymphoid malignancy, including Hilmo

113

649

1.82

7.70

8.7

7.2

24.16

24.39

mmol/l

0.25

106

627

Dental pulpitis, including avohilmo

3057

17573

1.12

7.69

6.7

7.2

24.54

24.49

mmol/l

0.40

2930

16823

Basal cell carcinoma

1655

9762

1.17

7.65

6.2

6.8

24.34

24.56

mmol/l

1.70

1586

9397

Supervision of normal pregnancy

216

1831

0.67

7.64

4.2

6.6

23.71

24.34

mmol/l

2.01

208

1759

Actinic keratosis

1594

12561

1.17

7.62

6.2

6.7

24.38

24.56

mmol/l

1.14

1521

12055

Septal defects

171

1068

1.61

7.61

9.8

7.5

24.71

24.37

mmol/l

0.54

165

1026

Sequelae of injuries of lower limb

299

2138

1.43

7.60

7.8

7.1

24.86

24.49

mmol/l

1.08

284

2046

Adalimumab

279

1969

1.44

7.58

5.7

7.5

24.40

24.43

mmol/l

0.04

269

1886

Tuberculosis

236

1621

1.50

7.56

7.6

6.6

25.13

24.38

mmol/l

1.77

226

1553

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

475

3644

1.32

7.56

6.1

7.4

24.24

24.41

mmol/l

0.49

454

3483

Other general symptoms and signs

136

813

1.69

7.54

7.6

6.2

24.64

24.20

mmol/l

0.56

131

774

Postmenopausal atrophic vaginitis

536

3748

0.77

7.53

5.5

6.8

24.52

24.79

mmol/l

1.06

521

3585

Skin changes due to chronic exposure to nonionizing radiation

1630

12817

1.16

7.51

6.2

6.7

24.37

24.57

mmol/l

1.34

1556

12297

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

399

2.01

7.43

9.1

7.9

25.30

24.34

mmol/l

1.27

380

Pedal cyclist injured in transport accident

696

5608

1.26

7.42

6.9

24.63

24.46

mmol/l

0.59

659

5364

Dementia due to Parkinsons disease, excluding more controls

539

1.89

7.42

5.3

5.8

25.30

24.17

mmol/l

2.28

515

Other and unspecified urticaria

554

4347

1.29

7.40

7.0

6.6

24.66

24.45

mmol/l

0.70

523

4157

Lichen planus, including avohilmo

654

5243

1.27

7.39

5.7

7.0

24.38

24.64

mmol/l

1.02

628

5018

Persons with potential health hazards related to communicable diseases

649

8001

0.80

7.31

4.9

6.9

24.41

24.31

mmol/l

0.28

620

7636

Dislocation, sprain and strain of joints and ligaments of knee

1925

15288

1.15

7.30

6.6

6.9

24.54

24.49

mmol/l

0.24

1842

14619

Psoriasis

951

7927

1.21

7.30

8.0

7.3

24.94

24.50

mmol/l

2.99

916

7590

Crohn's disease of small intestine

206

1384

1.52

7.29

7.1

6.7

24.45

mmol/l

0.00

200

1326

Other specified and unspecified retinal disorders

140

866

1.68

7.29

7.4

6.6

23.93

24.47

mmol/l

1.14

132

830

Carbimazole or st.post thyroidectomy, condition for graves disease

622

4962

1.27

7.27

5.8

6.8

24.74

24.59

mmol/l

0.53

588

4749

Other maternal disorders predominantly related to pregnancy

1371

7330

1.18

7.23

5.8

6.7

24.25

24.68

mmol/l

4.16

1309

7020

Other disorders of patella

467

3595

1.32

7.23

6.3

7.4

24.40

24.44

mmol/l

0.07

455

3450

Benign thyroid growths and nodules

1111

8730

1.20

7.17

6.7

6.4

24.81

24.68

mmol/l

0.57

1072

8366

Voice disturbances

888

7369

1.22

7.16

6.6

6.9

24.79

24.55

mmol/l

1.23

860

7057

Hepatocellular carcinoma

103

591

1.84

7.16

8.6

6.7

23.13

24.60

mmol/l

2.60

568

Open wound of forearm

328

2409

1.39

7.13

6.3

6.7

24.31

24.39

mmol/l

0.13

320

2303

Other diseases of hard tissues of teeth

2113

9651

1.14

7.08

6.6

6.7

24.45

24.54

mmol/l

0.49

2031

9218

Other contact dermatitis

246

1723

1.46

7.04

7.9

6.4

24.64

24.41

mmol/l

0.45

231

1642

Injuries involving multiple body regions

128

779

1.70

7.03

13.7

7.7

24.12

24.47

mmol/l

0.43

123

743

Injury of muscle and tendon at wrist and hand level

450

3471

1.32

6.98

6.7

7.7

24.50

mmol/l

0.00

431

3316

Other specified/unspecified dorsopathies

115

682

1.74

6.97

6.0

7.1

24.55

24.48

mmol/l

0.09

109

658

Other congenital malformations

218

1493

1.49

6.95

7.3

7.2

24.88

24.32

mmol/l

1.34

207

1424

Any prescribed medicine buy

7.74

6.93

4.4

2.8

22.73

25.65

mmol/l

1.31

Crohn's disease of large intestine

152

968

1.61

6.91

9.8

7.0

23.99

24.49

mmol/l

0.84

146

928

Basal cell carcinoma, including Hilmo

1694

10022

1.15

6.86

6.3

6.8

24.32

24.56

mmol/l

2.03

1623

9649

Nosocomial condition (hospital)

135

2.88

6.85

7.8

5.1

26.01

24.24

mmol/l

2.09

127

Cyst of kidney

275

1983

1.43

6.83

8.6

6.9

24.84

24.46

mmol/l

0.86

261

1900

Post-traumatic wound infection, not elsewhere classified

104

605

1.79

6.82

9.3

7.5

24.03

24.56

mmol/l

0.59

576

Necrobiosis lipoidica, not elsewhere classified

3.52

6.78

9.5

12.9

23.97

24.36

mmol/l

0.17

Other Crohn's disease

201

1365

1.51

6.78

6.2

6.7

23.85

24.50

mmol/l

1.72

194

1307

Acute pharyngitis

378

2825

1.34

6.73

6.2

6.9

24.67

24.33

mmol/l

1.06

364

2706

Blepharochalasis

1061

9008

1.19

6.71

7.0

6.7

24.95

24.65

mmol/l

2.19

1017

8618

Use of rivastigmine

671

5450

1.25

6.69

4.7

6.0

24.60

24.53

mmol/l

0.20

635

5217

Cystic kidney disease

113

677

1.74

6.66

11.2

7.4

22.91

24.41

mmol/l

4.15

108

651

Injury of unspecified body region

259

1853

1.43

6.66

9.1

7.1

24.81

24.44

mmol/l

0.98

252

1763

Burn and corrosion of trunk

104

610

1.77

6.62

8.7

7.7

24.68

24.39

mmol/l

0.28

585

Benign neoplasm: Skin of other and unspecified parts of face

369

2795

1.35

6.61

6.3

6.6

24.57

24.47

mmol/l

0.21

353

2669

Postzoster neuralgia

416

1.97

6.58

10.3

6.2

25.46

24.37

mmol/l

1.62

399

Hyperfunction of pituitary gland

132

822

1.65

6.58

8.2

7.1

25.18

24.36

mmol/l

1.79

122

783

Gingival hyperplasia

125

771

1.68

6.58

7.0

7.3

24.40

24.46

mmol/l

0.06

119

737

Squamous cell neoplasms and carcinomas of the skin

421

3252

1.32

6.56

6.6

6.1

24.31

24.48

mmol/l

0.42

398

3130

Thyroiditis

212

1466

1.48

6.55

7.1

24.62

24.48

mmol/l

0.27

203

1405

Malignant neoplasm of bladder, including Hilmo

476

3690

1.30

6.51

7.5

6.5

23.86

24.32

mmol/l

1.39

451

3556

Exposure to unspecified factor

3682

22902

1.10

6.50

7.7

6.8

24.72

24.47

mmol/l

3.60

3512

21955

Ulcerative colitis (strict definition, require KELA)

484

3803

1.29

6.48

6.3

7.3

24.25

24.41

mmol/l

0.44

462

3637

Plantar fascial fibromatosis

294

2155

1.39

6.48

6.3

7.1

24.77

24.49

mmol/l

0.74

285

2060

Other abnormal uterine and vaginal bleeding

671

3913

1.25

6.45

6.6

25.03

24.70

mmol/l

1.33

641

3738

Nonalcoholic fatty liver disease

314

2330

1.37

6.43

8.2

7.3

23.97

24.52

mmol/l

1.44

304

2237

Bullous disorders

212

1476

1.48

6.43

7.6

6.6

24.79

24.44

mmol/l

0.70

206

1408

Fourth [trochlear] nerve palsy

544

1.82

6.39

10.7

6.4

24.64

24.57

mmol/l

0.07

520

Unspecified/other endometriosis

200

1341

1.48

6.38

5.0

7.0

23.62

24.31

mmol/l

2.45

195

1283

Superficial injury of ankle and foot

332

2483

1.36

6.38

6.7

6.6

24.37

24.28

mmol/l

0.17

326

2366

Continuous positive airway pressure

255

1512

1.42

6.36

5.3

4.4

24.86

24.68

mmol/l

0.32

246

1455

Conjunctivitis

2025

18280

0.89

6.32

7.0

6.8

24.63

24.53

mmol/l

0.56

1945

17510

Contact with heat and hot substances

169

1127

1.54

6.30

6.9

7.4

24.52

24.34

mmol/l

0.28

160

1079

Benign neoplasm of other and unspecified intrathoracic organs

235

2.29

6.30

14.5

6.8

25.71

24.43

mmol/l

1.61

223

Hydrocele

443

3463

1.30

6.29

7.8

7.7

24.49

24.24

mmol/l

0.69

416

3326

Benign neoplasm of urinary organs

176

1187

1.53

6.29

6.2

6.5

24.21

24.38

mmol/l

0.20

167

1129

Sixth [abducent] nerve palsy

129

814

1.65

6.27

9.0

6.4

25.13

24.45

mmol/l

1.26

121

778

Vascular dementia (subcortical)

152

997

1.58

6.26

4.9

5.9

24.74

24.35

mmol/l

0.59

147

954

Other crystal arthropathies

474

1.87

6.23

4.1

7.5

25.12

24.16

mmol/l

1.19

452

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

518

4130

1.27

6.16

6.2

7.4

24.22

24.44

mmol/l

0.75

496

3947

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

205

1424

1.46

6.15

6.3

7.8

24.40

24.43

mmol/l

0.04

198

1369

Alcohol-induced acute pancreatitis

139

897

1.61

6.14

14.9

7.1

23.97

24.56

mmol/l

0.75

134

863

Simple and mucopurulent chronic bronchitis

137

878

1.61

6.14

6.4

6.5

25.29

24.15

mmol/l

3.14

132

843

Cystic kidney disease, including avohilmo

120

747

1.66

6.13

10.8

7.3

23.03

24.46

mmol/l

4.09

114

716

Ankylosing spondylitis

249

1794

1.41

6.12

6.6

7.5

24.97

24.33

mmol/l

2.03

236

1726

Psoriasis vulgaris

604

4907

1.25

6.12

8.3

7.3

24.90

24.51

mmol/l

1.68

579

4705

Hypermobility syndrome

120

743

1.65

6.12

4.9

7.6

24.19

24.31

mmol/l

0.13

115

710

Glucosamine medication

1788

12643

1.14

6.11

6.0

6.6

24.92

24.59

mmol/l

3.50

1726

12115

Disorders of vitreous body and globe

1907

16054

1.13

6.08

6.8

7.0

24.72

24.59

mmol/l

0.82

1830

15408

Ehlers-Danlos syndrome

112

2.81

6.07

4.0

6.5

23.73

24.47

mmol/l

0.70

107

Crystal arthropathies, rheuma endpoint

478

1.85

6.07

4.1

7.2

25.12

24.13

mmol/l

1.26

457

Other and specified injuries of hip and thigh

514

1.81

6.05

4.4

6.9

24.38

24.47

mmol/l

0.07

492

Scabies, including avohilmo

379

2916

1.32

5.97

7.3

6.9

24.77

24.26

mmol/l

1.96

364

2786

Achilles tendinitis

311

2332

1.36

5.96

8.5

7.4

24.93

24.44

mmol/l

1.75

304

2234

Mucosal proctocolitis

363

2782

1.32

5.94

7.4

6.8

24.18

24.41

mmol/l

0.61

352

2661

conjunctival haemorrhage

281

2084

1.38

5.91

7.9

6.7

24.65

24.58

mmol/l

0.11

265

1997

Use of levodopa decarbox-comt-inhibitor

136

884

1.61

5.91

5.6

6.5

25.77

24.34

mmol/l

6.00

130

845

Acne

204

1416

1.45

5.91

6.6

7.1

23.91

23.81

mmol/l

0.14

198

1347

Polycystic kidney disease

548

1.77

5.90

12.6

7.6

22.53

24.42

mmol/l

5.04

524

Fissure and fistula of anal and rectal regions

753

6275

1.21

5.88

6.5

6.7

24.54

24.58

mmol/l

0.11

724

5994

Need for immunization against other single viral diseases

409

0.23

5.83

3.4

8.3

24.11

24.48

mmol/l

—

393

Toxic effect of other gases, fumes and vapours

110

2.87

5.83

4.0

11.4

25.23

24.56

mmol/l

0.52

103

Prepatellar bursitis

162

1092

1.53

5.82

7.4

7.7

23.81

24.39

mmol/l

1.15

154

1042

Faecal incontinence

288

2146

1.37

5.79

7.3

6.1

24.56

24.83

mmol/l

0.62

274

2054

Lichen ruber planus, wide definition including periferal and oral lichen planus

748

6246

1.21

5.78

5.5

7.1

24.37

24.64

mmol/l

1.20

718

5975

UC patients in KELA-register (code 208), prior to 1994

153

1023

1.55

5.76

7.2

6.9

23.91

24.56

mmol/l

1.42

148

981

Other vitreous opacities

150

999

1.55

5.74

6.0

6.9

25.21

24.24

mmol/l

2.57

144

955

Other inflammation of eyelid, including avohilmo

1020

11879

0.85

5.74

6.1

6.9

24.61

24.47

mmol/l

0.68

982

11363

Nephrotic syndrome

105

645

1.69

5.69

10.1

7.5

23.04

24.51

mmol/l

2.49

619

Inflammatory diseases of prostate (prostatitis)

481

3852

1.27

5.66

6.6

8.0

24.48

24.31

mmol/l

0.47

453

3713

Erectile dysfunction

317

2417

1.35

5.61

7.5

7.3

24.38

24.33

mmol/l

0.09

294

2321

Left hemicolectomy

597

1.72

5.59

10.2

6.6

23.75

24.53

mmol/l

1.66

573

Femoral hernia, unilateral

104

642

1.69

5.57

8.8

6.6

24.31

24.42

mmol/l

0.12

610

Inguinal of femoral hernia, unilateral

104

642

1.69

5.57

8.8

6.6

24.31

24.42

mmol/l

0.12

610

Inguinal hernia, unilateral

104

642

1.69

5.57

8.8

6.6

24.31

24.42

mmol/l

0.12

610

Malignant neoplasm of oral cavity

128

830

1.60

5.56

11.6

6.3

25.43

24.58

mmol/l

2.33

123

803

Suppurative and unspecified otitis media

942

7109

1.18

5.55

7.0

6.8

24.24

24.35

mmol/l

0.42

901

6785

Speech disturbances, not elsewhere classified

327

2503

1.33

5.54

7.5

6.6

25.01

24.45

mmol/l

1.71

316

2394

Degeneration of the brain due to alcohol

578

1.73

5.46

9.7

8.4

23.29

24.37

mmol/l

1.43

550

Injury of nerves and spinal cord at thorax level

2.94

5.42

18.2

7.5

26.37

24.78

mmol/l

1.28

Aspergillosis, including avohilmo

203

2.28

5.42

8.2

6.2

24.90

24.19

mmol/l

0.63

193

Benign neoplasm: Liver

426

1.83

5.40

7.3

6.9

24.49

24.30

mmol/l

0.20

407

Primary open-angle glaucoma, strict

1005

8641

1.17

5.37

5.9

6.5

24.29

24.61

mmol/l

1.87

961

8286

Certain zoonotic bacterial diseases, including avohilmo

108

679

1.65

5.36

5.7

7.2

24.62

24.54

mmol/l

0.07

102

648

Stenosis and insufficiency of lacrimal passages

311

2374

1.33

5.36

5.7

6.7

24.68

24.70

mmol/l

0.03

297

2265

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

225

1640

1.41

5.32

5.5

7.3

24.55

24.44

mmol/l

0.15

216

1571

Lesion of plantar nerve

186

1312

1.45

5.29

6.3

6.8

24.38

24.59

mmol/l

0.34

179

1253

Benign neoplasm: Choroid

229

1676

1.40

5.29

8.0

7.0

24.68

24.46

mmol/l

0.38

218

1609

Noise effects on inner ear

160

1101

1.50

5.28

6.3

7.6

24.52

24.48

mmol/l

0.04

151

1059

Other and unspecified disorders of skin and subcutaneous tissue

1444

0.60

5.27

7.8

6.8

25.02

24.40

mmol/l

0.77

1373

Other facial nerve disorders

566

1.70

5.24

5.7

7.6

24.34

24.43

mmol/l

0.11

543

Endometriosis diagnosis and infertility diagnosis occurring together

215

1552

1.40

5.24

5.1

6.7

23.59

24.42

mmol/l

3.94

204

1483

Benign neoplasm: Kidney

134

891

1.56

5.24

6.4

6.7

24.06

24.48

mmol/l

0.53

127

852

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1025

8733

1.17

5.22

6.8

6.9

24.45

24.40

mmol/l

0.17

989

8324

N06DA Anticholinesterases

1477

10081

1.14

5.22

4.7

6.4

24.44

24.51

mmol/l

0.31

1410

9658

Use of anticholinesterases

1477

10081

1.14

5.22

4.7

6.4

24.44

24.51

mmol/l

0.31

1410

9658

Sequelae of infectious and parasitic diseases, including avohilmo

239

1763

1.38

5.20

7.1

6.6

25.36

24.40

mmol/l

3.20

234

1689

Other keratitis

335

2592

1.31

5.19

8.7

7.0

24.75

24.46

mmol/l

0.78

323

2485

Primary biliary cholangitis (PBC)

417

1.82

5.19

11.2

5.9

24.34

24.65

mmol/l

0.28

396

Non-small cell lung cancer, adenocarcinoma

233

1716

1.39

5.19

6.4

6.3

25.16

24.48

mmol/l

2.33

220

1654

Pedal cyclist injured in other and unspecified transport accidents

341

2646

1.31

5.18

6.8

7.1

24.78

24.40

mmol/l

1.03

319

2538

Vasomotor rhinitis (mode)

230

1690

1.39

5.15

5.4

7.2

24.39

24.44

mmol/l

0.08

220

1614

Benign neoplasm of ovary

495

4017

1.25

5.15

5.8

6.4

24.56

24.78

mmol/l

0.64

480

3843

Embedded and impacted teeth

559

3708

1.23

5.15

6.0

6.8

24.15

24.09

mmol/l

0.14

532

3535

141

2.46

5.14

4.4

9.5

24.65

24.42

mmol/l

0.13

131

Degeneration of nervous system due to alcohol

588

1.69

5.13

9.7

8.2

23.29

24.46

mmol/l

1.61

560

Maternal care for known or suspected fetal abnormality and damage

141

1760

0.67

5.13

6.6

6.4

23.76

24.08

mmol/l

0.44

132

1689

Vasomotor and allergic rhinitis

1063

9005

1.16

5.12

7.0

6.9

24.35

24.44

mmol/l

0.36

1015

8621

Sequelae of infectious and parasitic diseases

232

1708

1.39

5.12

6.8

6.6

25.28

24.37

mmol/l

2.90

227

1637

Malignant neoplasm of breast, HER-positive

875

5553

1.18

5.11

5.5

6.1

25.16

24.81

mmol/l

2.34

841

5320

Gangrene, not elsewhere classified

162

2.39

5.09

8.4

4.9

23.88

23.92

mmol/l

0.02

152

Respiratory tuberculosis

194

1392

1.43

5.06

7.9

6.9

24.90

24.41

mmol/l

0.85

184

1335

Respiratory tuberculosis, confirmed and not-confirmed

194

1392

1.43

5.06

7.9

6.9

24.90

24.41

mmol/l

0.85

184

1335

Melanocytic naevi

939

8083

1.17

5.06

6.9

7.0

24.39

24.46

mmol/l

0.24

893

7735

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

420

3349

1.27

5.04

6.5

6.1

24.38

24.42

mmol/l

0.09

411

3195

Malignant neoplasm of breast, ER-positive, including Hilmo

875

5556

1.18

5.01

5.5

6.1

25.15

24.81

mmol/l

2.29

841

5323

Chronic periodontitis, complicated

2052

18086

1.11

5.01

7.2

7.1

24.51

24.59

mmol/l

0.41

1967

17380

IgA nephropathy (IgA glomerulonephritis)

490

1.74

5.00

9.8

8.0

23.09

24.48

mmol/l

1.99

467

Special screening examination for other diseases and disorders

334

2593

1.30

4.99

6.0

24.04

24.37

mmol/l

0.70

319

2466

Other and unspecified rosacea

280

2130

1.34

4.97

7.2

7.0

24.38

24.42

mmol/l

0.07

265

2043

Crohn disease (strict definition, require KELA, min 2 HDR)

168

1176

1.46

4.96

8.9

7.3

24.06

24.46

mmol/l

0.77

161

1123

Endometriosis

890

4414

1.18

4.95

5.8

6.5

24.30

24.57

mmol/l

1.40

852

4217

Ehlers-Danlos syndrome, including avohilmo

137

2.43

4.93

3.9

6.6

23.99

24.92

mmol/l

0.93

131

Malignant neoplasm of head and neck

287

2195

1.33

4.93

9.5

6.4

25.18

24.49

mmol/l

2.44

270

2117

Disorders of vitreous body

1831

15676

1.12

4.91

6.8

6.9

24.71

24.59

mmol/l

0.70

1757

15051

Aspergillosis

198

2.22

4.91

8.0

6.2

24.93

24.19

mmol/l

0.65

188

Chondropathies

433

3482

1.26

4.90

6.0

7.0

24.44

24.45

mmol/l

0.01

411

3325

Other specified/unspecified hearing loss

309

2391

1.32

4.87

6.9

6.8

24.61

24.54

mmol/l

0.12

300

2275

Other and unspecified corneal deformities and disorders

109

704

1.60

4.85

7.6

7.0

25.00

24.57

mmol/l

0.66

104

676

Other disorders of iris and ciliary body

107

690

1.61

4.84

5.6

6.4

24.05

24.52

mmol/l

0.60

101

657

Malignant neoplasm of other connective and soft tissue, including Hilmo

141

963

1.51

4.83

6.6

6.9

24.50

24.55

mmol/l

0.05

136

927

Granulomatous disorders of skin and subcutaneous tissue

510

1.70

4.81

9.7

7.6

24.56

24.52

mmol/l

0.04

487

Psoriatic arthropathies

292

2245

1.32

4.79

6.6

7.6

24.93

24.56

mmol/l

0.80

281

2154

Restless leg syndrome

452

3666

1.25

4.78

6.1

6.8

24.91

24.56

mmol/l

1.37

440

3499

Von Willebrand disease

185

2.20

4.77

7.8

6.8

24.80

24.87

mmol/l

0.05

177

Coarctation of the aorta

146

2.37

4.77

17.9

10.6

23.68

24.76

mmol/l

0.75

138

Mental and behavioural disorders due to hallucinogens

3.10

4.75

4.3

14.1

24.62

25.05

mmol/l

0.27

Atypical facial pain

153

1065

1.47

4.72

5.7

7.4

24.86

24.46

mmol/l

0.91

148

1019

Preparatory care for dialysis

1090

0.57

4.71

6.7

7.6

22.34

24.48

mmol/l

3.47

1047

Benign neoplasm: Bronchus and lung

299

1.94

4.70

9.1

6.6

25.41

24.59

mmol/l

1.13

287

Haemangioma and lymphangioma, any site

274

2096

1.33

4.70

6.5

7.1

24.43

24.49

mmol/l

0.10

265

2005

Other diseases of gallbladder

150

1044

1.47

4.66

6.9

5.9

24.05

24.57

mmol/l

1.05

145

999

Haemangioma, any site

258

1961

1.34

4.64

6.5

7.2

24.43

24.49

mmol/l

0.10

249

1873

Pediculosis, acariasis and other infestations

183

1320

1.42

4.62

8.6

7.1

25.07

24.45

mmol/l

1.56

178

1271

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

264

1.98

4.62

6.2

6.0

24.48

24.29

mmol/l

0.16

251

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

419

1.78

4.61

7.4

5.6

24.67

24.49

mmol/l

0.15

402

Nonspecific lymphadenitis

164

1161

1.44

4.60

6.0

7.3

24.78

24.44

mmol/l

0.56

156

1105

Family history of certain disabilities and chronic diseases leading to disablement

113

742

1.55

4.59

5.4

6.4

24.15

24.29

mmol/l

0.17

106

703

Adenocarcinoma of pancreas

112

740

1.57

4.57

7.2

6.4

24.38

24.55

mmol/l

0.22

105

715

Crohn disease (strict definition, require KELA)

169

1204

1.43

4.56

8.8

7.3

24.00

24.47

mmol/l

0.96

162

1150

Dermatographic urticaria

175

1255

1.42

4.54

5.6

6.9

24.14

24.41

mmol/l

0.46

164

1201

Epidermolysis bullosa

7.37

4.53

20.0

8.6

23.12

24.23

mmol/l

—

Non-small cell lung cancer, squamous

179

1293

1.42

4.53

9.7

6.2

25.76

24.38

mmol/l

4.42

172

1249

Other coagulation defects

220

1640

1.37

4.52

10.7

6.9

24.88

24.34

mmol/l

1.20

211

1568

Other specified and unspecified disorders of eye and adnexa

822

0.52

4.48

7.1

7.4

25.11

24.31

mmol/l

0.83

785

Isolated proteinuria

607

1.62

4.48

7.8

7.6

23.26

24.45

mmol/l

2.12

579

Dissection of cerebral arteries, nonruptured

132

2.42

4.46

10.0

6.6

24.28

24.74

mmol/l

0.33

127

Ulcerative rectosigmoiditis

236

1783

1.35

4.43

6.9

7.0

24.43

24.45

mmol/l

0.03

227

1704

Ulcerative colitis (strict definition, all Crohn cases excluded)

398

3210

1.25

4.43

6.2

7.1

24.25

24.42

mmol/l

0.45

382

3070

Maternal care for other conditions predominantly related to pregnancy

376

2931

1.26

4.41

6.6

6.5

23.85

24.31

mmol/l

1.94

353

2804

Excessive attrition of teeth

1905

17102

1.11

4.40

7.1

24.56

24.48

mmol/l

0.41

1842

16366

Pigmented purpuric dermatosis

228

2.04

4.36

4.4

6.4

24.74

24.28

mmol/l

0.34

220

Entropion and trichiasis of eyelid

329

2612

1.28

4.32

6.6

6.3

24.80

24.51

mmol/l

0.76

321

2494

Nontoxic goitre/thyroid nodule

931

8124

1.16

4.28

6.8

6.4

24.81

24.70

mmol/l

0.42

897

7772

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

178

1298

1.39

4.22

9.0

7.1

24.03

24.45

mmol/l

0.86

171

1243

Urolithiasis

1158

10268

1.14

4.19

7.3

24.26

24.40

mmol/l

0.69

1111

9841

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

824

7141

1.16

4.13

6.5

7.2

24.39

24.44

mmol/l

0.15

801

6834

Carcinoma in situ of skin of other and unspecified parts of face

216

2829

0.75

4.11

5.8

6.2

23.90

24.49

mmol/l

1.48

203

2710

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

281

1.87

4.11

10.5

7.8

23.31

24.58

mmol/l

1.64

267

Pedestrian injured in transport accident

213

1606

1.35

4.11

6.1

7.2

24.45

24.44

mmol/l

0.01

208

1535

Etanercept

174

1275

1.39

4.03

7.9

7.7

24.54

24.47

mmol/l

0.10

168

1219

Tongue abnormality

197

1475

1.36

4.03

7.7

6.9

25.26

24.52

mmol/l

2.22

184

1413

Speech therapy

651

7603

0.85

4.02

4.6

7.0

24.90

24.56

mmol/l

1.15

600

7295

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

256

1.91

3.98

10.3

8.8

24.16

24.38

mmol/l

0.10

238

Adenocarcinoma and papillary adenocarcinoma of stomach

105

706

1.53

3.97

7.3

6.3

25.20

24.33

mmol/l

1.51

100

682

Benign neoplasm of eye and adnexa

349

2818

1.26

3.96

7.6

6.8

24.63

24.52

mmol/l

0.18

330

2694

Superficial injury of shoulder and upper arm

364

2955

1.25

3.89

6.2

6.9

24.70

24.42

mmol/l

0.74

355

2824

Contact with and exposure to communicable diseases

496

5889

0.83

3.88

5.0

6.9

24.36

24.21

mmol/l

0.41

474

5620

Cardiomyopathies, Secondary/extrinsic

102

2.48

3.86

8.6

6.1

23.77

24.48

mmol/l

0.34

Inguinal hernia, bilateral

393

3225

1.24

3.86

5.8

6.9

24.50

24.31

mmol/l

0.53

381

3078

Traumatic amputation of wrist and hand

152

1103

1.42

3.84

6.9

7.8

24.41

24.55

mmol/l

0.20

147

1053

Bacterial meningitis

109

744

1.51

3.83

10.1

7.9

24.89

24.42

mmol/l

0.70

103

712

Injuries to the wrist and hand

3566

22096

1.07

3.83

6.6

7.0

24.40

24.52

mmol/l

1.16

3433

21148

Chronic lymphocytic leukaemia, helper endpoint

111

762

1.50

3.83

6.9

6.5

24.60

24.59

mmol/l

0.01

106

733

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

111

762

1.50

3.83

6.9

6.5

24.60

24.59

mmol/l

0.01

106

733

Chronic lymphocytic leukaemia

111

762

1.50

3.83

6.9

6.5

24.60

24.59

mmol/l

0.01

106

733

Undefined dementia

456

3502

1.22

3.80

4.2

5.5

24.46

24.40

mmol/l

0.11

434

3350

Other disorders of bladder

427

3539

1.22

3.79

6.5

7.1

24.87

24.45

mmol/l

1.35

412

3374

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

411

3391

1.23

3.79

6.5

7.0

24.57

24.51

mmol/l

0.13

393

3240

Behavioural syndromes associated with physiological disturbances and physical factors

3226

20343

1.08

3.78

6.6

7.0

24.50

24.52

mmol/l

0.12

3125

19453

Inguinal or femoral hernia, bilateral

398

3280

1.23

3.76

5.9

6.9

24.50

24.30

mmol/l

0.59

386

3129

Hypertrophy of breast in women and men

497

4173

1.20

3.75

6.9

24.49

24.50

mmol/l

0.03

480

3987

Supervision of high-risk pregnancy

369

1794

1.24

3.73

5.0

6.7

23.73

24.37

mmol/l

2.98

357

1724

Single delivery by forceps and vacuum extractor

143

1184

0.71

3.72

3.8

6.8

23.37

24.07

mmol/l

1.85

138

1137

Other osteochondropathies

196

1485

1.34

3.70

7.2

7.3

24.33

24.43

mmol/l

0.12

186

1427

Inflammatory disorders of breast

143

1030

1.41

3.69

4.2

6.6

24.21

24.46

mmol/l

0.35

137

981

Other and unspecified bullous disorders

235

1.93

3.68

6.4

6.2

24.64

24.74

mmol/l

0.07

224

Ventricular septal defect, a heart condition

261

1.84

3.68

10.4

7.7

23.69

24.37

mmol/l

0.43

250

Anomalies of dental arch relationship, including avohilmo

479

3627

1.20

3.66

6.5

6.9

24.52

24.29

mmol/l

0.77

461

3466

Spinal enthesopathy

651

1.52

3.65

4.7

5.1

24.76

24.25

mmol/l

0.66

627

Dentofacial anomalies [including malocclusion]

2087

14997

1.09

3.64

6.2

7.2

24.51

24.55

mmol/l

0.22

2005

14351

Conductive hearing loss, unspecified

243

1900

1.30

3.64

5.4

7.1

24.64

24.60

mmol/l

0.06

234

1813

Superficial injury of wrist and hand

556

4727

1.19

3.63

6.4

7.1

24.51

24.43

mmol/l

0.23

536

4512

Amblyopia ex anopsia

105

718

1.49

3.63

5.8

7.0

24.23

24.42

mmol/l

0.19

687

Myopia

307

2465

1.26

3.62

7.3

6.6

24.63

24.33

mmol/l

0.66

295

2352

Deviated nasal septum

1103

9838

1.13

3.58

6.9

7.5

24.67

24.44

mmol/l

1.39

1052

9425

Lymphoid leukaemia

189

1435

1.35

3.58

7.4

6.8

24.62

24.35

mmol/l

0.51

178

1375

Polypectomy (DHB20)

219

1696

1.32

3.58

5.4

7.3

24.73

24.41

mmol/l

0.60

204

1625

Use of selegiline

163

1212

1.38

3.58

5.2

6.6

25.79

24.39

mmol/l

8.22

154

1163

Herpesviral [herpes simplex] infections, including avohilmo

685

5928

1.16

3.57

6.4

6.8

24.35

24.43

mmol/l

0.25

665

5664

Other disorders of conjunctiva

487

4109

1.20

3.57

7.8

6.9

24.69

24.56

mmol/l

0.33

460

3927

Caught, crushed, jammed or pinched in or between objects

152

1116

1.39

3.55

6.2

7.6

24.34

24.43

mmol/l

0.12

140

1070

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

181

1367

1.35

3.54

6.5

6.4

24.31

24.64

mmol/l

0.60

174

1309

Mandibular retrognathia

137

984

1.41

3.54

6.4

7.9

24.22

24.40

mmol/l

0.18

129

941

Benign neoplasm of middle ear and respiratory system

257

2034

1.29

3.53

6.8

7.0

24.79

24.51

mmol/l

0.64

249

1944

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

142

1011

1.40

3.52

5.0

7.4

23.97

24.18

mmol/l

0.28

134

964

Biological medicines for asthma

380

1.68

3.51

7.5

8.4

24.92

24.57

mmol/l

0.38

366

Use of rasagiline

671

1.52

3.50

5.8

6.1

25.90

24.39

mmol/l

4.53

643

Personal history of malignant neoplasm

122

1700

0.71

3.49

7.9

6.1

24.38

24.70

mmol/l

0.42

115

1617

Hordeolum and other deep inflammation of eyelid

169

1266

1.36

3.47

8.8

7.1

24.56

24.40

mmol/l

0.23

162

1206

Reactive arthropathies

243

1914

1.29

3.44

9.3

7.4

24.45

24.48

mmol/l

0.04

232

1834

Foreign body in respiratory tract

145

1066

1.39

3.38

7.7

7.4

25.01

24.39

mmol/l

1.24

138

1021

Chromosomal abnormalities, not elsewhere classified

254

1.81

3.37

8.8

8.9

23.97

24.48

mmol/l

0.40

238

Otitis externa, unspecified

319

2598

1.24

3.37

6.3

7.2

24.33

24.39

mmol/l

0.12

305

2485

Bacterial, viral and other infectious agents

236

1858

1.29

3.37

8.3

7.5

24.82

24.41

mmol/l

0.93

227

1780

Syndrome of inappropriate secretion of antidiuretic hormone

151

2.16

3.36

7.5

5.6

24.80

24.25

mmol/l

0.35

143

Benign leiomyoma with endometriosis

299

3677

0.80

3.35

5.7

6.5

24.47

24.78

mmol/l

0.80

285

3517

Deep endometriosis

234

1841

1.29

3.35

7.1

6.5

24.31

24.58

mmol/l

0.67

229

1758

Vascular dementia (undefined)

156

1152

1.37

3.34

4.7

5.6

24.89

24.43

mmol/l

0.66

145

1104

Perforation of oesophagus

117

2.31

3.34

11.4

6.8

25.42

24.43

mmol/l

0.72

109

Endometriosis of rectovaginal septum and vagina

205

1587

1.31

3.34

7.5

6.5

24.46

24.61

mmol/l

0.30

200

1522

Congenital malformations of spine and bony thorax

2.52

3.34

14.6

12.0

25.79

25.54

mmol/l

0.09

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

506

1.58

3.33

10.2

6.9

25.28

24.60

mmol/l

1.01

492

Convergent concomitant strabismus

133

965

1.40

3.33

11.8

7.0

24.58

24.48

mmol/l

0.11

126

922

Giant cell arteritis

150

1116

1.38

3.31

7.0

6.0

24.25

24.37

mmol/l

0.15

144

1064

Other and unspecified psoriasis

216

1688

1.30

3.31

9.6

7.6

25.17

24.59

mmol/l

1.56

207

1611

Superficial frostbite

137

2.16

3.30

7.6

10.8

24.82

24.57

mmol/l

0.11

130

Calculus of kidney and ureter

1049

9397

1.13

3.30

7.0

7.2

24.24

24.42

mmol/l

0.88

1004

9011

Rosacea

359

2967

1.22

3.29

6.9

7.0

24.43

24.46

mmol/l

0.06

341

2840

Adjustment and management of implanted device

492

5764

0.84

3.28

4.9

6.2

24.36

24.44

mmol/l

0.19

469

5530

Noninflammatory disorders of female genital tract

1025

4571

1.13

3.27

5.7

6.4

24.30

24.53

mmol/l

1.14

980

4366

Striking against or struck by other objects

996

8878

1.13

3.27

7.4

7.3

24.66

24.40

mmol/l

1.43

956

8508

Disorders of conjunctiva

2432

20238

0.93

3.24

7.0

6.8

24.64

24.50

mmol/l

1.00

2330

19381

Complications associated with artificial fertilization

178

1.95

3.24

5.0

8.7

23.25

23.93

mmol/l

0.75

168

Contact with other hot fluids

556

1.53

3.23

4.8

7.7

24.49

24.52

mmol/l

0.02

529

Hemiplegia

148

1101

1.37

3.22

8.5

6.8

24.36

24.43

mmol/l

0.07

141

1053

Hallux rigidus

425

3578

1.20

3.22

7.1

24.71

24.66

mmol/l

0.10

410

3440

Ptosis of eyelid

383

3199

1.21

3.20

8.2

6.8

24.50

24.65

mmol/l

0.36

367

3060

Atrophic disorders of skin

438

3701

1.19

3.17

6.4

6.7

24.59

24.69

mmol/l

0.23

417

3543

Ménière disease

301

2464

1.24

3.10

5.9

6.8

24.81

24.58

mmol/l

0.57

286

2362

Endometriosis ASRM stages 3,4

551

4749

1.17

3.10

6.4

6.3

24.44

24.62

mmol/l

0.65

526

4542

Thyrotoxicosis

737

6487

1.14

3.10

5.8

6.7

24.48

24.62

mmol/l

0.46

703

6210

Carcinoma in situ of other and unspecified digestive organs

160

1216

1.35

3.09

6.6

6.9

24.45

24.43

mmol/l

0.02

151

1167

Non-small cell lung cancer, squamous, helper endpoint

179

1381

1.32

3.07

9.7

6.3

25.76

24.25

mmol/l

5.19

172

1326

Juvenile osteochondrosis

489

1.54

3.07

4.6

8.9

24.40

24.33

mmol/l

0.05

462

Acute epiglottitis

302

1.71

3.06

7.9

7.1

25.14

24.69

mmol/l

0.47

289

Myotonic disorders

141

2.08

3.06

9.5

7.0

25.81

24.76

mmol/l

0.67

135

Pedal cyclist injured in collision with motor vehicle

605

1.49

3.04

4.9

8.0

24.66

24.47

mmol/l

0.19

578

Maxillary prognathism

2.67

3.04

8.9

8.4

24.33

25.38

mmol/l

0.96

Bacterial, viral and other infectious agents, including avohilmo

251

2019

1.26

3.03

8.0

7.4

24.77

24.40

mmol/l

0.86

241

1935

Chronic iridocyclitis

143

1071

1.36

3.01

6.9

6.6

24.07

24.51

mmol/l

0.59

133

1020

Other/unspecified enthesopathies, not elsewhere classified

250

2012

1.26

3.01

5.7

7.1

24.64

24.55

mmol/l

0.15

237

1917

Osteomalacia

142

2.07

3.01

6.6

9.6

24.36

24.99

mmol/l

0.32

135

Pediculosis, acariasis and other infestations, including avohilmo

432

3663

1.19

2.99

7.0

7.1

24.80

24.31

mmol/l

2.05

416

3498

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

103

734

1.44

2.99

6.6

5.9

24.88

24.42

mmol/l

0.53

706

Alzheimer’s disease (Late onset)

964

7115

1.12

2.96

4.4

6.1

24.39

24.51

mmol/l

0.46

928

6800

Respiratory tuberculosis, not confirmed, including avohilmo

139

1042

1.36

2.95

7.5

6.6

25.17

24.34

mmol/l

1.42

132

998

Hypersomnia

254

1.75

2.87

6.4

8.2

25.73

24.76

mmol/l

0.98

241

Coxibs

942

4412

1.13

2.87

5.2

7.4

24.43

24.30

mmol/l

0.46

902

4218

Melanocytic naevi of trunk

350

2931

1.21

2.86

6.8

7.1

24.53

24.40

mmol/l

0.28

336

2805

Malignant neoplasm of tongue, including Hilmo

615

1.47

2.86

10.3

6.6

25.32

24.67

mmol/l

0.99

597

Nasal polyp

627

5500

1.15

2.84

5.7

7.2

24.49

24.40

mmol/l

0.24

599

5272

Persons encountering health services for specific procedures, not carried out

218

1739

1.27

2.84

11.0

6.0

24.71

24.33

mmol/l

0.92

218

1666

Bicipital tendinitis

148

1126

1.34

2.83

6.3

8.0

24.97

24.56

mmol/l

0.78

141

1070

Haemorrhagic disorder due to circulating anticoagulants

390

1.61

2.82

10.5

6.7

25.01

24.32

mmol/l

0.54

375

Respiratory tuberculosis, not confirmed

137

1033

1.35

2.81

7.5

6.6

25.18

24.31

mmol/l

1.48

131

990

Sleep disorders

3063

19852

1.07

2.80

6.6

7.0

24.48

24.53

mmol/l

0.36

2960

18977

Other inflammation of eyelid

433

3700

1.18

2.80

6.8

6.9

24.65

24.58

mmol/l

0.16

416

3538

Scleritis and episcleritis

165

1276

1.31

2.78

6.8

7.1

24.22

24.47

mmol/l

0.44

159

1211

Oral lichen planus

602

1.47

2.77

4.6

7.8

24.16

24.63

mmol/l

0.81

578

Drug phototoxic response

5.64

2.77

3.9

8.3

25.00

24.96

mmol/l

—

Fall on and from ladder

261

2136

1.24

2.77

6.2

7.3

24.50

24.42

mmol/l

0.15

252

2049

Benign neoplasm: Endocrine pancreas

155

2.00

2.77

10.5

6.3

24.01

24.65

mmol/l

0.35

148

Thyrotoxicosis, other and/or unspecified

563

4911

1.16

2.75

5.5

6.7

24.33

24.60

mmol/l

0.97

536

4696

Malignant neoplasm of retroperitoneum and peritoneum

177

1.91

2.73

11.8

5.6

24.27

24.77

mmol/l

0.51

172

Nonalcoholic steatohepatitis

169

1.91

2.73

7.9

10.5

23.78

24.82

mmol/l

0.99

159

Infection due to other mycobacteria, including avohilmo

344

1.62

2.72

6.3

6.1

25.84

24.63

mmol/l

0.92

326

Varus deformity, not elsewhere classified

191

1.85

2.71

7.2

7.0

24.77

24.51

mmol/l

0.20

180

Erosion of teeth , including avohilmo

696

6162

1.14

2.71

8.6

7.0

24.54

24.42

mmol/l

0.39

672

5871

Disorders of synovium and tendon in diseases classified elsewhere

498

1.51

2.70

5.8

7.5

24.67

24.47

mmol/l

0.15

470

Motor- or nonmotor-vehicle accident in traffic area

127

2.06

2.70

6.8

10.5

24.82

24.71

mmol/l

0.06

122

Degenerative conditions of globe

114

2.15

2.68

4.5

6.3

24.70

24.22

mmol/l

0.23

109

Otalgia

217

1743

1.26

2.68

5.6

7.0

24.81

24.50

mmol/l

0.73

208

1663

Perineal laceration during delivery

182

1864

0.78

2.68

5.4

5.8

23.80

24.04

mmol/l

0.46

172

1780

Non-small cell lung cancer, adenocarcinoma, helper endpoint

233

1894

1.25

2.66

6.4

6.7

25.16

24.43

mmol/l

2.69

220

1810

Myeloproliferative diseases

268

2209

1.23

2.65

8.2

6.7

24.04

24.53

mmol/l

1.24

259

2114

Primary angle-closure glaucoma

148

1140

1.33

2.64

4.5

6.8

24.31

24.53

mmol/l

0.27

138

1082

Ectopic pregnancy

377

3200

1.19

2.64

6.2

6.7

24.49

24.67

mmol/l

0.42

362

3052

Dermatophytosis, including avohilmo

2200

20152

1.07

2.63

6.7

7.0

24.65

24.51

mmol/l

1.00

2122

19295

Other noninflammatory disorders of vulva and perineum

232

1881

1.25

2.63

5.5

6.3

24.72

24.52

mmol/l

0.41

224

1796

Episcleritis

140

1069

1.33

2.62

6.9

7.1

24.19

24.52

mmol/l

0.59

135

1022

Drug-induced gout

116

2.15

2.61

11.7

6.0

24.69

24.19

mmol/l

0.17

111

Congenital malformations of spine and bony thorax, including avohilmo

101

2.17

2.61

14.1

11.1

25.65

25.58

mmol/l

0.02

Prolapse and hernia of ovary and fallopian tube

134

1011

1.34

2.59

5.2

24.71

24.72

mmol/l

0.01

124

977

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

2.18

2.58

5.0

4.0

26.16

23.93

mmol/l

0.97

Cysts of oral region, not elsewhere classified

175

1380

1.29

2.58

5.8

7.7

24.14

24.48

mmol/l

0.65

165

1322

Defects in the complement system

116

2.08

2.54

19.3

6.6

25.59

24.57

mmol/l

0.57

109

Melanoma in situ of other and unspecified parts of face

349

0.47

2.54

5.4

6.0

25.68

24.50

mmol/l

0.57

340

Atopic dermatitis, strict definition with reimbursement

690

5887

1.13

2.53

6.6

6.5

24.53

24.29

mmol/l

0.99

664

5612

Intercostal neuropathy

152

1.93

2.53

9.1

10.3

25.77

24.24

mmol/l

1.71

145

Other salmonella infections, including avohilmo

117

877

1.36

2.51

6.1

7.1

24.47

24.61

mmol/l

0.19

112

841

Other specified/unspecified bacterial intestinal infections

197

1582

1.26

2.50

7.0

6.9

23.71

24.52

mmol/l

1.89

190

1511

Subacute thyroiditis

698

1.40

2.50

6.2

7.4

24.64

24.47

mmol/l

0.22

664

Antenatal screening

281

1896

0.83

2.49

4.3

6.6

23.88

24.34

mmol/l

1.44

272

1823

Mild or no visual impairment, binocular

2.24

2.49

7.0

5.6

24.58

24.68

mmol/l

0.05

APECED

7.40

2.48

21.8

5.8

23.84

25.64

mmol/l

—

Allergic urticaria

200

1608

1.26

2.48

6.3

6.8

24.34

24.44

mmol/l

0.15

186

1533

Other disorders of eye and adnexa

385

3295

1.18

2.48

6.3

6.9

24.38

24.44

mmol/l

0.14

373

3150

Background retinopathy and retinal vascular changes

500

1.48

2.47

10.9

6.6

23.40

24.45

mmol/l

1.64

482

Other lesions of median nerve

651

1.42

2.46

7.6

6.9

24.88

24.35

mmol/l

0.66

622

Disorders of optic nerve, not elsewhere classified

503

1.47

2.41

7.3

7.6

24.29

24.49

mmol/l

0.16

481

Bitten or struck by other mammals

279

2329

1.21

2.41

6.8

7.0

24.32

mmol/l

0.00

267

2231

Temporal arteritis

128

982

1.33

2.40

7.0

6.2

24.23

24.40

mmol/l

0.21

123

935

Thyroiditis, unspecified

260

1.66

2.40

9.5

6.7

25.03

24.56

mmol/l

0.42

248

Flatulence and related conditions

184

1.80

2.39

13.5

7.3

24.71

24.35

mmol/l

0.20

177

Occupant of special vehicle mainly used on industrial premises injured in transport accident

113

2.08

2.38

9.0

6.7

24.00

24.54

mmol/l

0.21

108

Inhalation and ingestion of food causing obstruction of respiratory tract

223

1.73

2.38

11.5

8.3

25.32

24.64

mmol/l

0.55

212

Reactive arthropathies, FINNGEN

181

1448

1.27

2.37

9.7

7.5

24.42

24.34

mmol/l

0.11

170

1384

Autoimmune hyperthyroidism

149

1164

1.30

2.37

6.1

6.4

24.64

24.56

mmol/l

0.11

141

1104

Other disorders of penis

316

2676

1.19

2.34

7.2

8.0

24.32

mmol/l

0.00

301

2570

All dysplastic lesions of the vulva

105

784

1.36

2.33

6.7

6.8

24.81

24.67

mmol/l

0.15

100

745

Varicose veins of other sites

187

1507

1.26

2.33

6.8

7.4

24.60

24.38

mmol/l

0.32

181

1448

Other obstructed labour

153

1202

1.29

2.32

6.7

6.1

24.56

24.49

mmol/l

0.08

145

1143

Pedal cyclist injured in noncollision transport accidents

309

2614

1.19

2.32

8.3

7.3

24.68

24.40

mmol/l

0.71

299

2502

Other and unspecified iridocyclitis

135

1047

1.31

2.31

6.1

7.2

23.93

24.49

mmol/l

0.92

130

997

Colonic or urogenital fistula

829

7497

1.11

2.30

7.4

7.1

24.54

24.50

mmol/l

0.12

798

7177

Effects of heat and light

165

1.84

2.29

9.8

8.4

23.29

24.35

mmol/l

0.58

154

Isolated patent ductus arteriosus

2.07

2.28

6.8

11.3

24.45

24.29

mmol/l

0.09

Liposarcoma

173

1.82

2.28

12.1

6.7

24.42

24.17

mmol/l

0.22

166

Lack of expected normal physiological development

2.06

2.26

7.7

5.1

24.44

23.61

mmol/l

0.42

Infection due to other mycobacteria

329

1.56

2.25

6.6

6.2

25.99

24.69

mmol/l

0.92

311

Ovarian hyperstimulation (induction)

187

1.74

2.24

5.3

8.5

23.03

23.42

mmol/l

0.35

177

Benign neoplasm: Skin of eyelid, including canthus

491

4319

1.15

2.23

6.9

6.7

24.56

24.60

mmol/l

0.10

471

4135

Other infestations, including avohilmo

424

0.55

2.22

3.6

8.0

24.36

24.72

mmol/l

0.17

405

Giant cell arteritis with polymyalgia rheumatica

128

994

1.32

2.22

7.0

6.2

24.23

24.48

mmol/l

0.36

123

947

Failed induction of labour

660

1.38

2.21

3.6

5.8

24.49

23.90

mmol/l

0.99

621

Crushed, pushed or stepped on by crowd or human stampede

168

1345

1.26

2.20

7.6

7.4

24.27

24.25

mmol/l

0.02

161

1288

Autoimmune polyglandular failure

3.59

2.20

18.4

23.4

24.38

24.84

mmol/l

—

Other and unspecified haemorrhagic conditions

323

1.56

2.19

8.0

6.1

23.92

24.62

mmol/l

0.67

310

Exposure to vibration

6.03

2.19

4.0

15.5

23.12

23.94

mmol/l

—

Superficial injury of neck

314

1.56

2.19

6.3

8.1

24.66

24.27

mmol/l

0.30

299

Open bite that required surgery (Lefort1 or BSSO)

109

1.98

2.15

2.9

11.4

24.47

mmol/l

0.00

101

Other disorders of amino-acid metabolism

2.10

2.15

15.1

6.5

23.74

24.89

mmol/l

0.46

Lactose intolerance

505

1.43

2.14

6.6

7.7

24.71

24.47

mmol/l

0.21

482

Other hereditary haemolytic anaemias

110

2.00

2.13

9.7

7.4

25.36

24.90

mmol/l

0.19

105

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

650

1.38

2.13

7.3

8.3

24.82

24.49

mmol/l

0.45

615

Congenital malformations of eye, ear, face and neck

139

1094

1.28

2.12

7.0

7.4

25.07

24.23

mmol/l

1.82

129

1046

FESS (DNB20)

341

2936

1.17

2.11

5.2

7.5

24.62

24.41

mmol/l

0.59

322

2805

Lichen sclerosus et atrophicus

314

2687

1.18

2.10

5.9

6.8

24.60

24.75

mmol/l

0.31

301

2562

Vulvovaginal ulceration/inflammation in other diseases

134

1053

1.28

2.07

4.5

6.4

24.75

24.38

mmol/l

0.74

129

1000

Contact with hot air and gases

126

1.91

2.06

7.6

6.7

24.65

24.38

mmol/l

0.15

121

Mature T/NK-cell lymphomas, hilmo

329

1.54

2.06

6.0

7.8

23.37

24.56

mmol/l

1.15

316

Ethmoidectomy

355

3073

1.17

2.05

5.1

7.5

24.55

24.42

mmol/l

0.35

334

2937

Fenamates

355

2793

0.86

2.05

5.1

7.4

24.58

24.43

mmol/l

0.32

339

2669

Other and unspecified types of non-Hodgkin lymphoma, hilmo

137

1086

1.29

2.04

10.8

6.4

25.23

24.42

mmol/l

1.41

126

1036

Progressive external ophthalmoplegia

5.24

2.03

11.2

13.4

27.22

24.30

mmol/l

—

Hypertrophy of tongue papillae

289

1.57

2.02

9.2

7.9

25.10

24.51

mmol/l

0.57

275

Otitis externa

665

5993

1.12

2.02

6.3

7.0

24.63

24.48

mmol/l

0.51

641

5728

Retinal detachments and breaks

1261

11706

1.08

2.01

6.3

6.8

24.32

24.57

mmol/l

1.57

1200

11200

Injury of muscle and tendon at ankle and foot level

488

1.42

1.99

6.8

8.3

24.61

24.51

mmol/l

0.09

463

Other and unspecified acne

195

1.68

1.97

6.6

9.6

24.19

24.36

mmol/l

0.08

185

Carcinoma in situ of skin

215

2561

0.83

1.94

5.2

6.4

23.92

24.54

mmol/l

1.51

201

2451

Injury of muscle and tendon at lower leg level

456

4035

1.14

1.94

6.7

7.2

24.61

24.47

mmol/l

0.41

443

3872

Alzheimer’s disease, strict definition

1010

7507

1.09

1.93

4.8

6.2

24.39

24.52

mmol/l

0.52

972

7171

Ankylosing spondylitis, ICD10

234

1972

1.20

1.92

6.7

7.4

25.02

24.43

mmol/l

1.76

221

1891

Disorders of puberty, all

128

1.82

1.92

3.9

11.1

24.97

23.51

mmol/l

0.98

118

Disorders of tooth development and eruption

406

2895

1.15

1.92

7.4

6.4

24.64

24.44

mmol/l

0.51

390

2755

L01XX Other antineoplastic agents

189

1565

1.23

1.91

7.2

6.9

23.90

24.47

mmol/l

1.56

181

1500

Propionic acid derivatives

964

4443

1.10

1.91

6.8

7.4

24.40

24.29

mmol/l

0.37

919

4248

Other disorders of cornea

289

2481

1.18

1.90

6.7

24.95

24.56

mmol/l

1.15

275

2371

Hypertension, portal

2.20

1.90

11.7

7.8

23.57

25.30

mmol/l

0.60

Pregnancy examination and test

241

1253

1.20

1.89

6.6

23.79

24.25

mmol/l

1.33

230

1202

Allergic colitis

181

1.68

1.89

18.9

5.0

24.29

23.86

mmol/l

0.27

171

Endometriosis of ovary

402

3323

1.15

1.89

6.1

6.9

24.46

24.66

mmol/l

0.55

381

3175

Insomnia

2947

19530

1.05

1.88

6.4

7.0

24.45

24.54

mmol/l

0.75

2848

18677

Cellulitis of external ear

230

1.61

1.88

7.0

24.03

24.53

mmol/l

0.31

219

Alcohol abuse counselling and surveillance

327

1.51

1.88

11.3

8.8

25.51

24.68

mmol/l

1.37

312

Sacrococcygeal disorders, not elsewhere classified

536

1.38

1.87

6.0

7.1

25.01

24.51

mmol/l

0.60

517

Diastasis of muscle

145

1.78

1.86

13.9

7.1

24.55

24.09

mmol/l

0.23

137

Transient global amnesia

293

2526

1.17

1.86

5.9

6.9

24.57

24.63

mmol/l

0.12

284

2419

Deficiency of other B group vitamins

470

1.41

1.85

8.6

7.4

23.56

24.35

mmol/l

0.87

454

Dislocation, sprain and strain of joints and ligaments of elbow

150

1214

1.25

1.85

6.0

7.3

24.54

24.42

mmol/l

0.17

143

1155

Lactose intolerance, other/unspecified

452

1.42

1.85

6.6

8.0

24.59

24.52

mmol/l

0.05

434

Liposarcoma, including Hilmo

232

1.61

1.84

10.5

6.7

24.62

24.46

mmol/l

0.14

221

Hereditary angioödema type 1

3.77

1.83

6.8

7.1

26.05

23.92

mmol/l

—

Motorcycle rider injured in other and unspecified transport accidents

136

1091

1.26

1.82

9.1

7.7

24.99

24.39

mmol/l

1.52

129

1050

malignant neoplasm of male genital organs

1075

5984

1.09

1.82

6.3

7.5

24.43

24.34

mmol/l

0.35

1016

5789

Diseases of middle ear and mastoid

1664

12766

1.07

1.81

7.0

6.8

24.30

24.41

mmol/l

0.53

1593

12210

Other congenital malformations of face and neck

463

1.40

1.80

5.8

8.0

25.14

24.53

mmol/l

0.59

444

Other osteochondrodysplasias, including avohilmo

209

1.62

1.79

8.0

8.6

24.88

24.80

mmol/l

0.05

201

Injury of nerves at wrist and hand level

101

785

1.31

1.78

8.7

7.9

23.93

24.48

mmol/l

0.90

751

Dementia due to Parkinson's disease

753

1.32

1.77

5.3

5.8

25.30

24.28

mmol/l

2.03

718

Acute appendicitis, with complications

581

5247

1.11

1.76

7.0

24.43

mmol/l

0.00

564

5030

Congenital malformations of genital organs

168

1375

1.22

1.75

9.2

7.0

24.18

24.29

mmol/l

0.13

157

1307

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

188

1.66

1.73

6.8

6.0

26.20

24.33

mmol/l

1.29

180

Dementia in other diseases classified elsewhere

148

1209

1.24

1.73

7.9

6.6

25.06

24.41

mmol/l

1.33

141

1156

Disorders of vagus nerve

3.14

1.73

14.1

9.6

26.01

24.50

mmol/l

—

Other puerperal infections

950

0.74

1.73

4.7

6.8

23.70

23.98

mmol/l

0.39

901

HSIL lesion of the cervix uteri, vagina or vulva

373

3283

1.14

1.73

5.3

6.2

24.26

24.28

mmol/l

0.03

360

3128

Postmenopausal bleeding

789

3773

1.10

1.72

6.2

6.6

25.05

24.82

mmol/l

1.07

751

3608

Spermatocele

261

2247

1.18

1.71

5.8

7.9

24.14

24.32

mmol/l

0.34

254

2158

Medical treatment for female infertility

337

2919

1.15

1.71

5.6

6.3

23.82

24.14

mmol/l

1.20

321

2773

Rash and other nonspecific skin eruption

268

2310

1.17

1.71

7.8

6.9

24.83

24.50

mmol/l

0.84

262

2214

Anogenital herpesviral [herpes simplex] infection, including avohilmo

153

1860

0.82

1.70

7.3

6.8

24.49

24.14

mmol/l

0.78

145

1779

Degenerative macular diseases

410

3643

1.14

1.70

6.8

6.3

24.42

24.62

mmol/l

0.50

395

3491

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

120

1.83

1.69

9.3

10.8

24.91

24.32

mmol/l

0.44

114

Other and unspecified atrophic disorders of skin

1.93

1.69

10.3

5.5

25.01

25.02

mmol/l

0.00

Other congenital malformations, including avohilmo

287

2486

1.16

1.68

7.0

24.75

24.37

mmol/l

1.01

273

2383

Palmar fascial fibromatosis [Dupuytren]

517

4658

1.12

1.67

6.4

7.0

24.06

24.37

mmol/l

1.23

496

4472

Pollen allergy

276

3140

0.86

1.66

5.7

6.8

24.03

24.25

mmol/l

0.55

262

3005

Scar conditions and fibrosis of skin

775

1.29

1.66

6.2

7.8

24.66

24.46

mmol/l

0.22

735

Unspecified privation

226

2643

0.85

1.66

7.7

6.8

24.76

24.44

mmol/l

0.61

220

2527

Disorders of amino-acid transport

2.71

1.66

11.1

5.4

24.55

24.80

mmol/l

—

Disease of hard tissues of teeth, NOS

1869

9240

1.06

1.66

6.3

6.8

24.52

24.55

mmol/l

0.10

1797

8823

Raynaud syndrome

225

1918

1.18

1.65

5.2

7.2

24.47

24.40

mmol/l

0.12

215

1835

Demyelinating diseases of the central nervous system

188

1578

1.20

1.65

6.3

7.6

24.34

24.38

mmol/l

0.05

178

1507

Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere

4.18

1.64

1.6

5.4

24.00

25.68

mmol/l

—

Malignant neoplasm of placenta, including Hilmo

3.27

1.64

7.8

5.0

26.48

25.17

mmol/l

—

Other disorders of white blood cells

155

1283

1.22

1.61

7.4

7.0

24.84

24.37

mmol/l

0.74

146

1231

Prurigo nodularis

596

1.34

1.61

9.7

6.5

24.43

24.56

mmol/l

0.13

570

Ankyloglossia

128

1.74

1.60

11.5

10.0

23.23

23.18

mmol/l

0.03

118

Allergic rhinitis

716

6479

1.09

1.59

6.4

6.9

24.30

24.36

mmol/l

0.18

683

6184

Other congenital malformations of kidney

2.13

1.59

8.9

6.6

23.52

25.08

mmol/l

0.69

Myeloproliferative diseases (CML excluded)

230

1975

1.18

1.58

8.5

6.7

24.03

24.54

mmol/l

1.14

223

1887

Otitis media, unspecified

229

1804

1.18

1.58

6.3

6.7

25.03

24.08

mmol/l

3.26

217

1723

Malignant neoplasm of other and ill-defined digestive organs

209

1.59

1.58

4.3

5.3

24.97

24.59

mmol/l

0.19

199

Galactorrhea

122

1.76

1.58

5.4

6.9

24.77

24.70

mmol/l

0.04

117

Burns and corrosions of multiple body regions

169

1.65

1.57

15.0

7.3

24.59

24.64

mmol/l

0.03

163

Guillain-Barre syndrome

366

1.43

1.57

11.7

6.1

25.41

24.43

mmol/l

1.14

350

Asphyxiation

3.18

1.57

16.8

5.0

22.33

23.98

mmol/l

—

Endometriosis of intestine

184

1.60

1.56

7.3

9.7

23.60

24.14

mmol/l

0.38

175

Other bursitis of elbow

226

1.56

4.5

6.1

25.18

24.19

mmol/l

0.74

213

Spontaneous abortion

1058

6589

1.08

1.56

5.7

6.6

24.29

24.66

mmol/l

2.87

1015

6312

Disorders of phosphorus metabolism and phosphatases

1.94

1.55

8.7

6.8

24.40

24.82

mmol/l

0.17

Microscopic polyangiitis

147

1.71

1.55

8.6

9.2

23.89

24.92

mmol/l

0.80

142

Ulcerative enterocolitis

581

1.33

1.55

7.5

7.0

23.39

24.53

mmol/l

1.51

554

malignant neoplasm of male genital organs, including Hilmo

1084

6067

1.08

1.54

6.3

7.5

24.40

24.34

mmol/l

0.19

1021

5870

Atopic dermatitis, strict definition

642

5737

1.10

1.53

6.5

6.8

24.47

24.25

mmol/l

0.80

618

5484

Other disorders of breast

237

2743

0.86

1.53

6.0

6.6

24.95

24.66

mmol/l

0.72

231

2616

Retained placenta and membranes, without haemorrhage

249

2155

1.16

1.52

4.9

6.4

24.46

24.63

mmol/l

0.29

241

2057

Severe mental retardation

2.57

1.52

2.0

7.9

23.39

23.86

mmol/l

—

Exposure to uncontrolled fire, not in building or structure

2.29

1.52

2.8

6.5

23.53

24.09

mmol/l

0.15

Poor fetal growth

183

1544

1.19

1.52

7.1

6.2

23.67

23.97

mmol/l

0.67

172

1468

Polyuria

762

7032

1.09

1.51

6.4

7.0

24.86

24.40

mmol/l

2.89

729

6729

Chronic suppurative otitis media, including avohilmo

202

1723

1.18

1.51

7.1

7.2

24.16

24.41

mmol/l

0.42

194

1641

Benign neoplasm of bone and articular cartilage

214

1835

1.18

1.50

7.1

7.2

24.88

24.48

mmol/l

1.01

206

1758

Thyrotoxicosis with diffuse goitre

342

3030

1.14

1.49

5.6

6.7

24.71

24.58

mmol/l

0.26

322

2889

Unspecified lump in breast

312

3535

0.88

1.49

7.8

6.5

24.87

24.74

mmol/l

0.27

299

3381

Crossbite

125

938

1.24

1.48

6.6

7.6

24.68

24.26

mmol/l

0.72

117

898

Anti-inflammatory and antirheumatic products, non-steroids

952

4443

1.08

1.48

6.7

7.4

24.34

24.29

mmol/l

0.15

904

4248

Childhood allergy (age < 16)

184

1281

1.19

1.47

5.7

5.9

23.71

23.48

mmol/l

0.44

179

1210

Postpartum hemorraghe, parous women as controls

373

3499

0.89

1.47

5.0

6.0

23.45

24.26

mmol/l

5.61

358

3337

Progressive vascular leukoencephalopathy

1197

0.79

1.46

7.7

5.5

24.75

24.46

mmol/l

0.27

1143

Erythema nodosum

605

1.31

1.45

7.6

24.47

mmol/l

0.00

583

Malignant neoplasm of breast, ER-negative, including Hilmo

544

4630

1.10

1.45

5.8

6.1

25.11

24.82

mmol/l

1.16

526

4437

Use of riluzole

104

1.83

1.44

5.8

11.8

28.55

24.76

mmol/l

2.49

Hyperkinetic disorders (excl. ADHD)

154

1.62

1.44

5.0

10.3

24.48

24.30

mmol/l

0.12

145

Granuloma annulare

271

1.47

1.43

11.6

6.7

25.13

24.54

mmol/l

0.58

259

Familial chondrocalcinosis

0.00

1.42

0.0

5.2

—

24.76

—

Burn and corrosion of ankle and foot

289

1.45

1.41

9.9

8.7

24.50

24.36

mmol/l

0.09

273

Benign neoplasm: Liver/bile ducts (ICD-9)

3.27

1.41

9.6

10.2

24.34

26.42

mmol/l

—

Tracheo-bronchomalasia

2.46

1.40

3.4

4.9

26.47

25.15

mmol/l

—

Disorders of glycoprotein metabolism

3.18

1.40

13.8

10.8

25.90

25.89

mmol/l

—

Other, unspecified and serous retinal detachments

100

806

1.26

1.39

7.1

7.0

24.41

24.46

mmol/l

0.06

769

Malignant neoplasm of gum, including Hilmo

216

1.53

1.39

11.2

5.9

25.83

24.75

mmol/l

1.34

211

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

224

1943

1.16

1.38

5.6

7.2

24.72

24.61

mmol/l

0.19

212

1852

Persons encountering health services in other circumstances, wide

3916

20830

0.96

1.38

7.4

6.8

24.57

24.48

mmol/l

0.67

3768

19918

Premature rupture of membranes

274

2221

0.87

1.38

9.0

6.4

23.74

24.19

mmol/l

1.19

259

2119

Muscle wasting and atrophy, not elsewhere classified

144

1.66

1.38

8.3

8.8

24.46

24.08

mmol/l

0.11

137

Chorioretinal inflammation

619

1.30

1.38

7.3

6.9

24.36

24.53

mmol/l

0.13

591

Psoriatic arthropathies, ICD10

281

2478

1.14

1.36

6.5

7.4

24.88

24.51

mmol/l

0.75

271

2367

Drug-induced aplastic anaemia

2.56

1.35

6.4

4.4

24.34

24.78

mmol/l

—

Carcinoma in situ of cervix uteri

172

1462

1.18

1.35

5.9

6.5

24.29

24.10

mmol/l

0.26

164

1389

Visual impairment including blindness (binocular or monocular)

207

1791

1.17

1.34

8.1

6.2

24.63

24.52

mmol/l

0.17

200

1708

Disorders of puberty

113

1.70

1.33

3.8

11.3

25.03

23.49

mmol/l

0.86

104

Hypertrophy of breast

372

3341

1.12

1.32

6.2

6.7

24.47

24.59

mmol/l

0.31

357

3196

Lipodystrophy, not elsewhere classified

2.93

1.31

5.0

10.4

24.96

24.28

mmol/l

—

Use of teriflunomide

131

0.45

1.31

2.5

7.1

22.87

24.54

mmol/l

—

123

Carcinoma in situ of stomach

2.68

1.30

5.2

5.4

23.75

25.12

mmol/l

—

Mental and behavioural disorders associated with the puerperium

122

1.67

1.29

5.0

9.3

26.16

24.98

mmol/l

0.42

114

Mental and behavioural disorders of puerperium, not classified elsewhere

122

1.67

1.29

5.0

6.1

26.16

24.22

mmol/l

0.83

116

Burn and corrosion of head and neck

423

1.35

1.29

6.4

8.0

23.95

24.53

mmol/l

0.57

402

Other and unspecified disorders of psychological development

1.86

1.28

12.4

13.4

25.11

24.18

mmol/l

0.44

Polyp of the female genital tract

783

4114

1.08

1.28

5.9

6.6

24.72

24.71

mmol/l

0.04

756

3930

Malignant neoplasm of prostate

1047

5816

1.07

1.27

6.3

7.4

24.43

24.32

mmol/l

0.41

989

5628

Use of donepezil

805

7160

1.08

1.27

4.3

6.1

24.38

24.53

mmol/l

0.50

768

6846

Other psoriatic arthropathies

271

2399

1.14

1.26

6.6

7.4

24.87

24.49

mmol/l

0.75

261

2291

Other demyelinating diseases of the central nervous system

591

1.28

1.26

8.4

8.3

24.21

24.30

mmol/l

0.07

565

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

264

2335

1.14

1.26

8.1

6.9

24.49

24.59

mmol/l

0.16

258

2238

Additional codes for the location of defect, injury or illness

158

1346

1.19

1.26

5.1

7.4

24.68

24.45

mmol/l

0.37

148

1282

Beningn neoplasm: Meninges, unspecified

366

1.37

1.24

7.2

6.4

24.71

24.54

mmol/l

0.16

351

Enteritis due to Yersinia enterocolitica

101

1.74

1.24

6.1

6.8

24.23

24.39

mmol/l

0.06

Benign neoplasm: Skin of trunk

113

936

1.22

1.23

5.5

7.5

24.41

24.51

mmol/l

0.10

107

901

Other diseases of blood and blood-forming organs

198

1721

1.16

1.23

8.9

7.2

25.23

24.54

mmol/l

1.47

192

1641

Pedestrian injured in collision with car, pick-up truck or van

525

1.30

1.20

6.9

7.3

23.76

24.49

mmol/l

0.68

501

Contact with venomous snakes and lizards

198

1.50

1.20

4.6

8.9

24.43

24.62

mmol/l

0.13

188

Acute mastoiditis

149

1.58

1.20

15.2

6.4

24.12

24.72

mmol/l

0.52

142

Other congenital malformations of skin, including avohilmo

139

1637

0.84

1.20

5.7

7.0

24.39

24.44

mmol/l

0.05

133

1561

Malignant neoplasm of breast, HER-negative

500

4403

1.10

1.19

5.7

6.1

25.11

24.82

mmol/l

1.07

482

4214

Other assisted single delivery

186

0.53

1.18

10.3

7.5

22.50

24.05

mmol/l

—

177

Diving or jumping into water causing injury other than drowning or submersion

1.75

1.18

5.8

13.1

25.69

24.64

mmol/l

0.84

Tinnitus

700

6516

1.08

1.18

7.6

7.2

24.77

24.57

mmol/l

0.91

680

6231

Aphakia

309

1.38

1.16

6.8

6.5

24.39

24.42

mmol/l

0.01

290

Vitiligo

200

1.48

1.15

6.1

9.3

24.25

24.53

mmol/l

0.13

190

Acute myringitis

119

1.64

1.15

4.5

6.4

25.45

24.66

mmol/l

0.65

112

Pain and other conditions associated with female genital organs and menstrual cycle

414

3150

1.10

1.14

5.5

6.8

23.87

24.40

mmol/l

2.42

394

3013

Chronic myeloproliferative disease

364

1.35

1.13

5.6

7.0

22.63

24.52

mmol/l

2.43

346

Benign neoplasm: other/unspecified salivary gland

656

1.25

1.13

9.5

7.5

24.62

24.56

mmol/l

0.04

631

Chronic suppurative otitis media

170

1471

1.16

1.13

7.3

7.0

24.16

24.44

mmol/l

0.41

163

1400

Other and unspecified degenerative diseases of nervous system

738

1.24

1.13

5.6

7.0

24.65

24.24

mmol/l

0.46

708

Benign neoplasm of major salivary glands

288

2583

1.12

8.6

6.8

24.92

24.54

mmol/l

0.88

276

2472

Malignant neoplasm of prostate, including Hilmo

1058

5891

1.06

1.12

6.3

7.4

24.38

24.33

mmol/l

0.15

996

5701

MS-disease / Multiple Sclerosis

149

1277

1.17

1.12

5.7

7.7

24.43

24.42

mmol/l

0.01

143

1220

L02BX Other hormone antagonists and related agents

161

1856

0.86

1.11

5.0

7.0

23.93

24.28

mmol/l

0.42

155

1778

HSIL lesion of the vagina

235

1.43

1.11

4.2

6.7

24.60

24.74

mmol/l

0.09

230

Pectus carinatum

2.52

1.11

2.8

27.0

24.72

24.02

mmol/l

—

Use of antiglaucoma preparations and miotics

252

2245

1.13

1.11

5.7

6.2

24.29

24.56

mmol/l

0.47

235

2156

Disorder of the sleep-wake schedule

269

1.39

1.11

4.1

8.6

24.84

24.37

mmol/l

0.50

254

Prolonged pregnancy

176

1727

0.87

1.10

5.2

6.4

24.03

mmol/l

0.01

169

1653

Severe visual impairment, monocular

245

1.42

1.10

6.4

5.9

24.43

24.40

mmol/l

0.02

235

Nonsuppurative otitis media

514

4111

1.09

1.08

6.7

6.4

24.17

24.23

mmol/l

0.11

498

3914

Injury of muscle and tendon at hip and thigh level

273

2448

1.12

1.07

6.2

7.1

24.66

24.42

mmol/l

0.55

262

2338

Single delivery by caesarean section

296

1513

1.12

1.07

7.5

6.8

23.72

24.18

mmol/l

1.27

284

1451

Benign neoplasm: Bones of skull and face

196

1.46

1.05

9.1

7.1

25.68

24.91

mmol/l

0.62

191

Other appendicitis

219

1941

1.14

1.05

7.5

7.0

24.71

24.47

mmol/l

0.44

210

1857

Benign neoplasm: salivary glands, exclude unknown (D119)

252

2254

1.13

1.05

8.4

6.9

24.94

24.54

mmol/l

0.90

243

2156

Malignant neoplasm of lip, including Hilmo

273

1.39

1.05

8.0

5.0

23.48

24.51

mmol/l

0.68

262

Other/unspecified mastoiditis and related conditions

107

0.45

1.04

11.2

6.5

25.30

24.59

mmol/l

—

101

Varicella [chickenpox], including avohilmo

115

971

1.19

1.04

7.0

8.1

23.66

24.45

mmol/l

1.48

109

924

Impacted teeth

337

2621

1.11

1.04

5.7

6.7

23.85

24.00

mmol/l

0.36

325

2496

Disorders of orbit

107

900

1.20

1.03

7.4

7.5

24.03

24.48

mmol/l

0.60

101

861

Acquired atrophy of ovary and fallopian tube

2.07

1.02

14.0

9.4

26.29

24.77

mmol/l

—

Other congenital malformations of skull and face bones

2.06

1.01

2.6

17.9

25.84

24.68

mmol/l

—

Other and unspecified disorders of white blood cells

109

921

1.20

1.01

8.6

7.5

25.15

24.36

mmol/l

1.17

102

884

Other disorders of the genitourinary system

358

3269

1.10

1.01

7.1

6.6

24.56

24.75

mmol/l

0.47

341

3116

Enterobiasis, including avohilmo

261

0.64

1.00

9.2

8.3

24.98

24.35

mmol/l

0.37

247

Follicular adenocarcinoma of thyroid gland

124

1.58

1.00

2.9

5.4

24.29

25.18

mmol/l

0.83

118

Postinfectious hypothyroidism

108

1.63

1.00

11.6

7.0

23.05

24.74

mmol/l

0.91

102

Female infertility

588

3275

1.08

0.99

5.9

7.1

23.95

24.50

mmol/l

3.13

556

3132

Benign neoplasm: Appendix

250

1.39

0.99

4.9

7.1

24.13

24.85

mmol/l

0.64

241

Follicular adenocarcinoma of thyroid gland, including Hilmo

199

1.44

0.98

4.8

6.0

24.63

24.77

mmol/l

0.11

193

Other specified disorders of external ear

1020

0.82

0.98

7.1

7.6

25.08

24.40

mmol/l

0.93

973

Otosclerosis

159

1815

0.87

0.97

6.2

7.2

24.60

24.52

mmol/l

0.09

151

1739

Chalazion

296

2685

1.11

0.96

7.1

6.9

24.66

24.50

mmol/l

0.31

284

2570

Bus occupant injured in other and unspecified transport accidents

144

0.54

0.96

4.6

5.9

24.10

24.79

mmol/l

—

135

All dysplastic lesions of the cervix uteri, vagina or vulva

561

5098

1.08

0.95

6.0

6.3

24.41

24.37

mmol/l

0.09

536

4859

Unspecified renal colic

126

1.55

0.95

12.3

6.4

23.36

24.31

mmol/l

0.44

119

Malignant neoplasm of uterus, part unspecified, including Hilmo

110

1.60

0.94

6.5

3.9

24.69

24.73

mmol/l

0.02

103

Uterine polyps

732

4018

1.07

0.93

6.1

6.7

24.73

24.71

mmol/l

0.06

712

3840

Mandibular hypoplasia

1.63

0.93

13.1

7.9

23.29

24.79

mmol/l

1.07

Alzheimer’s disease (Early onset), excluding more controls

103

823

1.19

0.93

9.1

5.2

24.77

24.10

mmol/l

1.05

783

Deep bite

233

1835

1.12

0.92

6.4

6.9

24.49

24.31

mmol/l

0.33

225

1757

Infections with a predominantly sexual mode of transmission, including avohilmo

788

7632

0.94

0.92

7.3

6.7

24.32

24.31

mmol/l

0.02

753

7280

Vestibular neuronitis

253

2287

1.11

0.91

7.6

7.2

24.64

24.49

mmol/l

0.28

244

2187

Torsion of testis

271

1.34

0.90

8.1

9.4

23.45

24.52

mmol/l

0.80

256

Postpartum haemorrhage

373

3344

0.92

0.90

5.0

6.4

23.45

24.34

mmol/l

6.49

358

3179

Nontoxic single thyroid nodule

141

1612

0.87

0.89

5.5

6.5

24.39

24.54

mmol/l

0.23

131

1529

Synovial hypertrophy, not elsewhere classified

144

1.48

0.89

5.8

9.4

24.95

24.30

mmol/l

0.39

134

Varicella [chickenpox]

104

887

1.18

0.89

7.2

8.2

23.75

24.54

mmol/l

1.37

844

Other/unspecified reactive arthropathies

162

1429

1.14

0.88

9.9

7.5

24.37

24.43

mmol/l

0.08

152

1365

Atypical mycobacterium lung infection

282

1.34

0.88

5.2

7.8

27.51

24.55

mmol/l

2.38

269

Certolizumab pegol

255

1.35

0.88

7.7

9.3

23.58

24.51

mmol/l

0.90

242

Normotensive glaucoma

277

2522

1.11

0.88

5.1

6.4

24.28

24.71

mmol/l

1.22

266

2417

Failed attempted abortion

128

1.50

0.87

2.6

9.0

23.91

24.01

mmol/l

0.06

120

Foreign body or object entering through skin

155

1366

1.14

0.86

8.7

7.6

24.36

24.44

mmol/l

0.10

147

1312

Impaction of intestines

154

1.47

0.86

18.3

6.2

25.20

24.36

mmol/l

0.42

145

Shoulder region

327

1.31

0.86

5.1

7.6

24.27

24.49

mmol/l

0.16

315

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

214

1.39

0.86

8.8

8.6

25.51

24.51

mmol/l

0.96

205

Covid-19 suspected case

489

4560

1.08

0.85

6.6

6.5

23.95

24.35

mmol/l

1.50

456

4353

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

1.71

0.85

6.8

12.9

22.35

24.99

mmol/l

1.20

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

1.66

0.84

9.1

7.4

25.54

25.01

mmol/l

0.30

Malignant melanoma of skin

304

3312

0.91

0.83

6.3

6.8

24.79

24.51

mmol/l

0.59

291

3181

Oral lichen planus, including avohilmo , including avohilmo

183

1637

1.13

0.82

4.0

7.3

24.27

24.63

mmol/l

0.98

174

1566

Single spontaneous delivery

951

5276

0.95

0.81

6.0

6.2

24.60

24.72

mmol/l

0.41

917

5057

Toxic effect of organic solvents

1.68

0.81

8.9

13.9

26.65

24.09

mmol/l

1.29

Anogenital herpesviral [herpes simplex] infection

1000

0.85

0.80

9.3

7.2

24.45

24.23

mmol/l

0.28

954

Urethritis and urethral syndrome

429

1.25

0.80

9.4

8.0

25.92

24.36

mmol/l

2.75

407

Persons encountering health services in other circumstances

1301

12363

1.04

0.79

6.0

6.7

24.59

24.47

mmol/l

0.64

1256

11830

Postpartum haemorrhage due to retained placenta

162

1819

0.89

0.79

5.4

6.1

22.97

24.15

mmol/l

5.22

157

1735

Malignant melanoma

410

4398

0.93

0.77

6.0

6.8

24.73

24.47

mmol/l

0.66

390

4224

Thyrotoxicosis with toxic multinodular goitre

168

1503

1.13

0.77

6.0

6.8

24.99

24.58

mmol/l

0.73

163

1432

Other disorders of veins

1150

11792

0.96

0.76

7.0

6.7

25.07

24.54

mmol/l

4.79

1116

11289

Other cestode infections, including avohilmo

1.58

0.75

6.6

5.9

25.79

24.69

mmol/l

0.35

Benign neoplasm: Rectum/anal canal icd-9

193

1.37

0.75

4.9

5.5

24.72

24.45

mmol/l

0.15

185

Cervical polyps

230

2094

1.10

0.75

5.0

6.9

24.85

24.75

mmol/l

0.16

220

2008

Abnormal findings on diagnostic imaging of breast

281

1.30

0.74

10.2

6.8

24.68

24.88

mmol/l

0.08

273

Hydrocephalus in other diseases

117

1.49

0.74

12.5

11.1

25.59

24.63

mmol/l

0.58

111

Hydatidiform mole

202

1.35

0.74

2.3

9.6

25.10

24.58

mmol/l

0.47

189

Acetic acid derivatives and related substances

891

4387

1.05

0.73

5.5

7.4

24.30

mmol/l

0.00

853

4193

Benign neoplasm: Parotid gland

222

2023

1.10

0.73

8.4

7.0

25.09

24.54

mmol/l

1.32

215

1935

Whooping cough

1.65

0.73

2.7

5.2

24.09

24.51

mmol/l

0.18

Tic and related disorders

100

1.51

0.73

3.9

6.1

24.41

23.91

mmol/l

0.24

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

109

953

1.15

0.73

6.8

7.6

24.90

24.46

mmol/l

0.69

103

912

Biomechanical lesions, not elsewhere classified

139

1235

1.13

0.72

6.6

24.26

24.46

mmol/l

0.34

132

1180

Other specified and unspecified disorders of choroid

1.56

0.72

12.1

7.1

24.93

24.64

mmol/l

0.13

Other cestode infections

1.59

0.72

6.5

5.5

25.95

24.67

mmol/l

0.39

Other osteochondrodysplasias

143

1.42

0.72

10.7

9.8

25.01

24.88

mmol/l

0.04

138

Long labour

365

3322

0.93

0.71

5.6

6.4

23.96

24.36

mmol/l

1.48

351

3158

Ankylosing spondylitis, strict definition

787

1.16

0.70

6.8

8.7

25.21

24.57

mmol/l

1.55

753

Pectus carinatum, including avohilmo

1.92

0.70

2.8

22.0

24.72

24.00

mmol/l

—

Drowning and submersion while in natural water

119

1.47

0.70

3.9

11.3

23.12

24.25

mmol/l

0.88

113

Sexual dysfunction

365

1.25

0.69

5.0

8.3

23.54

24.59

mmol/l

0.80

346

Meningococcal infection

117

0.59

0.69

10.9

5.8

27.47

24.59

mmol/l

—

111

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

1.56

0.69

8.3

7.7

24.90

24.27

mmol/l

0.23

Injury of blood vessels at ankle and foot level

1.88

0.68

3.8

5.3

24.80

24.17

mmol/l

—

Sudden idiopathic hearing loss

285

2637

1.09

0.68

8.1

6.9

24.59

mmol/l

0.00

277

2517

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

114

1291

0.88

0.67

5.8

6.9

24.72

24.35

mmol/l

0.60

105

1234

Osteitis due to dental implant

180

1.36

0.67

9.2

9.3

25.35

24.88

mmol/l

0.30

173

Other mosquito-borne viral fevers, including avohilmo

128

1.43

0.67

5.7

7.9

24.37

24.63

mmol/l

0.16

121

Personal history of medical treatment

206

1.33

0.67

12.8

6.5

26.18

24.18

mmol/l

1.40

195

Leiomyoma of uterus

1608

9319

0.97

0.67

6.5

6.2

24.71

24.76

mmol/l

0.22

1538

8917

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

104

0.56

0.64

16.0

5.4

24.48

24.40

mmol/l

—

Optic neuritis

710

1.16

0.64

6.3

7.8

23.88

24.33

mmol/l

0.51

680

Postpartum hemorraghe, all women as controls

373

3883

0.93

0.64

5.0

6.2

23.45

24.22

mmol/l

5.05

358

3701

Melanocytic naevi of scalp and neck

470

1.20

0.63

5.3

8.0

23.68

24.35

mmol/l

0.64

449

Melanocytic naevi of other and unspecified parts of face

139

1248

1.12

0.63

5.2

7.0

24.52

24.38

mmol/l

0.17

134

1195

Persistent hyperplasia of thymus

0.00

0.63

0.0

4.3

—

23.95

—

Disorder of carbohydrate metabolism, other/unspecified

1.64

0.63

2.6

14.9

22.31

24.71

mmol/l

—

Malignant neoplasm of parotid gland, including Hilmo

236

1.29

0.62

5.8

6.4

24.34

24.53

mmol/l

0.11

227

Arthropathic psoriasis

289

2688

1.08

0.62

6.5

7.3

24.92

24.49

mmol/l

0.98

279

2569

Follow-up examination after treatment for conditions other than malignant neoplasms

1034

7154

0.96

0.62

7.6

6.2

24.37

24.40

mmol/l

0.10

997

6801

Other and/or unspecified nontoxic goitre

209

1919

1.09

0.61

6.6

25.28

24.66

mmol/l

2.07

203

1824

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

210

1.32

0.61

10.3

5.4

23.20

24.40

mmol/l

0.91

203

Adenomyosis (Endometriosis of uterus)

279

2995

0.93

0.61

5.2

6.7

24.42

24.76

mmol/l

0.88

267

2868

Haemorrhagic and haematological disorders of fetus and newborn

100

1.44

0.60

9.5

3.2

24.77

22.91

mmol/l

0.78

Triptan medication for migraine, min. 3 purchases

1341

9688

1.04

0.60

7.2

6.8

24.26

24.51

mmol/l

1.92

1292

9254

Alzheimer’s disease (Early onset)

103

1161

0.88

0.60

9.1

6.2

24.77

24.46

mmol/l

0.38

1114

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

114

1276

0.89

0.58

5.8

6.9

24.72

24.35

mmol/l

0.60

105

1216

Dacryoadenitis

167

1.34

0.58

5.6

9.5

24.42

24.58

mmol/l

0.08

158

Presbyopia

189

1733

1.10

0.58

5.3

7.0

24.95

24.59

mmol/l

0.84

184

1666

Traumatic amputation of hip and thigh

1.70

0.58

4.8

6.5

25.67

24.44

mmol/l

—

Pregnancy with abortive outcome

1713

8664

1.03

0.58

5.9

6.2

24.54

24.65

mmol/l

0.59

1652

8278

Burn and corrosion, body region unspecified

124

1.40

0.57

11.2

7.7

24.16

24.52

mmol/l

0.18

117

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

141

1.36

0.57

2.4

10.4

24.73

24.66

mmol/l

0.05

131

HSIL lesion of the cervix uteri

304

2843

1.07

0.56

5.5

6.3

24.26

24.22

mmol/l

0.07

293

2707

Other specified/unspecified nutritional deficiencies

133

1.38

0.56

3.2

7.1

24.20

24.84

mmol/l

0.40

126

Other abnormal products of conception

564

3519

1.05

0.56

5.4

6.5

24.05

24.37

mmol/l

1.41

531

3354

Injury of blood vessels at wrist and hand level

151

1.35

0.56

16.6

10.3

23.55

24.40

mmol/l

0.67

142

Drug-induced headache, not elsewhere classified

1.44

0.55

4.9

7.1

22.94

24.94

mmol/l

1.18

Other disorders of Eustachian tube

655

1.15

0.55

6.8

6.5

24.94

24.51

mmol/l

0.58

626

Abscess of tendon sheath

125

1.39

0.55

4.9

6.1

26.49

24.66

mmol/l

2.35

119

Undescended testicle

125

0.63

0.55

8.4

10.5

26.63

24.01

mmol/l

—

118

Macular hole

176

1616

1.10

0.55

6.6

6.5

24.93

24.59

mmol/l

0.69

171

1541

Need for other prophylactic measures

118

1310

0.90

0.55

2.8

7.8

25.13

24.38

mmol/l

1.19

113

1251

Complications of labour and delivery

1362

7801

0.97

0.54

7.0

6.5

24.50

24.67

mmol/l

1.02

1311

7456

Testicular hypofunction

826

1.13

0.54

10.6

7.9

25.39

24.34

mmol/l

1.71

792

Labour and delivery complicated by fetal stress [distress]

306

2124

0.94

0.53

4.8

6.2

23.44

24.04

mmol/l

2.80

294

2022

Benign lipomatous neoplasm of other sites/unspecified

243

2263

1.08

0.53

7.6

6.6

24.54

24.56

mmol/l

0.02

234

2164

Retinoschisis and retinal cysts

611

1.16

0.53

5.3

6.8

24.28

24.50

mmol/l

0.34

585

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

1.46

0.53

4.5

5.8

25.35

24.50

mmol/l

0.44

Obstructed labour due to maternal pelvic abnormality

316

2973

1.07

0.51

8.4

6.4

24.70

24.79

mmol/l

0.18

303

2839

Maternal care for known or suspected malpresentation of fetus

261

1736

1.07

0.51

5.1

6.3

23.68

24.07

mmol/l

1.11

246

1656

Nonsuppurative otitis media, including avohilmo

678

6107

0.96

0.51

6.4

6.7

24.08

24.36

mmol/l

1.17

659

5821

Benign lipomatous neoplasm of of intra-abdominal organs

1.54

0.51

3.6

7.8

24.45

24.65

mmol/l

—

Other infective (teno)synovitis

1.46

0.51

7.6

7.2

23.92

24.35

mmol/l

0.15

Other noninflammatory disorders of cervix uteri

1103

0.89

0.50

7.1

6.7

24.41

24.79

mmol/l

0.42

1057

Other superficial injuries of ankle and foot

101

1.41

0.50

7.9

5.9

22.59

24.05

mmol/l

0.48

Malignant melanoma, including Hilmo

474

4973

0.95

0.50

5.9

6.7

24.62

24.51

mmol/l

0.25

451

4780

Foreign body granuloma of skin and subcutaneous tissue

1.49

0.50

9.9

5.6

24.70

24.20

mmol/l

0.21

Typhoid and paratyphoid fevers, including avohilmo

119

1.37

0.49

7.8

5.6

25.09

24.78

mmol/l

0.11

114

Urethral stricture

179

1655

1.09

0.49

5.0

7.4

24.70

24.43

mmol/l

0.40

164

1589

Malignant neoplasm of anus and anal canal, including Hilmo

290

1.22

0.49

6.1

23.59

24.65

mmol/l

1.06

281

Acute poliomyelitis

290

1.22

0.49

4.3

6.4

25.19

24.55

mmol/l

0.48

279

Acute poliomyelitis, including avohilmo

290

1.22

0.49

4.3

6.4

25.19

24.55

mmol/l

0.48

279

Defect, injury or illness of lumbar spine

1.48

0.47

10.3

8.4

22.90

25.24

mmol/l

—

Meningococcal infection, including avohilmo

120

0.66

0.46

9.9

5.8

26.66

24.60

mmol/l

—

114

Other bursitis, not elsewhere classified

201

1.26

0.46

4.4

6.5

25.00

24.32

mmol/l

0.62

191

Benign neoplasm of mouth and pharynx

297

2804

1.06

0.46

7.4

6.9

24.61

24.46

mmol/l

0.30

282

2684

Melanocytic naevi of lower limb, including hip

104

941

1.11

0.46

5.9

7.7

24.06

24.45

mmol/l

0.62

895

Colitis, primary sclerosing, strict definition

174

1.28

0.46

13.6

10.4

23.42

24.65

mmol/l

0.93

164

Contact with nonpowered hand tool

110

999

1.11

0.46

8.5

7.5

24.43

24.53

mmol/l

0.11

104

954

Other disorders of carbohydrate metabolism

1.48

0.45

3.0

12.9

22.53

24.85

mmol/l

—

Atypical virus infections of central nervous system

193

1.26

0.44

5.0

7.5

25.92

24.81

mmol/l

0.76

184

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

128

0.69

0.44

3.9

6.2

24.73

24.96

mmol/l

—

118

Delivery

972

5285

0.97

0.44

6.4

6.2

24.57

24.71

mmol/l

0.55

937

5066

Meningitis, viral

1.44

0.44

5.0

12.1

24.65

24.39

mmol/l

0.13

Other noninflammatory disorders of vagina

171

1587

1.08

0.44

5.9

6.4

24.36

24.58

mmol/l

0.38

163

1515

Chronic rhinitis, nasopharyngitis and pharyngitis

881

8532

1.03

0.43

7.1

7.0

24.64

24.50

mmol/l

0.58

850

8175

Tuberculosis of nervous system

1.62

0.43

43.6

7.2

26.70

23.91

mmol/l

—

Tuberculosis of nervous system, including avohilmo

1.62

0.43

43.6

7.2

26.70

23.91

mmol/l

—

Cholinergic urticaria

0.65

0.43

3.7

11.6

25.10

24.37

mmol/l

—

Thyrotoxicosis with toxic single thyroid nodule

162

0.73

0.43

5.0

6.4

23.13

25.01

mmol/l

0.95

154

Heberden's nodes [with arthropathy]

194

1.26

0.43

7.3

6.9

26.36

24.90

mmol/l

1.28

186

Localized adiposity

1.40

0.43

16.9

11.6

24.32

25.09

mmol/l

0.16

Glanders and melioidosis

0.00

0.43

0.0

5.7

—

24.27

—

Glanders and melioidosis, including avohilmo

0.00

0.43

0.0

5.7

—

24.27

—

Toxic effect of other inorganic substances

0.00

0.43

0.0

5.8

—

22.46

—

Vibratory urticaria

0.00

0.42

0.0

10.9

—

25.39

—

Myiasis, including avohilmo

0.00

0.42

0.0

9.5

—

24.87

—

Carcinoma in situ, bladder

119

1093

1.10

0.41

6.8

7.2

24.43

24.39

mmol/l

0.04

112

1043

In situ neoplasms

1302

12702

1.03

0.41

6.0

6.6

24.39

24.54

mmol/l

0.79

1234

12160

Testicular dysfunction

103

940

1.10

0.40

10.3

7.8

25.46

24.44

mmol/l

1.87

905

Bilateral cryptorchidism (undescended testicles)

0.00

0.40

0.0

5.9

—

24.13

—

Other changes in lacrimal passages

1.47

0.40

4.8

5.1

23.96

25.80

mmol/l

—

Atypical virus infections of central nervous system, including avohilmo

196

1.24

0.40

5.0

7.4

25.92

24.75

mmol/l

0.81

187

274

2599

1.06

0.39

12.5

7.1

22.75

24.47

mmol/l

6.31

268

2496

L02BG Aromatase inhibitors

775

7886

0.97

0.38

5.5

6.4

25.20

24.84

mmol/l

2.45

743

7554

Villonodular synovitis (pigmented)

143

1.27

0.38

6.1

10.6

24.11

24.36

mmol/l

0.08

136

Multiple gestation

133

1232

1.08

0.38

7.5

6.6

24.14

24.23

mmol/l

0.13

127

1180

Crushing injury of ankle and foot

1.39

0.37

12.9

6.1

25.48

24.75

mmol/l

0.30

Other disorders of breast and lactation associated with childbirth

180

0.77

0.37

4.3

5.7

24.16

24.01

mmol/l

0.07

172

Other sideroblastic anaemias

0.63

0.36

6.4

5.4

24.92

24.38

mmol/l

—

Delivery, wide proxy

829

4529

0.97

0.36

6.5

6.0

24.27

24.72

mmol/l

2.55

798

4325

Rheumatic heart disease, other

1.43

0.36

2.5

5.1

23.22

23.57

mmol/l

—

Maternal care for other known or suspected fetal problems

336

2010

1.05

0.36

5.7

6.3

23.51

24.05

mmol/l

2.41

318

1921

Other and unspecified disorders of vitreous body

1314

13131

0.98

0.36

6.3

7.0

24.82

24.62

mmol/l

1.39

1258

12599

Other nonthrombocytopenic purpura

236

1.20

0.36

5.4

8.4

24.81

24.46

mmol/l

0.21

224

Carcinoma in situ of breast, intraductal

199

1876

1.06

0.36

5.7

6.6

25.01

24.84

mmol/l

0.28

186

1789

Blepharospasm

218

1.21

0.35

9.7

8.7

24.02

24.48

mmol/l

0.19

209

Medical abortion

1616

8568

1.02

0.35

6.2

24.52

24.66

mmol/l

0.75

1560

8190

Dermatitis due to ingested food

279

1.17

0.35

19.6

5.9

24.41

23.72

mmol/l

0.52

265

Felty syndrome

127

1.28

0.34

14.3

6.2

21.36

24.66

mmol/l

1.55

122

Deaf mutism, not elsewhere classified

100

1.32

0.34

3.2

6.5

25.72

24.34

mmol/l

0.56

Palindromic rheumatism

210

0.80

0.34

3.8

6.6

24.10

24.52

mmol/l

0.17

202

Other congenital malformations of peripheral vascular system

221

0.81

0.34

13.3

8.6

26.80

24.51

mmol/l

0.84

210

Superficial injury of ankle and foot, unspecified

0.67

0.33

25.2

7.1

24.12

24.81

mmol/l

—

Carcinoma in situ of skin of trunk

976

0.92

0.32

6.3

5.9

24.30

24.37

mmol/l

0.07

933

Benign neoplasm: Parathyroid gland

251

0.83

0.32

3.6

6.8

24.89

24.57

mmol/l

0.16

240

Follicular lymphoma, hilmo

117

1091

1.08

0.31

6.6

6.5

25.24

24.39

mmol/l

1.52

110

1042

Respiratory tuberculosis, clinically confirmed

296

1.16

0.31

10.9

7.4

25.81

24.37

mmol/l

0.90

284

Other peripheral vertigo

256

2445

1.05

0.31

5.8

7.0

24.78

24.59

mmol/l

0.35

242

2342

Disorders of pituitary gland, other and/or unspecified

120

1.27

0.31

33.9

10.6

24.08

24.46

mmol/l

0.22

115

Obstructed labour due to malposition and malpresentation of fetus

338

3257

0.96

0.31

6.8

6.5

24.15

24.37

mmol/l

0.66

326

3095

Benign neoplasm: Scapula and long bones of upper limb

185

1.20

0.30

4.1

9.4

25.60

24.59

mmol/l

0.74

175

Medicines for HER+ breast cancer

991

9025

1.02

0.29

5.6

6.4

25.06

24.81

mmol/l

1.63

952

8650

Malignant neoplasm of hypopharynx, including Hilmo

173

0.80

0.29

10.5

5.7

27.04

24.32

mmol/l

1.60

166

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

378

3647

1.04

0.29

6.7

24.01

24.26

mmol/l

0.68

360

3479

Other congenital malformations of male genital organs

1.33

0.28

3.2

12.5

23.18

24.20

mmol/l

—

Use of dimethyl fumarate

1.29

0.28

2.8

7.9

22.35

24.49

mmol/l

1.41

Xanthelasma of eyelid

177

1.20

0.28

7.0

7.6

24.38

24.81

mmol/l

0.26

168

Carcinoma in situ of other and unspecified sites

126

1185

1.07

0.28

6.7

7.1

24.33

24.34

mmol/l

0.01

119

1131

Malignant melanoma of skin, including Hilmo

391

4043

0.97

0.27

6.1

6.8

24.59

24.52

mmol/l

0.13

374

3883

Hypertrophy of (infrapatellar) fat pad

159

1.20

0.27

6.3

10.3

26.45

24.41

mmol/l

1.88

151

Infections with a predominantly sexual mode of transmission

601

6157

0.97

0.27

7.9

6.6

24.49

24.33

mmol/l

0.52

572

5868

Puerperal sepsis

256

2457

1.04

0.26

5.8

6.9

24.78

24.74

mmol/l

0.06

248

2350

Contact with lifting and transmission devices, not elsewhere classified

386

1.12

0.26

8.0

8.5

25.56

24.39

mmol/l

1.87

365

Organ-limited amyloidosis

123

1.24

0.26

4.9

6.0

24.27

24.56

mmol/l

0.10

115

119

1.23

0.25

6.4

4.0

24.32

22.86

mmol/l

0.63

113

Malignant neoplasm of eye and adnexa

198

1.17

0.25

3.7

7.2

25.01

24.98

mmol/l

0.01

191

Degenerative myopia

142

1.21

0.25

5.4

6.4

25.59

25.02

mmol/l

0.24

137

Chronic diseases of tonsils and adenoids

2324

14463

1.01

0.25

6.5

7.2

24.58

24.50

mmol/l

0.58

2218

13852

Abrasion of teeth

979

9979

0.98

0.24

6.4

7.2

24.69

24.61

mmol/l

0.31

939

9561

Congenital malformations of breast

199

1.16

0.23

4.0

5.8

24.63

24.49

mmol/l

0.07

191

Memory loss

246

2554

0.96

0.23

6.6

6.8

24.68

24.57

mmol/l

0.15

235

2443

Alcoholic cardiomyopathy

134

1.21

0.23

14.0

7.8

24.93

24.50

mmol/l

0.12

128

Gilbert syndrome

125

0.79

0.23

15.4

10.1

25.32

24.39

mmol/l

—

119

Gestational diabetes (for exclusion)

570

4018

0.97

0.23

5.7

6.4

23.70

24.22

mmol/l

3.04

548

3826

Other operation for atrial fibrillation

125

1.22

0.23

8.3

7.5

25.65

24.01

mmol/l

0.45

119

LSIL lesion of the cervix uteri

164

1717

0.95

0.22

7.0

6.6

24.33

24.29

mmol/l

0.06

158

1638

Other fluke infections

0.00

0.22

0.0

14.0

—

25.45

—

Open wound of wrist and hand

1295

12699

0.98

0.22

6.3

7.5

24.23

24.43

mmol/l

1.20

1248

12144

Other fluke infections, including avohilmo

0.00

0.22

0.0

14.0

—

25.45

—

Enophthalmos

0.00

0.22

0.0

12.0

—

25.36

—

Other chronic figurate erythema

0.00

0.22

0.0

4.4

—

24.39

—

Carcinoma in situ, other and unspecified urinary organs

0.00

0.22

0.0

4.5

—

25.11

—

Hereditary factor IX deficiency

0.00

0.22

0.0

51.9

—

23.47

—

Myiasis

0.00

0.22

0.0

6.6

—

26.12

—

Other and unspecified disease of Bartholin gland

536

1.09

0.22

4.7

7.1

24.79

24.72

mmol/l

0.04

510

Paget disease

103

0.77

0.21

3.4

6.3

26.22

24.08

mmol/l

—

Other congenital malformations of posterior segment of eye (coloboma)

0.00

0.21

0.0

43.3

—

24.97

—

Congenital absence, atresia and stenosis of small intestine

0.00

0.21

0.0

4.3

—

22.95

—

Tonsillectomy and adenotomy

1294

8864

1.02

0.21

5.5

7.2

24.32

24.36

mmol/l

0.17

1227

8473

Maze procedure for atrial fibrillation

117

1.22

0.21

8.7

7.2

22.71

24.33

mmol/l

1.26

112

Venous complications and haemorrhoids in the puerperium

177

0.84

0.21

8.7

7.3

23.34

25.07

mmol/l

1.34

170

Defect, injury or illness of skull

0.00

0.21

0.0

4.3

—

23.27

—

Ascariasis, including avohilmo

0.00

0.21

0.0

8.2

—

25.22

—

Other otitis externa (chronic)

164

1571

1.05

0.21

5.2

7.2

24.55

24.45

mmol/l

0.12

153

1497

Disorders of visual cortex

0.00

0.21

0.0

5.8

—

23.75

—

L02BA Anti-estrogens

375

3853

0.97

0.20

5.1

6.5

24.77

24.76

mmol/l

0.01

360

3688

Benign neoplasm: Other parts of oropharynx

183

1.16

0.20

7.1

9.4

26.02

24.79

mmol/l

0.66

175

Shigellosis, including avohilmo

115

0.78

0.20

6.1

5.8

24.00

24.88

mmol/l

—

109

Other disorders of male genital organs

899

1.06

0.19

6.0

7.8

24.65

24.24

mmol/l

0.54

861

Pregnancy, childbirth and the puerperium

756

4018

0.98

0.18

6.1

5.8

24.41

24.69

mmol/l

1.20

736

3821

Twin gestation

124

1184

1.05

0.18

8.0

6.6

24.08

24.22

mmol/l

0.20

118

1133

Testicular dysfunction, other/unspecified

110

1.19

0.17

11.7

12.0

26.44

24.21

mmol/l

2.12

103

All dysplastic lesions of the cervix uteri

442

4255

1.02

0.17

5.9

6.3

24.30

24.28

mmol/l

0.04

424

4055

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

0.71

0.17

7.0

5.3

23.22

24.68

mmol/l

—

Other disorders of amniotic fluid and membranes

184

1715

1.04

0.17

6.4

23.49

24.11

mmol/l

1.57

176

1644

Maternal care for known or suspected abnormality of pelvic organs

404

2664

1.02

0.17

5.4

6.3

23.73

24.26

mmol/l

2.62

388

2542

Livedoid vasculitis

1.21

0.16

8.4

12.5

23.25

24.92

mmol/l

0.99

Glaucoma-related operations

164

1584

1.04

0.16

4.7

6.4

23.93

24.49

mmol/l

0.95

159

1510

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.10

0.16

2.5

4.6

22.64

23.70

mmol/l

—

Respiratory and cardiovascular disorders specific to the perinatal period

116

1.16

0.15

10.7

4.3

23.67

22.97

mmol/l

0.30

111

Seminoma of testis, including Hilmo

182

0.87

0.15

7.9

9.4

24.14

24.43

mmol/l

0.16

177

Female infertility, cervical, vaginal, other or unspecified origin

512

3212

1.02

0.15

5.9

7.1

23.93

24.51

mmol/l

3.13

486

3075

Degenerative macular diseases, drug-induced

1.10

0.15

6.9

5.2

23.38

24.68

mmol/l

—

Foreign body on external eye

380

3721

1.02

0.15

7.6

7.7

24.56

24.46

mmol/l

0.28

360

3558

Other and unspecified disorders of pigmentation

129

0.85

0.15

3.5

10.3

24.44

24.48

mmol/l

0.02

122

Benign neoplasm: Prostate

202

0.88

0.15

4.6

6.0

23.74

24.15

mmol/l

0.17

195

Inflammatory disease of cervix uteri

130

1348

0.96

0.14

6.7

6.3

24.69

24.68

mmol/l

0.01

124

1283

L02BB Anti-androgens

297

3038

0.98

0.14

4.4

6.9

23.83

24.23

mmol/l

0.89

280

2917

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

919

0.96

0.13

4.7

7.1

24.30

24.11

mmol/l

0.25

877

Benign neoplasm: Skin, unspecified

908

0.96

0.13

6.6

7.2

23.83

24.43

mmol/l

0.98

871

Other specified transport accidents

113

1.16

0.13

6.1

10.4

25.33

24.59

mmol/l

0.48

104

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

104

1.16

0.12

11.8

10.9

24.53

24.24

mmol/l

0.06

Persons encountering health services in circumstances related to reproduction

1510

10028

1.01

0.12

7.3

7.5

24.63

24.61

mmol/l

0.10

1428

9618

Benign mammary dysplasia

341

3347

1.02

0.12

6.3

6.4

24.75

24.80

mmol/l

0.09

328

3204

Intentional self-harm by hanging, strangulation and suffocation

133

1.14

0.12

5.0

10.5

25.47

24.12

mmol/l

1.54

125

Overjet

238

1.09

0.12

5.4

7.9

22.63

24.04

mmol/l

0.77

225

Idiopathic hypercalciuria

124

1.14

0.11

4.6

8.4

25.31

24.66

mmol/l

0.25

116

Other and unspecified glaucoma

195

1995

0.98

0.11

6.9

6.3

24.23

24.57

mmol/l

0.59

189

1910

Short stature, not elsewhere classified

124

1.12

0.11

3.9

9.6

23.93

23.19

mmol/l

0.23

117

Contraceptive management

974

6740

1.01

0.10

7.0

7.6

24.41

24.60

mmol/l

0.90

930

6475

Acute thyroiditis

1.16

0.09

6.7

7.7

24.45

24.97

mmol/l

—

Benign neoplasm: Vagina

242

1.08

0.09

3.7

6.2

24.90

24.87

mmol/l

0.02

232

Arteriovenous malformation of peripheral vessels

1.16

0.09

13.9

12.8

26.42

24.67

mmol/l

—

138

1.11

0.09

7.5

4.0

24.55

23.06

mmol/l

0.69

132

Triptan medication for migraine, single purchase ok

2032

13835

0.99

0.09

6.6

7.1

24.43

24.61

mmol/l

1.58

1954

13234

Migraine, single triptan purchase ok & required. ICD-code if available is included

2032

13835

0.99

0.09

6.6

7.1

24.43

24.61

mmol/l

1.58

1954

13234

Use of galantamine

255

2593

0.98

0.09

4.4

5.7

24.38

24.41

mmol/l

0.04

245

2481

Congenital malformations of breast, including avohilmo

214

1.08

0.08

4.0

6.0

24.63

24.38

mmol/l

0.15

206

Unattended death

236

0.93

0.08

4.7

6.1

25.61

24.38

mmol/l

0.75

227

Unspecified visual impairment (binocular)

317

0.94

0.08

3.5

8.2

24.85

24.75

mmol/l

0.04

303

Benign neoplasm: Conjunctiva

747

1.03

0.07

7.4

7.3

25.11

24.52

mmol/l

0.64

714

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.87

0.07

12.0

12.5

26.87

24.40

mmol/l

—

Effects of air pressure and water pressure

1.03

0.07

5.6

14.3

24.65

24.72

mmol/l

—

Hereditary sideroblastic anaemia

1.08

0.07

8.6

5.4

26.32

24.37

mmol/l

—

Malignant neoplasm of testis, including Hilmo

354

1.05

0.06

8.3

8.5

24.29

24.32

mmol/l

0.02

338

Pediculosis and phthiriasis, including avohilmo

104

0.86

0.06

5.6

7.3

26.77

24.28

mmol/l

—

Cleft lip and cleft lip and palate

109

1.10

0.06

3.2

11.6

25.25

24.42

mmol/l

0.57

103

Other predominantly sexually transmitted diseases, not elsewhere classified

300

3034

0.99

0.06

7.2

6.8

24.21

24.28

mmol/l

0.13

285

2890

Small cell lung cancer

632

1.03

0.06

6.2

6.3

25.45

24.48

mmol/l

0.77

611

Small cell lung cancer, including Hilmo

632

1.03

0.06

6.2

6.3

25.45

24.48

mmol/l

0.77

611

Retinal detachment with retinal break

385

3814

1.01

0.06

7.0

23.89

24.54

mmol/l

2.53

367

3657

Unspecified transport accident

1.12

0.05

13.4

8.4

24.55

24.76

mmol/l

—

Vascular dementia (sudden onset)

1.12

0.05

3.8

4.9

24.16

24.14

mmol/l

—

Cleft lip and palate

1.12

0.05

3.3

12.0

25.58

24.36

mmol/l

—

Other superficial mycoses, including avohilmo

215

2177

0.99

0.05

6.3

7.1

24.62

24.28

mmol/l

0.75

208

2082

Benign neoplasm: Connective and other soft tissue of thorax

100

1.11

0.05

8.5

7.1

24.14

24.92

mmol/l

0.45

LSIL lesion of the cervix uteri, vagina or vulva

228

2307

0.99

0.05

7.3

6.4

24.58

24.38

mmol/l

0.41

217

2198

Dysplasia of cervi uteri

463

3280

0.99

0.05

6.0

6.9

24.25

24.53

mmol/l

0.90

447

3133

Contact with blunt object, undetermined intent

110

1.10

0.05

6.4

11.5

25.38

24.24

mmol/l

0.67

104

Premenstrual syndrome

169

1.07

0.05

7.3

10.1

24.14

24.12

mmol/l

0.01

163

Small cell lung cancer, helper endpoint

666

0.97

0.05

6.2

6.0

25.45

24.30

mmol/l

0.99

641

Maternal care related to the fetus and amniotic cavity and possible delivery problems

833

4856

1.01

0.04

6.4

6.5

24.36

24.50

mmol/l

0.56

800

4639

Tic disorders

130

1.08

0.04

4.1

10.3

24.09

24.50

mmol/l

0.20

119

Foreign body entering into or through eye or natural orifice

186

1882

0.99

0.04

7.5

7.6

24.71

24.41

mmol/l

0.47

178

1805

Malignant neoplasm of testis

308

1.04

0.04

8.8

8.6

24.44

mmol/l

0.00

294

Acne, including avohilmo

350

2809

1.01

0.04

7.3

6.4

23.95

23.93

mmol/l

0.04

340

2664

Ankylosis of joint

109

0.91

0.04

5.9

5.3

24.57

24.23

mmol/l

—

104

Macular pucker

510

5072

1.01

0.04

6.8

6.9

24.43

24.60

mmol/l

0.54

489

4860

Tic and related disorders

141

1.07

0.03

3.9

9.5

24.41

mmol/l

0.00

129

Graves disease, strict definition

203

2012

1.01

0.03

4.3

7.1

24.62

24.45

mmol/l

0.32

192

1922

Benign neoplasm: Vulva

400

1.03

0.02

5.4

6.7

25.39

24.73

mmol/l

0.66

383

Laparoscopic left hemicolectomy

440

0.98

0.02

11.5

6.8

24.19

24.50

mmol/l

0.25

418

Presence of other devices

769

7542

1.00

0.02

7.0

6.0

24.34

24.56

mmol/l

0.90

739

7212

Complications predominantly related to the puerperium

467

4651

1.00

0.02

5.7

6.5

24.23

24.44

mmol/l

0.63

456

4434

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1083

7946

1.00

0.02

5.5

6.5

24.43

24.58

mmol/l

0.72

1035

7599

Diseases of external ear

1076

10735

1.00

0.02

6.3

6.9

24.65

24.48

mmol/l

0.81

1034

10284

Chronic laryngitis and laryngotracheitis

370

3686

1.00

0.02

7.8

7.2

24.97

24.50

mmol/l

1.47

358

3531

Lower leg

113

1.06

0.02

2.5

6.7

25.37

24.64

mmol/l

0.29

107

Mesial bite

113

1.06

0.02

18.0

10.7

23.68

24.56

mmol/l

0.42

106

Overexertion and strenuous or repetitive movements

228

2292

0.99

0.01

9.7

7.0

24.68

24.44

mmol/l

0.48

221

2192

Allergic contact dermatitis

283

2818

1.00

0.01

6.2

6.4

24.53

24.50

mmol/l

0.05

270

2683

Peroneal tendinitis

267

0.97

0.01

3.9

8.6

25.28

24.97

mmol/l

0.19

260

Intrahepatic Cholestasis of Pregnancy (ICP)

888

0.99

0.01

4.7

7.0

24.30

24.18

mmol/l

0.15

847

Rheumatic fever with heart involvement

114

1.06

0.01

18.4

6.2

25.64

24.73

mmol/l

0.38

109

Unequal limb length (acquired)

116

0.95

0.00

5.2

9.8

23.74

24.21

mmol/l

0.29

108

Injury of nerves at ankle and foot level

126

0.95

0.00

26.1

7.4

28.08

24.65

mmol/l

1.13

119

Pervasive developmental disorders excl. Autism + Asperger

1.06

0.00

2.9

11.3

23.82

24.22

mmol/l

—

Whooping cough, including avohilmo

205

1.03

0.00

3.4

6.1

23.32

24.31

mmol/l

0.55

192

Benign neoplasm: Lip

505

1.01

0.00

6.9

6.3

25.27

24.50

mmol/l

0.76

482

Exposure to ignition of highly flammable material

1.04

0.00

10.1

12.0

26.12

24.40

mmol/l

—

Calcaneal spur

261

1.00

0.00

2.7

6.5

24.76

24.31

mmol/l

0.37

249

Disorders of breast

1220

10732

1.00

0.00

6.4

6.2

24.65

24.67

mmol/l

0.08

1173

10267

Malignant neoplasm of parotid gland

203

0.98

0.00

4.7

6.3

24.61

24.60

mmol/l

0.00

196

Scissor bite

257

1.00

0.00

7.4

8.7

24.83

23.91

mmol/l

0.74

245

Disorders of parathyroid gland, other and/or unspecified

166

1.03

0.00

10.6

6.5

26.08

24.95

mmol/l

0.50

158

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

156

1.03

0.00

5.0

7.3

24.15

24.56

mmol/l

0.38

150

Other deformity of hallux (acquired)

166

1.03

0.00

2.7

6.4

23.43

24.09

mmol/l

0.20

160

Alcohol induced polyneuropathy

244

0.98

0.00

22.8

7.3

26.28

24.31

mmol/l

1.83

233

Toxic effect of noxious substances eaten as seafood

0.00

0.0

6.2

—

26.62

—

Anthrax, including avohilmo

0.00

0.0

7.2

—

26.49

—

Fetal blood loss

0.00

0.0

3.6

—

23.86

—

Other protozoal diseases, not elsewhere classified/unspecified

0.00

0.0

90.2

—

24.25

—

Systemic disorders of connective tissue in diseases classified elsewhere

1.02

0.00

4.1

5.9

23.11

24.10

mmol/l

—

Zygomycosis

0.00

0.0

4.2

—

23.20

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

0.97

0.00

2.3

4.6

22.24

23.70

mmol/l

—

Other disorders of intestinal carbohydrate absorption

0.00

0.0

4.0

—

24.38

—

Acute hepatitis A, including avohilmo

0.96

-0.00

11.8

12.9

25.29

24.88

mmol/l

—

Pedal cyclist injured in collision with train or tram

0.00

-0.00

0.0

8.9

—

22.14

—

Digestive system disorders of fetus and newborn

0.00

-0.00

0.0

10.0

—

24.30

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.90

-0.00

14.0

6.4

23.16

24.52

mmol/l

—

Aortic hypoplasia

0.00

-0.00

0.0

62.1

—

24.71

—

Pneumoconiosis associated with tuberculosis

0.00

-0.00

0.0

4.8

—

23.42

—

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

-0.00

0.0

3.9

—

23.27

—

Anthrax

0.00

-0.00

0.0

7.1

—

26.97

—

Tetralogy of Fallot, a congenital heart defect.

0.98

-0.00

7.2

9.7

25.00

24.59

mmol/l

—

Other respiratory conditions originating in the perinatal period

0.00

-0.00

0.0

2.3

—

24.37

—

Other conditions of integument specific to fetus and newborn

0.00

-0.00

0.0

2.6

—

26.24

—

Beau lines

0.00

-0.00

0.0

17.4

—

25.20

—

Other perinatal digestive system disorders

0.00

-0.00

0.0

12.8

—

24.15

—

Chlamydia psittaci infection

0.00

-0.00

0.0

3.1

—

24.87

—

Apocrine sweat disorders, other sweat gland disorders

0.92

-0.00

4.8

7.2

23.29

24.98

mmol/l

—

Pustulosis subcornealis

0.00

-0.00

0.0

5.0

—

26.21

—

Intracranial laceration and haemorrhage due to birth injury

0.00

-0.00

0.0

11.5

—

22.47

—

Hereditary factor XI deficiency

0.00

-0.00

0.0

3.3

—

23.16

—

Androgen resistance syndrome

0.00

-0.00

0.0

3.8

—

22.57

—

Plasmodium malariae malaria, including avohilmo

0.00

-0.00

0.0

2.4

—

25.80

—

Leptospirosis

0.00

-0.00

0.0

5.1

—

22.11

—

Trichuriasis

0.00

-0.00

0.0

7.1

—

27.31

—

Interstitial emphysema and related conditions originating in the perinatal period

0.00

-0.00

0.0

4.3

—

24.25

—

Acquired keratosis follicularis

0.00

-0.00

0.0

6.0

—

24.52

—

Leptospirosis, including avohilmo

0.00

-0.00

0.0

5.1

—

22.11

—

Chlamydia psittaci infection, including avohilmo

0.00

-0.00

0.0

3.1

—

24.87

—

Other disorders of blood and blood-forming organs in diseases classified elsewhere

0.00

-0.00

0.0

6.9

—

25.11

—

Explosion of other materials

0.90

-0.00

2.2

7.4

21.25

23.62

mmol/l

—

Granuloma inguinale

0.00

-0.00

0.0

5.8

—

25.65

—

Trichuriasis, including avohilmo

0.00

-0.00

0.0

7.1

—

27.31

—

Reduction defects of lower limb, including avohilmo

0.98

-0.00

6.2

6.7

26.25

24.71

mmol/l

—

Plasmodium malariae malaria

0.00

-0.00

0.0

2.4

—

25.80

—

Laboratory evidence of human immunodeficiency virus [HIV]

0.00

-0.00

0.0

9.8

—

24.43

—

Benign neoplasm: Floor of mouth

0.96

-0.00

7.9

7.5

25.11

24.87

mmol/l

—

Ascariasis

0.00

-0.00

0.0

4.8

—

24.45

—

Zygomycosis, including avohilmo

0.00

-0.00

0.0

4.2

—

23.20

—

Neuropathic heredofamilial amyloidosis

0.00

-0.00

0.0

7.5

—

25.65

—

Macular hole, drug-induced

0.00

-0.00

0.0

3.3

—

22.82

—

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

0.89

-0.00

13.4

8.1

26.79

24.94

mmol/l

—

Haemophagocytic syndrome, infection-associated

0.00

-0.00

0.0

1.7

—

26.68

—

Granuloma inguinale, including avohilmo

0.00

-0.00

0.0

5.5

—

25.56

—

Disorders of glycosaminoglycan metabolism, other/unspecified

0.00

-0.00

0.0

3.6

—

21.15

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Bicarbonate [Moles/volume] in Arterial blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS